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Peptidoglycan is the major structural component of the bacterial cell wall; essential for 
viability and shape determination. This crucial function makes peptidoglycan synthesis 
an important target for antibiotics such as penicillin. In order to develop novel 
antimicrobials, especially against drug resistant Staphylococcus aureus it is important 
to understand peptidoglycan dynamics at the molecular level. S. aureus makes 
peptidoglycan primarily during septation and divides on 3 orthogonal planes resulting 
in cell wall sectoring, with each cell having material of different ages. However, how 
peptidoglycan is biosynthesised at the molecular level is still not understood. 
In order to approach the issue of peptidoglycan synthesis I have used a combination of 
novel probes and fluorescence microscopy. A range of fluorescent probes, based on 
analogues of peptidoglycan constituents were used in order to allow imaging. I have 
used 2 new microscopy approaches, structured illumination microscopy (SIM) and 
stochastic optical reconstruction microscopy (STORM). Previously unresolved features 
of peptidoglycan synthesis were revealed.  Firstly, peptidoglycan synthesis occurs as a 
zone across the septum, secondly, there is an apparent split in the septum at the 
mother cell wall-septum interface and finally synthesis is not confined to the septum 
but occurs throughout the cell wall. 
As well as molecular level information my study has given cellular level insights. The 
dynamics of peptidoglycan insertion showed progression of synthesis during a division 
cycle and the inheritance of material over several generations. It was observed that 
within a population there is a degree of heterogeneity in peptidoglycan insertion both 
at the cellular and population level. The existence of transiently non-growing cells 
within larger exponentially growing population alluded to the presence of potential 
persisters, able to withstand environmental assault. My work has led to a 
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Chapter 1  
Introduction 
 
1.1 The bacterial cell envelope 
Bacterial cells exist within demanding and dynamic environments. To survive they have 
evolved a sophisticated, multi-layered structure to protect them, yet permit 
interaction with the environment e.g. for nutrient acquisition and waste removal 
(Silhavy et al., 2010). Species within the bacterial kingdom fall mainly into one of two 
groups due to the structure of the cell envelope; Gram negative and Gram positive 
(Figure 1.1). 
 Gram negative 
The Gram negative cell wall consists of three primary layers; the outer membrane, the 
peptidoglycan, and the cytoplasmic membrane (Figure 1.1 A). The two membranes 
define the periplasm, a cellular compartment containing a specific set of proteins and 
processes (Hoppert and Mayer, 1999). The cytoplasmic membrane, common to both 
Gram positive and negative bacteria, is composed of a phospholipid bilayer and is the 
site of many important cellular processes such as energy production and lipid 
biosynthesis (Silhavy et al., 2010). In comparison, the outer membrane of Gram 
negative bacteria is composed of a mixture of phospholipids comprising the inner 
leaflet and lipopolysaccharide composing the outer leaflet (Kamio and Nikaido, 1976). 
The peptidoglycan is an essential, more rigid exoskeleton which is required to 
withstand internal turgor pressure to maintain cell shape (Vollmer and Höltje, 2004). 
Peptidoglycan is a polymer containing glycan strands crosslinked by peptide sidechains 
(Vollmer et al., 2008a). In Gram negative bacteria this peptidoglycan layer is 
approximately 2-6 nm thick (Vollmer and Seligman, 2010). 
 Gram positive 
The Gram positive cell envelope differs from that of the Gram negative bacteria mainly 




Figure 1.1. General Structure of the Gram positive and Gram negative cell envelopes. 




is the protection of Gram negative bacteria from the environment. To replicate this the 
peptidoglycan layer of Gram positive bacteria is many times thicker than that of Gram 
negatives (Silhavy et al., 2010). In fact, Gram positive peptidoglycan comprises 
approximately 30-70% of the cell wall and it is ~ 20-35 nm thick (Schleifer and Kandler, 
1972). The cell wall of the Gram positive bacteria is often decorated with secondary 
anionic polymers called teichoic acids (Navarre and Schneewind, 1999). These can 
either be covalently attached to the peptidoglycan (wall teichoic acids, WTAs) or 
anchored via the head groups of the membrane lipids (lipoteichoic acids, LTAs) 
(Neuhaus and Baddiley, 2003). It was initially thought that Gram positive bacteria 
would lack a periplasm however, a periplasmic space exists between the cytoplasmic 
membrane and the peptidoglycan of the cell wall (Matias and Beveridge, 2007).  
1.2 Chemical structure of peptidoglycan 
Peptidoglycan is composed of polymeric glycan strands crosslinked by peptide 
sidechains. Glycan strands are comprised of alternating N-acetlyglucosamine (GlcNAc) 
and N-acetylmuramic acid (MurNAc) residues linked by β 1-4 glycosidic bonds. The 
lactyl group of the MurNAc residue is substituted by a peptide side chain consisting of 
both ᴅ- and ʟ- isoforms of amino acids (Vollmer et al., 2008a). The muropeptide 
structure of Staphylococcus aureus is shown in Figure 1.2. 
 Glycan strands 
The glycan strands are produced via oligomerisation of lipid II through the 
transglycosylation reaction. This glycan strand structure is conserved among bacterial 
species and the major variation comes from distribution of glycan chain length. The 
average glycan chain length does not correlate with cell wall thickness as 
Staphylococcus aureus has characteristic short glycan chains while Bacillus subtilis has 
long glycan chains despite peptidoglycan of relatively similar thicknesses (Boneca et al., 
2000; Hayhurst et al., 2008). S. aureus glycans have been shown to contain 
approximately 3 – 10 disaccharides with the average glycan chain containing 6 
disaccharides (Boneca et al., 2000). In addition, 10-15% of S. aureus glycan chains 
contained more than 26 disaccharides. However, B. subtilis has glycan strands up to 5 
µm in length which are longer than the bacterium itself (Hayhurst et al., 2008). Glycan 




Figure 1.2. Muropeptide structure of S. aureus. Monomer of peptidoglycan as 




example, S. aureus may have either MurNAc or GlcNAc at the reducing terminus, 
suggesting enzymatic cleavage of glycan strands (Boneca et al., 2000). In all Gram 
negatives and some Gram positives glycan strands can be terminated by 1,6-
anhydroMurNAc (Figure 1.3; red box)(Vollmer and Bertsche, 2008). 1,6-
anhydroMurNAc can be produced by a lytic transglycosylase reaction converting the 
glycosidic bond between MurNAc and GlcNAc but whether termination of glycan 
strands occurs via lytic transglycosylation of the polymerised strand or formed at the 
growing end of the strand remains unclear (Höltje, 1998; Höltje et al., 1975). MltG, an 
endolytic transglycosylase, was recently discovered to play a role in termination of 
Escherichia coli glycan strands via association with the biosynthetic machinery and 
cleavage of nascent peptidoglycan (Yunck et al., 2015). 
The glycan chains of bacteria also show some specific modifications in addition to 
diversity in glycan chain length distribution (Figure 1.3). Glycan strands have been 
shown to be N-deacetylated at both residues, O-acetylated and N-glycolylated at 
MurNAc, all of which have different physiological effects (Vollmer, 2008). Deacetylated 
peptidoglycan is a poor substrate for lysozyme (a host defence enzyme) as well as 
increasing the positive charge of the peptidoglycan, potentially also effecting 
interaction with the host (Atilano et al., 2010; Vollmer, 2008). N-glycolylation causes 
the acetate group of MurNAc to be modified to a glycolyl group (Figure 1.3; red circle), 
occurring mainly in bacteria containing mycolic acid e.g. Mycobacteria (Vollmer, 2008). 
The physiological effect of this is not understood although the addition of an extra 
hydroxyl group increases the hydrogen bonding potential and may influence cell 
envelope stability (Brennan and Nikaido, 1995). O-acetylation occurs on the C6-OH of 
MurNAc and has not been found on GlcNAc residues (Figure 1.3; green circle)(Vollmer, 
2008). It renders peptidoglycan resistant to lysozyme digestion in an O-acetylation 
concentration dependent manner (Clarke and Dupont, 1992). In addition, the O-
acetylation levels can control endogenous peptidoglycan hydrolase activity (Moynihan 
and Clarke, 2011). The components involved in the O-acetylation process have thus 
been proposed as new antibiotic targets (Moynihan and Clarke, 2013). 
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 Peptide sidechains 
There is a greater extent of variation among the peptide side chains of peptidoglycan 
than within the glycan strands. Variation occur either due to specificity of the peptide 
biosynthesis pathway or can occur at a later step during peptidoglycan assembly 
(Vollmer et al., 2008a). The peptide side chain generally has the composition of ʟ-Ala-γ-
ᴅ-Glu-m-DAP-ᴅ-Ala-ᴅ-Ala in the nascent peptidoglycan (Bouhss et al., 2008). The 
second amino acid, ᴅ-glutamic acid, is unusually linked via its γ-carboxyl group to the 
3rd amino acid (Figure 1.2)(Schleifer and Kandler, 1972). The greatest variability occurs 
at the 3rd amino acid which is often ʟ-Lysine in Gram positive bacteria (Figure 1.2), 
although it can also be other diamino or monoamino acids (Vollmer et al., 2008a). The 
terminal ᴅ-amino acid is also sometimes altered, particularly to ᴅ-Lactate which 
confers vancomycin resistance (Courvalin, 2006). Modifications to the peptide side 
chain often occur at the lipid II linked level. For example, the ᴅ-Glu α-carboxy group is 
amidated in S. aureus in an essential process mediated by the GatD/MurT enzyme 
(Figueiredo et al., 2012; Münch et al., 2012). 
Other variations occur not within the peptide side chain but within the crossbridge 
(Schleifer and Kandler, 1972). Most bacterial species crosslink between the 3rd amino 
acid of one strand with the 4th amino acid of the next, however in coryneform bacteria 
this occurs between the 2nd and the 4th (Schleifer and Kandler, 1972). Some bacteria 
e.g. E. coli have a direct crosslink while other bacteria can have a cross bridge 
containing up to 7 amino acids, including some branched cross bridges (Vollmer et al., 
2008a). S. aureus peptidoglycan contains a pentaglycine cross bridge forming a 3-4 
crosslinkage (Shockman and Barrett, 1983). S. aureus also has highly crosslinked 
peptidoglycan, between 70-80%, mainly due to the action of PBP4 (Snowden and 
Perkins, 1990; Wyke et al., 1981). 
1.3 Teichoic acids 
Teichoic acids are anionic glycopolymers that decorate the cell envelope of Gram 
positive bacteria and are linked to either peptidoglycan (WTAs) or to the cytoplasmic 
membrane (LTAs) (Xia et al., 2010). WTAs are linked to the C6 OH group of 






Figure 1.3. Modifications of glycan residues. Structure of unmodified residues (green box), glycan modifications and the structure of 1,6-
anhydro MurNAc (red box). Adapted from (Vollmer, 2008). 
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box) (Brown et al., 2013). They consist of a disaccharide linkage unit appended to 
polyribitol phosphate (polyRboP) or polyglycerol phosphate (polyGroP) containing up 
to 60 repeats (Silhavy et al., 2010). In bacteria the structure of WTA varies between 
species and strains however, S. aureus WTA is linked to MurNA via GlcNAc-1-P an N-
acetylmannosamine (ManNAc), which is followed by 2 polyGroP residues and 11-40 
residues of polyRboP dependent upon the strain (Figure 1.4 A) (Xia et al., 2010). OH 
groups on the polyRboP are regularly decorated with substitutions e.g. ᴅ-alanine and 
glycosyl moieties, which play a role in WTA function (Silhavy et al., 2010). The LTA of S. 
aureus is linked to the cytoplasmic membrane via a glycolipid anchor which is 
diglucosyl diacylglycerol in the case of most staphylococci (Figure 1.4 B) (Xia et al., 
2010). Most LTAs are formed of repeating polyGroP residues that can be decorated in 
the same manner as in WTAs (Silhavy et al., 2010).  
Together WTAs and LTAs contribute to a negative charge on the cell surface. This is an 
important feature for bacterial survival because while bacteria can survive the deletion 
of WTA or LTA separately, albeit with morphological defects, they are synthetically 
lethal and strains cannot survive without any teichoic acids (Silhavy et al., 2010). LTA 
deficient S. aureus strains can only survive in high sucrose or salt media, due to the 
osmoprotectant nature of such growth conditions (Corrigan et al., 2011). Some of the 
roles of WTAs include regulation of cell morphology & division, regulation of 
peptidoglycan autolysins and protection from host defences/antibiotics (Brown et al., 
2013). In particular S. aureus strains that lack ᴅ-alanine have an increased susceptibility 
to phagocytes and neutrophil killing (Collins et al., 2002). 
1.4 Peptidoglycan synthesis 
Peptidoglycan synthesis follows a common pathway across both Gram positive and 
Gram negative bacteria (Bugg et al., 2011; Lovering et al., 2012). The process can be 
split into 3 overall stages; precursors are synthesised in the cytoplasm, lipid-linked 
muropeptides are assembled and flipped across the membrane, monomers are 
polymerized and the resulting glycan strands are inserted into the mature 
peptidoglycan (Figure 1.5)(Typas et al., 2012). The enzymes involved in the 
biosynthetic pathway are essential and have no known mammalian homologs 





Figure 1.4 Chemical structures of S. aureus teichoic acids. (A) Wall teichoic acid, 
decorations of poly(RboP) are noted by red A & B, A= α or β GlcNAc, B=ᴅ-Alanine or 
Hydrogen. Based on (Swoboda et al., 2010).(B) Lipoteichoic acid, GlcNAc and ᴅ-Alanine 







Figure 1.5. Peptidoglycan biosynthetic pathway. Precursors are synthesised in the 
cytoplasm, translocated across the cytoplasmic membrane and inserted into the 
peptidoglycan sacculus through transglycosylase (TGase) and transpeptidase(TPase) 




 Cytoplasmic steps of precursor biosynthesis 
Peptidoglycan synthesis is initiated in the cytoplasm with the formation of soluble 
nucleotide precursors (Figure 1.5) (Bouhss et al., 2008). The first step is the transfer of 
a enolpyruvyl moiety to UDP-GlcNAc (Uridine diphosphate-GlcNAc) catalysed by MurA 
(Lovering et al., 2012). This is followed by the Flavin dependent reductase reaction of 
MurB to convert the MurA product into UDP-MurNAc (Bugg et al., 2011; Lovering et 
al., 2012). The pentapeptide is then synthesised via the ATP-dependent Mur ligases, 
Mur C-F, that add each amino acid in a stepwise manner (Bouhss et al., 2008; Lovering 
et al., 2012). UDP-MurNAc-pentapetide is then linked to the transport lipid, 
undecaprenyl-phosphate (also known as bactoprenol), on the cytoplasmic side of the 
membrane via MraY (van Dam et al., 2009). This produces undecaprenyl-
pyrophosphate -MurNAc-pentapeptide, also known as lipid I (Typas et al., 2012). Lipid I 
is then converted to lipid II via the transfer of GlcNAc from UDP-GlcNAc to lipid I 
catalysed by MurG (Bouhss et al., 2008). In E. coli there are only approximately 700 
molecules of lipid I per cell which suggests that there is an interaction between MraY 
and MurG (Bouhss et al., 2004; van Heijenoort, 2007). The S. aureus peptidoglycan 
muropeptide is modified by the addition of a pentaglycine sidechain, involved in the 
crosslinking of peptidoglycan (Qiao et al., 2014). The femABX genes have been shown 
to be required for addition of glycines into the pentaglycine bridge with FemX 
catalysing the addition of the first glycine, FemA catalysing the addition of the 
subsequent two glycines and FemB catalysing the addition of the final two glycines 
(Bouhss et al., 2008). This requires both lipid II and glycyl tRNA therefore this process 
occurs in the cytoplasm immediately following conversion of lipid I to lipid II but prior 
to flipping of lipid II to the cell surface (Bouhss et al., 2008). In addition, the amidation 
of ᴅ-glu by GatD/MurT occurs at the lipid II level (Figueiredo et al., 2012; Münch et al., 
2012). 
 Translocation of lipid II 
Lipid II is entirely assembled on the inner leaflet of the cytoplasmic membrane and so 
this hydrophilic molecule must cross the hydrophobic cytoplasmic membrane (Figure 
1.5)(van Heijenoort, 2007; Young, 2014). In addition, the pool of lipid II is limited, 
about 1,000-2,000 molecules in E. coli and while increased in other organisms with 
higher peptidoglycan content it remains low (van Heijenoort, 2007). In fact, in Gram 
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positive bacteria such as S. aureus, the lipid II pool is less than 1 mole percent of the 
phospholipid content of the cytoplasmic membrane (Ruiz, 2015). Therefore lipid II 
translocation must be fast and efficient and must require a flippase to act as a 
mechanism of passage for the hydrophilic moiety (Ruiz, 2015). 
The identity of such a flippase has been the source of some controversy (Scheffers and 
Tol, 2015). There are two prospective candidates for the flippase, first the FtsW/RodA 
type and secondly the MurJ/AmJ type. FtsW/RodA are integral membrane proteins 
belonging to the shape, elongation, division and sporulation (SEDS) protein family 
(Ruiz, 2015). In addition the ftsW gene is found in an operon associated with 
peptidoglycan synthesis (Young, 2014). The evidence for FtsW as the lipid II flippase is 
that membrane vesicles extracted from E. coli have lipid II translocation that correlates 
with the amount of FtsW and also purified FtsW facilitates translocation of lipid II in 
large unilamellar vesicles (Mohammadi et al., 2011). However, in this system MurJ did 
not cause lipid II translocation (Mohammadi et al., 2011). The evidence for MurJ 
conversely comes from in vivo work where inactivation or depletion of murJ resulted in 
a decrease in lipid II translocation as measured by amount of colicin M (ColM) cleaved 
lipid II product (Sham et al., 2014). Lipid II was found to instead accumulate on the 
inner leaflet of the membrane (Sham et al., 2014). In the in vivo system, lipid II 
translocation was maintained on FtsW depletion in a ΔrodA background, although 
some remaining active FtsW could be present in this case (Sham et al., 2014). The murJ 
ortholog in Gram positive bacteria (ytgP) was shown to be essential in S. aureus and 
Streptococcus pneumoniae but not in B. subtilis as a strain missing all four ytgP 
homologs remained viable. However a protein with redundancy to YtgP called AmJ was 
discovered to be synthetically lethal, therefore suggesting that MurJ/AmJ could in fact 
be the flippase (Ruiz, 2015). Both the experimental systems used have limitations and 
it remains a possibility that both the FtsW/RodA and MurJ/AmJ proteins could act as 
the lipid II flippases in vivo. 
 Incorporation of Lipid II into peptidoglycan 
Once lipid II has been translocated to the outer leaflet, it is polymerized into glycan 
strands by transglycosylase activity (Figure 1.5)(Lovering et al., 2012). There are two 
types of transglycosylases in bacteria, monofunctional and bifunctional enzymes, 
bifunctional enzymes usually also possess transpeptidase activity and are therefore 
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called Class A PBPs (Lovering et al., 2012; Typas et al., 2012). S. aureus possesses one 
bifunctional PBP (PBP2) and two monofunctional transglycosylases (MGT and SgtA) 
(Reed et al., 2015). Polymerisation occurs via the formation of a glycosidic bond 
between the lipid-anchored MurNAc on the growing nascent glycan strand and the 
GlcNAc on the lipid II molecule (Fuchs-Cleveland and Gilvarg, 1976; Ward and Perkins, 
1973). At this point undecaprenyl-pyrophosphate is released from the peptidoglycan 
subunit and transported back to the cytoplasmic side. It is then dephosphorylated and 
recycled back into the synthesis pathway to form new lipid I molecules (van Dam et al., 
2009).  
Once glycan strands have been polymerised, crosslinking occurs via the transpeptidase 
activity of PBPs linking peptide units in adjacent glycan strands (Figure 1.5) (Lovering et 
al., 2012). This reaction occurs via the hydrolysis of the terminal ᴅ-ala of the donor 
strand forming an acyl-enzyme intermediate. This is resolved by the crosslinking with 
the amino group either from the third amino acid in the peptide strand of an acceptor 
strand or the N-terminal peptide of the acceptor strand crossbridge (Lovering et al., 
2012).  
1.5 Peptidoglycan hydrolysis 
Hydrolases exist that are able to specifically cleave the many different bonds found 
within bacterial peptidoglycan (Ghuysen, 1968). These can originate from the 
bacterium on which they act and are termed autolysins. They are also produced by 
other organisms, including other bacteria and eukaryotes (Ghuysen, 1968). There are 
examples of peptidoglycan hydrolases for every glyosidic and amide bond within 
peptidoglycan although not every species contains each of them (Figure 1.6)(Vollmer 
et al., 2008b). 
 Glycosidases 
Enzymes which catalyse the cleavage of the glycan backbone are known as 
glycosidases and fall into two main categories; glucosaminidases and muramidases 
depended on which of the two bonds they break (Figure 1.6 A)(Vollmer et al., 2008b). 
Glucosaminidases hydrolyse the bond between GlcNAc and MurNAc resulting in a 




Figure 1.6. Action of peptidoglycan hydrolases on the glycan backbone (A) and 




bacteria and are found not only as peptidoglycan hydrolases but also able to cleave the 
bond between N-acetyl glucosamine residues and adjacent monosaccharides in several 
polymers (Vollmer et al., 2008b). Muramidases cleave the β1,4-glycosidic bond 
between MurNAc and GlcNAc and can use one of two different mechanisms for this; 
Lysozyme-like enzymes that result in a terminal reducing MurNAc or lytic 
transglycosylases that cleave the bond with an intramolecular transglycosylase 
reaction resulting in the formation of the 1,6-anhydroMurNAc residue (Vollmer et al., 
2008b). 
 Amidases and peptidases 
Within the peptide side chain there are two bond types for which peptidoglycan 
hydrolases exist; the amide bond between MurNAc and the peptide side chain and the 
peptide bonds within the sidechain itself (Figure 1.6 B). Hydrolases that cleave the 
amide bond are known as N-acetyl-ʟ-alanine amidases (Ami)(Heidrich et al., 2001). 
Many species encode several versions of this protein, e.g. E. coli has five homologs 
within its genome (Heidrich et al., 2001; Uehara and Park, 2007). These amidases have 
been shown to play an important role in septum cleavage during cell division (Heidrich 
et al., 2001). Alternatively, the enzymes that cleave bonds between amino acids in 
both peptidoglycan and soluble peptidoglycan fragments are known as peptidases. 
These are known as carboxypeptidases (CPases) and endopeptidases (EPases) which 
catalyse the removal of the C-terminal amino acid and cleavage within the peptide 
respectively (Vollmer et al., 2008b).  
 The physiological role of peptidoglycan hydrolases 
There is a great deal of redundancy among the peptidoglycan hydrolases suggesting 
important or essential roles in many bacterial functions (Typas et al., 2012). The 
majority of these functions are within vegetative growth and division of bacteria but 
they are also involved in more specialised processes such as interactions between 
bacteria & their hosts and differentiation (Smith et al., 2000; Stapleton et al., 2007). A 
number of different studies have shown that hydrolases play a role in shape 
determination, peptidoglycan thickness and are essential for daughter cell separation 
during cell division (Typas et al., 2012). 
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During vegetative growth, E. coli removes up to 40-50% of total peptidoglycan during 
each generation via peptidoglycan turnover (Höltje and Heidrich, 2001). This value is 
reduced in hydrolase mutants, suggesting a role of these proteins in the turnover 
process (Kraft et al., 1999). This suggests a system of tightly coordinated peptidoglycan 
synthesis and hydrolysis and therefore growth should cease on hydrolase inactivation 
(Höltje, 1998). However due to the high degree of redundancy within the hydrolase 
system and essentiality of the synthesis and hydrolysis processes in cell growth it is 
difficult to assess the contributions of individual enzymes. 
E. coli encodes 3 hydrolytic enzymes that were found to act as endopeptidases. They 
are redundantly essential for growth and viability, as a conditional triple mutant is 
unable to incorporated new peptidoglycan and undergoes rapid lysis (Singh et al., 
2012). Two enzymes, MepS and MepH (formally Spr & YdhO respectively) were found 
to be members of the NlpC/P60 peptidase superfamily while the third, MepM 
(formally YebA) was part of the lysostaphin superfamily (Singh et al., 2012, 2015). 
These enzymes act to cleave the peptidoglycan cross-links therefore this process is 
thought to be essential for cell wall expansion (Singh et al., 2012). MepS was found to 
be modulated by rapid proteolytic degradation by a membrane 
lipoprotein/periplasmic protease system known as NlpI-Prc (Singh et al., 2015). NlpI-
Prc may also have a role in the formation of cross links suggesting that the NlpI-Prc 
control system may facilitate the concomitant cleavage and synthesis of cross links 
allowing expansion of the sacculus (Singh et al., 2015). 
Two endopeptidases from B. subtilis, CwlO & LytE were also shown to be synthetic 
lethal partners. A double mutant is not viable and depletion of either protein within a 
conditional mutant leads to defects in lateral cell wall synthesis (Bisicchia et al., 2007). 
This was shown to be due to the lack of ᴅ,ʟ-endopeptidase activity at the cylinder as 
the synthetic lethality could be suppressed by localisation of alternative ᴅ,ʟ-
endopeptidases, LytE & CwlS at the cylinder (Hashimoto et al., 2012). Similarly, S. 
aureus expresses 4 synthetically lethal glucosaminidases that are required for growth 
(Wheeler et al., 2015). 
Another role is the regulation of cell growth by ᴅᴅ-carboxypeptidases. In B. subtilis 
PBP5 (DacA) acts as a ᴅᴅ-carboxypeptidase and controls the amount of tetrapeptide 
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sidechains in peptidoglycan (Atrih et al., 1999). This suggests a role of PBP5 in the 
maturation of B. subtilis peptidoglycan. Deletion of PBP5 does not affect either the 
growth or morphology of vegetative cells however spores of the mutant were 10-fold 
less heat resistant and had an altered spore cortex structure suggesting an additional 
role of PBP5 in cortex synthesis (Todd et al., 1986). In E. coli, deletion of ᴅᴅ-
carboxypeptidase activity results in alteration of cell shape and aberrant z-ring 
formation (Nelson and Young, 2001; Potluri et al., 2012). In addition to cell growth and 
maintenance of cell shape, peptidoglycan hydrolases are also essential to the cell 
splitting process (Chapter 1.9.3). 
1.6 Cell division 
Cell division is a fundamental process by which a parental cell divides into 2 daughter 
cells (Figure 1.7).  Genetic information must be faithfully copied and equally divided 
between the daughter cells. Within the bacteria this process involves the coordinated 
action of multiple proteins forming a complex known as the divisome (Wu and 
Errington, 2011). 
 Cell division in rod-shaped bacteria 
Cell division in bacteria is a complex process which requires not only the replication 
and division of the intracellular contents such as DNA etc. but also the formation of a 
new cell envelope barrier between the daughter cells (Errington et al., 2003). 
Therefore, the entirety of the cell envelope layers must be remodelled to form the 
septum. In rod shaped bacteria, prior to cell division cells elongate to increase cell size 
while maintaining a constant diameter. This elongation is mediated by a version of the 
divisome known as the elongasome that directs lateral insertion of peptidoglycan 
along the long axis of the cell (Szwedziak and Löwe, 2013). 
Only once rod-shaped bacteria such as E. coli and B. subtilis reach a minimum cell 
length will cell division take place (Donachie and Begg, 1989; Sharpe et al., 1998). At 
this point the replicated chromosomes will separate to opposite poles of the dividing 
bacteria allowing the formation of a septum at the midcell (Donachie and Begg, 1989; 
Errington et al., 2003). Following septal completion, daughter cells are split due to the 









 Selection of division plane in rod shaped bacteria 
Determination of division plane selection needs to be controlled both temporally and 
spatially. Temporal selection ensures the correct cell length is reached and therefore 
requires coordination between growth rate and cell size. Nutrient availability is a 
strong determinant of cell size (Weart et al., 2007). Bacteria require the ability to 
determine when they have reached an appropriate size for a given growth rate and 
then transmit this to the divisome in order to initiate cell division (Weart et al., 2007). 
One such mechanism is the effector UgtP in B. subtilis that localises to the division site 
in a nutrient dependent manner & inhibits the assembly of FtsZ (Weart et al., 2007). 
When there are high levels of nutrients UgtP is highly expressed and distributed 
throughout the cell where it may inhibit FtsZ assembly or prolong the period between 
FtsZ ring formation and cytokinesis however, when nutrient levels are low, UgtP is not 
as highly expressed therefore FtsZ mediated division continues without inhibition 
allowing division at a smaller cell size (Weart et al., 2007). 
In theory cell division could take place at any point along the length of the rod-shaped 
cell however in practice localisation of FtsZ occurs at the midcell with high accuracy 
(Migocki et al., 2002). Therefore, control mechanism(s) must exist that ensure midcell 
placement. One such mechanism is the Min system, that when deleted leads to the 
formation of mini cells due to the placement of division septa towards the pole (de 
Boer et al., 1989). In E. coli this system consists of three proteins MinC, MinD and 
MinE. MinCD forms a complex which is a negative regulator of the z-ring. This is 
spatially regulated by MinE, a topological specificity factor that prevents MinC activity 
at the midcell (Raskin and de Boer, 1997). MinC and MinD oscillate from pole to pole in 
an MinE dependent manner, thereby the time-integrated concentration of MinC is 
highest at cell poles causing pole-specific negative regulation of FtsZ (Hu and 
Lutkenhaus, 1999). In B. subtilis homologs of MinCD are present, but not a homolog of 
MinE. However the topological specificity factor has been identified as DivIVA, which 
similarly to MinE has an affinity for phospholipids however, binds preferentially to 
strongly curved cell membranes and thus recruits MinCD to the poles (Bramkamp et 
al., 2008; Lenarcic et al., 2009). However the Min system has been shown to be not 
required for the precise placement of the midcell ring instead acts as a block to z-ring 
formation at the cell poles (Migocki et al., 2002).  
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A second system known as nucleoid occlusion inhibits division near the chromosome 
and thus prevents bisection of the nucleoid (Wu and Errington, 2011). Nucleoid 
occlusion factors, Noc in B. subtilis and SlmA in E. coli, prevent FtsZ ring formation over 
the chromosome through binding to specific DNA sequences and effecting FtsZ 
polymerisation (Bernhardt and De Boer, 2005; Wu and Errington, 2011). 
 Cell division in coccoid bacteria 
A lot of previous work has been carried out in rod shaped bacteria, however the use of 
the coccoid shaped organisms is becoming more popular due to the apparently simpler 
mode of division. Rod-shaped bacteria maintain two modes of cell wall synthesis; 
elongation and septation, however in cocci, FtsZ dependent cell wall synthesis is 
predominant (Pinho and Errington, 2003). In addition, many coccoid bacteria are 
important human pathogens. Therefore, understanding the division process within 
these bacteria may lead to identification of novel antimicrobial targets. 
Selection of division plane in coccoid bacteria is more complex than within rod-shaped 
bacteria due to the potential to divide in an infinite number of planes whereas rod-
shaped organisms must divide parallel to the short axis of the bacterium. Some coccoid 
species division occurs on one plane as in rod-shaped bacteria e.g. enterococci, 
streptococci (Zapun et al., 2008a). However some divide on more than one plane 
usually either two or three alternating planes (Zapun et al., 2008a). S. aureus divides 
on three perpendicular or orthogonal planes in a regular sequence (Figure 
1.8)(Tzagoloff and Novick, 1977). Thus the specification of the plane of division is not 
only determined by features of the cell but also by the positioning of the division plane 
for the two previous divisions (Tzagoloff and Novick, 1977). There must therefore be 
some internal indicator of geometric orientation to complete this. It is unlikely to be a 
genetic signal since it must be maintained over several generations, yet must change 
with each division. 
In addition to determining the geometric position of the division plane cocci do not 
possess a Min system for FtsZ ring placement at the midcell therefore nuclear 
occlusion is thought to play a greater role (Wu and Errington, 2011). Noc deletion in S. 









chromosome replication and segregation occur as normal (Veiga et al., 2011; Wu and 
Errington, 2011). The multiple z rings arising from Noc deletion are not placed in the 
division plane suggesting a role of nucleoid occlusion in determining the plane of 
septum formation (Veiga et al., 2011). Additionally, a model of division plane selection 
based on the inheritance of peptidoglycan architectural features, known as ribs, has 
been proposed (Turner et al., 2010a). These ribs (thickenings of the peptidoglycan) are 
produced at the site of septation and are faithfully inherited at each division, thereby 
they could mark the localisation of previous division planes. 
1.7 Cell division machinery 
The cell division machinery comprises of a number of different proteins, many of which 
are conserved among different bacterial species (Typas et al., 2012). Together these 
proteins form the divisome complex which provides both the constriction force and 
enzymatic actions required for completion of division (Wu and Errington, 2011). Using 
mutant and lethality studies, in vivo imaging, structure determination, biochemical 
assays and two-hybrid systems many members of the divisome of different organisms 
have been identified and characterised, particularly in rod-shaped organisms although 
also for S. aureus (Figure 1.9). 
 The z-ring  
FtsZ is the most highly conserved among the division proteins and has been shown to 
be involved in the first known stage of the E. coli division process (Margolin, 2000). 
FtsZ forms a ring at the division site (Figure 1.10)(Scheffers and Driessen, 2010). In the 
presence of GTP, FtsZ hydrolyses GTP and polymerises into thin protofilaments 
(Scheffers and Driessen, 2010). The z-ring is continuously remodelled by 
polymerisation and depolymerisation with a protein turnover time of a few seconds 
(Mingorance et al., 2010). FtsZ can provide the force to generate a constrictive force in 
liposomes without the interactions of other division proteins, suggesting that within 
bacteria FtsZ directs constriction during division (Osawa et al., 2008). 
FtsZ has weak homology to eukaryotic tubulin yet the 3D structure is similar to that of 
α- & β- tubulin (Löwe and Amos, 1998). The GTPase domain and C-terminal domain of 
unknown function are arranged around a central helix. The C-terminal tail acts as a 




Figure 1.9. Schematic of cell division machinery (divisome) from (A) E. coli, (B) B. 








Initial diffraction limited fluorescence microscopy of tagged FtsZ suggested FtsZ 
formed a thick band at the mid-cell, however electron cyro-tomography (ECT) of 
Caulobacter crescentus revealed the presence of short (~100 nm) filaments near the 
division site (Li et al., 2007). 2D single molecule super resolution imaging of FtsZ in E. 
coli showed a continuous ring formed of loose overlapping bundles (Buss et al., 2013; 
Fu et al., 2010). FtsZ in C. crescentus was initially determined to have a continuous 
structure (Biteen et al., 2012) however recent work revealed intensity variation 
suggesting the ring may be discontinuous (Holden et al., 2014). In Gram positives, 3D 
structured illumination microscopy (SIM) has shown a dynamic bead-like structure of 
FtsZ (Strauss et al., 2012).  
Reconstruction of FtsZ & its interacting partner FtsA in liposomes revealed the z-ring to 
be composed of a small single layered band of filaments that overlap via lateral 
filament contacts to form a continuous ring (Szwedziak et al., 2014). Self-arrangement 
of these filaments caused spontaneous constriction of liposomes independent of 
nucleotide hydrolysis, therefore not due to shortening of the filaments (Szwedziak et 
al., 2014). A model of filament sliding to constrict the z-ring was proposed. This would 
require a closed ring to generate force and this mechanism produces self-regulation 
since constriction cannot occur until a complete ring has formed (Szwedziak et al., 
2014). 
 FtsZ interacting proteins 
There are a number of different proteins that interact with FtsZ to maintain correct z-
ring function (Figure 1.9). The first of these, FtsA, is a membrane associated protein 
that interacts with FtsZ and enables FtsZ polymers to assemble at the membrane 
(Figure 1.9)(Loose and Mitchison, 2014; Wang et al., 1997). The cellular ratio of 
FtsA:FtsZ molecules is speculated to be an important feature, and is not constant 
across bacterial species (Feucht et al., 2001). It is thought that FtsA individually is not 
able to provide strong enough attachments to the membrane but that an FtsZ-
filament-FtsA complex allows multiple bonds for membrane association (Loose and 
Mitchison, 2014). Additionally, in E. coli, ZipA also recruits FtsZ to the membrane 
through interaction with the same part of the FtsZ molecule as FtsA (Loose and 
Mitchison, 2014). Z-ring formation requires the presence of only one of FtsA or ZipA 
however they are both required for septal constriction (Pichoff and Lutkenhaus, 2002). 
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ZipA and FtsA are also both required for the recruitment of FtsK and subsequent 
division proteins (Pichoff and Lutkenhaus, 2002). Additional FtsZ interacting proteins 
include ZapA, ZapB & ZapC (E. coli) and SepF (B. subtilis & S. aureus) which together 
with previously mentioned proteins help stabilise and maintain correct z-ring 
conformation throughout the cell cycle (Durand-Heredia et al., 2011; Galli and Gerdes, 
2010; Hamoen et al., 2006). ZapA & ZapB may act to align FtsZ clusters consisting of 
several proto-filaments since super-resolution microscopy determined that the 
abnormal septa and highly dynamic FtsZ in ΔzapA or ΔzapB strains was due to the 
disordered arrangement of the FtsZ clusters (Buss et al., 2013). 
EzrA is a member of the Gram positive divisome (Steele et al., 2011). It was shown to 
cause the destabilisation of FtsZ filaments in B. subtilis (Levin et al., 1999). Interaction 
between EzrA and FtsZ is through the same C-terminal tail as FtsA suggesting binding 
may be in competition with the positive regulator (Singh et al., 2007). While EzrA is 
non-essential in B. subtilis it was found to have an essential role in S. aureus (Levin et 
al., 1999; Steele et al., 2011). In S. aureus EzrA was shown to not only be essential for 
cell growth but depletion of the protein resulted in the delocalisation of cell division 
machinery and an inhibition of peptidoglycan synthesis (Steele et al., 2011). 
The EzrA protein consists of an N-terminal transmembrane helix and a cytoplasmic 
domain consisting of five linear repeats of an unusual triple helical bundle (Cleverley et 
al., 2014). The 3D structure of B. subtilis EzrA (minus the N-terminal transmembrane 
helix) was resolved and revealed the triple helical bundles bent into a semicircle of 
120Å diameter (Figure 1.11 A)(Cleverley et al., 2014). The orientation of EzrA was 
therefore proposed to result in the cytoplasmic domain of EzrA forming an arch over 
the membrane surface with the N-terminal domain within the membrane and the C-
terminal domain positioned close to the membrane surface (Figure 1.11 B) (Cleverley 
et al., 2014). This allows interaction of the C-terminal to the membrane or specific 
membrane associated proteins. This led to 2 possible models of EzrA regulation of FtsZ 
(Figure 1.11 B). The first suggesting regulation occurs through trapping of FtsZ 
filaments under the EzrA arch thereby disrupting lateral interactions and also 




Figure 1.11. Structure of EzrA. (A) Ribbon structure of B. subtilis monomer, each triple 
helical bundle repeat separately coloured. (B) Models of EzrA (light & dark blue) 
interaction with FtsZ (light & dark green) & FtsA (light & dark red). Taken from 




interact with the outer surface of EzrA leaving the inner surface for alternative 
interactions (Cleverley et al., 2014). 
 Septal biosynthesis machinery 
There are multiple proteins that belong to the divisome that are involved in the 
synthesis, remodelling and degradation of the peptidoglycan sacculus.  In E. coli these 
are mainly integral membrane proteins and are recruited in the following order; FtsK, 
FtsQ, FtsL, FtsW, FtsI, FtsN (Pichoff and Lutkenhaus, 2002). The putative flippase FtsW 
is not only required for this function but it is also involved in FtsI recruitment (Mercer 
and Weiss, 2002) and together these are required for the recruitment of 
monofunctional transglycosylases to the divisome (Derouaux et al., 2008). Many 
important components of the divisome, such as FtsZ, remain conserved across 
bacterial species while others have diverged significantly (Angert, 2005).  Within Gram 
positives homologs or all genes required for vegetative cell division in B. subtilis are 
conserved in S. aureus (Steele et al., 2011). 
An additional trimeric complex of proteins, DivIB, DivIC & FtsL (FtsQ, FtsB & FtsL 
respectively in Gram negatives), are conserved among species. It is thought that this 
trimer acts as a scaffold for other division proteins (Figure 1.9)(Daniel and Errington, 
2000). These genes are often found within operons containing genes involved in 
peptidoglycan precursor synthesis and mutants exhibit abnormal cell wall phenotypes 
suggesting a role in the mechanics of the cell wall (Le Gouëllec et al., 2008; Zapun et 
al., 2008a). Recently DivIB in S. aureus has been shown to act as a morphological 
checkpoint during cell division (Bottomley et al., 2014). 
 Penicillin-binding proteins 
Penicillin binding proteins (PBPs) catalyse both the polymerisation of the glycan 
strands (transglycosylation) and crosslinking of glycan strands (transpeptidation) of 
peptidoglycan (Chapter 1.4.3) (Sauvage et al., 2008). In addition, some catalyse the 
hydrolysis of the terminal ᴅ-alanine or the peptide crosslinkage. The PBPs can be 
divided into 2 main groups; high molecular weight (HMW) and low molecular weight 
(LMW). The HMW PBPs are multimodular with a cytoplasmic tail, transmembrane 
anchor and 2 domains on the outer surface linked by a β-sheet rich linker (Sauvage et 
al., 2008). These fall into two classes (A & B), both have transpeptidase activity on the 
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C-terminal domain. The N-terminal domain of class A has transglycosylase activity 
while the N-terminal domain of class B is thought to play a role in cell morphogenesis. 
The LMW PBPs usually have carboxypeptidase or endopeptidase activities. 
Lipid II is polymerised to form the glycan backbone of peptidoglycan by the 
transglycosylase reaction, catalysed either by the monofunctional transglycosylases or 
the bifunctional Class A PBPs (Lovering et al., 2012). Transglycosylation has 2 modes; 
initiation where two lipid II molecules are joined together to form lipid IV and 
elongation where processive addition of lipid II to the growing glycan strand occurs 
(Lovering et al., 2012). Enzymatically they are essentially identical only differing in the 
length of glycan strand substrate. Determination of the structure of the 
transglycosylase domain revealed that lipid II is the acceptor i.e. it maintains its 
undecaprenoyl-pyrophosphate group while the same group is lost from the glycan 
chain (Lovering et al., 2007). This occurs via the deprotonation of the lipid II GlcNAc by 
a glutamate residue within the transglycosylase domain and subsequent reaction with 
the MurNAc C1 of the glycan chain to form a β1,4-glycosidic linkage (Lovering et al., 
2007, 2012). In addition to class A PBPs, bacteria contain monofunctional 
transglycosylases capable of carrying out the transglycosylase reaction but do not 
contain a transpeptidase domain and are therefore not strictly PBPs (Spratt et al., 
1996). S. aureus has two non-essential monofunctional transglycosylases; SgtA and 
MGT (Reed et al., 2011). 
Transpeptidation occurs via three common steps; first a non-covalent complex is 
formed between the donor peptide strand and the enzyme transpeptidase domain, 
then the active site serine attacks the carbonyl carbon of the C-terminal ᴅ-alanine 
forming an acyl-enzyme complex. At this point the terminal ᴅ-alanine is released. 
Finally, the acyl-enzyme complex either undergoes hydrolysis to release a tetrapeptide 
product or a crosslinkage is formed due to reaction between an amino group on an 
acceptor peptide sidechain (Lovering et al., 2012; McDonough et al., 2002). The 
transpeptidase has a common structure whereby two subdomains, a 5 stranded β-
sheet covered by 3 α-helices and an all helical subdomain exist with the active site 
within the cleft between the two (Lovering et al., 2012). The active site contains 3 
conserved sequences including the SXXK motif which contains the active site serine. 
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Bacterial species contain a range of PBPs of the different classifications as well as 
monofunctional transglycosylases (Sauvage et al., 2008). For example, E. coli contains 
12 PBPs while B. subtilis has 16 (Sauvage et al., 2008). In this respect S. aureus provides 
a minimalist system in that it contains only 4 PBPs (Canepari et al., 1985). PBP2 is the 
only class A bifunctional PBP, PBP1 and PBP3 are both HMW PBPs containing 
transpeptidase activity only. S. aureus has one LMW PBP, PBP4 (Scheffers and Pinho, 
2005). PBP4 is an unusual LMW PBP in that it has transpeptidase activity, this 
contributes to the high degree of crosslinking in S. aureus peptidoglycan (Wyke et al., 
1981; Zapun et al., 2008b). In addition, methicillin resistant S. aureus (MRSA) strains 
have an additional PBP, MecA/PBP2A (Zapun et al., 2008b). PBP2A has a lower affinity 
for β-lactam antibiotics than the native PBPs of S. aureus i.e. the acylation rate of 
PBP2A is negligible at therapeutic concentrations (Zapun et al., 2008b). Therefore, 
PBP2A can restore transpeptidase function to S. aureus. However, the transglycosylase 
reaction of PBP2 is still required along with the activities of a number of additional 
proteins, e.g the Fem proteins. Following removal of β-lactam selective pressure native 
PBPs are quickly restored suggesting use of PBP2A in cell wall synthesis bears a 
significant cost in the absence of antibiotics (Zapun et al., 2008b).  
Of the PBPs, only PBP1 and PBP2 have been shown to be essential, in fact S. aureus has 
been shown to survive when PBP1 &2 are the only known peptidoglycan synthesis 
enzymes, however these strains have impaired survival in challenging environments 
(Reed et al., 2015). It has also been suggested that the essentiality of PBP1 may be 
independent of its enzymatic activity, however, the reason for this is unclear (Pereira 
et al., 2009). Both PBP1 and PBP2 have been localised to the septum where 
peptidoglycan synthesis is believed to mostly occur (Pereira et al., 2009; Pinho and 
Errington, 2003). 
1.8 Cell division as an antibiotic drug target 
The unique and universal chemical structure of peptidoglycan in bacteria makes it an 
ideal target for antibiotics as inactivation of peptidoglycan generally leads to cell death 
(Coyette and van der Ende, 2008). Due to the increased prevalence of antibiotic 
resistance there is an urgent need for the creation of new agents for the inhibition of 
bacterial cell wall synthesis (Bugg et al., 2011). The essentiality of proteins involved in 
all stages of peptidoglycan synthesis make them ideal targets for antibiotic 
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development although most current antibiotics are targeted to the later lipid-linked 
steps (Bugg et al., 2011; Lovering et al., 2012). Recent structure based drug design and 
targeted library screening has produced new lead compounds for targeting 
cytoplasmic steps in addition to fosfomycin and ᴅ-cycloserine, current inhibitors of 
MurA and ᴅ-ala-ᴅ-ala ligase respectively (Bugg et al., 2011). 
Lipid II is an attractive antibiotic target since it is highly conserved and any modification 
to the structure is difficult (Scheffers and Tol, 2015). Vancomycin, a current antibiotic 
in clinical use, targets lipid II by binding to the ᴅ-ala-ᴅ-ala motif in the pentapeptide 
stem of lipid II (Reynolds, 1989). This produces steric hindrance and prevents the 
activity of transpeptidases in the synthesis of peptidoglycan (Lovering et al., 2012; 
Reynolds, 1989). 
The major class of antibiotics targeting peptidoglycan synthesis are β-lactams, that 
mimic the ᴅ-ala-ᴅ-ala dipeptide (Lovering et al., 2012). These target the transpeptidase 
active site of PBPs (Waxman and Strominger, 1983). The transpeptidase active-site 
serine attacks the β-lactam ring, as it would the ᴅ-ala-ᴅ-ala substrate under normal 
conditions, forming a long-lived covalent acyl enzyme complex, this impairs PBP 
activity and thus PG crosslinking is reduced (Lovering et al., 2012). Resistance against 
β-lactams is highly prevalent, one mechanism is the acquisition of insensitive PBPs, 
such as PBP2A in S. aureus, in which the active site serine is in a poor position for a 
nucleophilic attack (Lovering et al., 2012). Another means of resistance is the 
acquisition of β-lactamases, enzymes that break down β-lactam antibiotics thereby 
reducing the effective concentration of β-lactams so that PBP transpeptidase activity is 
able to continue (Zapun et al., 2008b). 
Peptidoglycan synthesis is not the only process within cell division which can be 
targeted by antibiotics. There are a number of other essential proteins that make up 
the bacterial divisome and are required for correct localisation of peptidoglycan 
synthesis and progression of cell division that also provide attractive targets for 
antibiotics (Bottomley et al., 2014; Steele et al., 2011; Vollmer, 2006). In particular FtsZ 




1.9 Peptidoglycan dynamics 
 Synthesis of peptidoglycan 
The localisation of peptidoglycan synthesis in the sacculus is important for the 
determination of cell shape as well as growth of the organism. Using a fluorescent 
derivative of vancomycin, which binds to the terminal ᴅ-ala-ᴅ-ala of pentapeptides, 
present in nascent peptidoglycan and lipid II precursors only, it is possible to visualise 
synthesis using florescence microscopy (Daniel and Errington, 2003). In B. subtilis 
vancomycin labelling was shown to occur in a helical pattern on the cell cylinder as 
well as the expected intense staining at the active or recent division site (Daniel and 
Errington, 2003; Tiyanont et al., 2006). This helical pattern was reminiscent of the 
pattern seen in bacterial cytoskeletal proteins. 
Similar to B. subtilis a roughly helical pattern of new peptidoglycan synthesis was seen 
on the cylinder of E. coli when labelled with fluorescent immunodetectiom of ᴅ-
cysteine (Varma et al., 2007). New peptidoglycan insertion occurred as short arcs 
separating older material and despite a lack of defined periodicity this was ascribed to 
a helical distribution of peptidoglycan insertion sites (Varma et al., 2007). However 
recent super-resolution microscopy of E. coli sacculi labelled with fluorescent 
vancomycin revealed peptidoglycan insertion to occur as multiple discrete foci over 
the cylinder of the cell (Turner et al., 2013). This was unexpected since the elongation 
machinery in E. coli moves in a helical manner (van Teeffelen et al., 2011) however Lpo 
proteins, which are also required for peptidoglycan synthesis, have been shown to 
exist in patches (Paradis-Bleau et al., 2010; Typas et al., 2010). Therefore it is possible 
that there is additional control over peptidoglycan synthesis during elongation in E. coli 
rather than simply the localisation of the elongation machinery (Turner et al., 2014). 
Several cytoskeletal proteins have been identified in bacteria as determinants of cell 
shape. Deletions of the genes encoding these proteins in rod-shaped organisms cause 
spherical growth (Leaver and Errington, 2005). MreB and its paralogs in B. subtilis 
(MreB, Mbl & MreBH) form dynamic helical cables which suggests that they may direct 
peptidoglycan synthesis on the cylinder of the cell (Daniel and Errington, 2003; Jones 
et al., 2001). However more recent work has suggested that all three MreB homologs 
in B. subtilis were shown to form discrete structures that move independently with no 
underlying tracks or filaments (Domínguez-Escobar et al., 2011; Garner et al., 2011). 
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MreC & D are thought to stabilise the MreB cytoskeleton (Leaver and Errington, 2005). 
In C. crescentus MreC binds to the penicillin binding protein PBP2 thereby MreB & 
MreC are thought to control cell shape through localisation of the peptidoglycan 
synthesis machinery (Divakaruni et al., 2007). Additionally, in B. subtilis MreB interacts 
with DapI, a protein required for m-DAP synthesis (Rueff et al., 2014). While 
peptidoglycan biosynthesis proteins do not move with MreB they are thought to 
dynamically associate with them as recruitment platforms  (Chastanet and Carballido-
López, 2012). Some Mur enzymes have also been shown to display MreB like 
localisation (Divakaruni et al., 2007). Therefore MreB may contribute to tight coupling 
between peptidoglycan precursors and cell wall synthesis complexes (Rueff et al., 
2014). 
Determination of peptidoglycan synthesis localisation in the coccoid bacterium S. 
aureus showed that synthesis occurred primarily at the division site (Pinho and 
Errington, 2003). This is directed by FtsZ since deletion of FtsZ results in delocalisation 
of peptidoglycan synthesis, presumably due to the delocalisation of biosynthetic 
enzymes (Pinho and Errington, 2003). S. aureus can therefore act as a simpler model of 
peptidoglycan synthesis and dynamics due to the presence of a single cell wall 
synthesis machine. In addition, such a model of division within S. aureus may lead to 
the identification of novel drug targets in a clinically relevant organism. 
 Enlargement of the sacculus 
Peptidoglycan hydrolases are essential for bacterial survival and are thought to play a 
role in cell wall growth (Lee and Huang, 2013). It has been proposed that hydrolysis of 
existing bonds may allow for the growth of the sacculus but this may compromise cell 
wall integrity, therefore strict control between the synthesis and hydrolysis processes 
must exist. A three-for-one model of peptidoglycan insertion was postulated (Figure 
1.12 A); in this model, 3 new peptidoglycan strands are crosslinked together to form  
peptidoglycan triplet, this triplet is cross linked to free amino groups on the 
crossbridges of a single docking strand of peptidoglycan within the cell wall (Höltje and 
Heidrich, 2001). The docking strand is stress bearing while the triplet remains 
unstressed. Specific removal of the docking strand by hydrolase activity results in the 
insertion of the peptidoglycan triplet into the stress bearing layer (Figure 1.12 A)(Höltje 




Figure 1.12. Three-for-one model of peptidoglycan insertion. (A) Model in a single 
layer. (B) Schematic of how the three-for-one model may be applied in Gram positive 




layer of peptidoglycan however it can still occur in multi-layered peptidoglycan such as 
that found in Gram positive bacteria. Peptidoglycan is generally believed to expand 
from the inside out and with the three-for-one model newly synthesised peptidoglycan 
can be inserted “pack by pack” and transferred from the inner layer through the 
peptidoglycan such that each layer receives a new peptidoglycan triplet (Figure 1.12 
B)(Höltje and Heidrich, 2001). 
 Daughter cell splitting & septum expansion 
 Role of hydrolysis in cell splitting 
Both hydrolysis and synthesis of peptidoglycan important in the growth of a bacterial 
cell, however the coupling between the two processes is still not fully understood (Lee 
and Huang, 2013). During the cell cycle the septum must be synthesised and then the 
daughter cells split from one another, this splitting is thought to involve the action of 
peptidoglycan hydrolases (Giesbrecht et al., 1997; Heidrich et al., 2001; Ohnishi et al., 
1999). Gram negative bacteria such as E. coli require the additional constriction and 
separation of the outer membrane in addition to the peptidoglycan layer (Goley et al., 
2010).  
Recent work in C. crescentus discovered that the DipM protein plays a role in envelope 
invagination (Goley et al., 2010; Moll et al., 2010; Poggio et al., 2010). DipM contains 4 
LysM domains for peptidoglycan binding and is a putative LytM endopeptidase with 
peptidoglycan hydrolase activity (Moll et al., 2010). DipM was found to localise to the 
midcell in an FtsZ (Goley et al., 2010; Moll et al., 2010; Poggio et al., 2010) and FtsN 
dependent manner(Moll et al., 2010). Interaction between DipM and FtsN was 
detected suggesting a role for DipM in the divisome of C. crescentus (Moll et al., 2010). 
DipM is non-essential, except in fast growth conditions (Poggio et al., 2010), and 
mutants were found to have thickened peptidoglycan and blebbing of the outer 
membrane at division sites (Goley et al., 2010). This indicates that DipM is required for 
normal envelope invagination during division and to maintain a sacculus of a constant 
thickness, through direct hydrolysis of peptidoglycan. Additionally, a number of 




Many peptidoglycan hydrolases play a role in daughter cell separation and are 
localised to the division septa, although direct interaction between hydrolases and the 
divisome has not been demonstrated. E. coli contains three amidases AmiA, AmiB & 
AmiC, that are involved in splitting of the septum (Heidrich et al., 2001). Cell splitting 
can occur with only one amidase, although at a reduced rate (Höltje and Heidrich, 
2001). AmiC is localised to the midcell in a FtsN dependent manner, although direct 
interaction between the proteins was not shown (Bernhardt and De Boer, 2003). In 
addition to amidases both lytic transglycosylases (Slt70, MltA & MltB) and 
endopeptidases (MepA, PBP4, PBP7)  are able to cleave the septum, although 
amidases are presumed to be the major proteins involved since the effect of the other 
protein families are only apparent following deletion of the amidase activity (Heidrich 
et al., 2002).  In B. subtilis a number of different peptidoglycan hydrolases are involved 
in cell separation including LytF(CwlW) and CwlF (Ohnishi et al., 1999). 
In S. aureus there are a various autolysins involved in daughter cell splitting including 
Atl, Sle1, IsaA and SceD (Biswas et al., 2006; Kajimura et al., 2005; Stapleton et al., 
2007; Wheeler et al., 2015). Atl is the major autolysin in both S. aureus (AtlA) and 
Staphylococcus epidermidis (AtlE). Atl is a bifunctional enzyme composed of  amidase 
and glucosaminidase domains which undergoes proteolytic processing to generate two 
extracellular peptidoglycan hydrolases (Biswas et al., 2006; Yamada et al., 1996).  Atl 
has been shown to localise to the division septa and split into two rings on adjacent 
daughter cells during cell splitting (Yamada et al., 1996). On completion of cell splitting 
AtlA already starts to align at the site where the next division will occur, suggesting 
that whatever mechanism specifies division planes is already in place (Yamada et al., 
1996). 
 Daughter cell splitting in S. aureus 
Initial EM data suggested that the staphylococcal cell wall was composed of two parts; 
a transitory and a permanent part. The transitory part was thought to comprise 
approximately 1/3 of the cell wall and was lost during cell separation (Giesbrecht et al., 
1997). Two compatible mechanisms for cell separation were proposed, both initiated 
by lysis of the mature cell wall in a punctate pattern, thought to be due to the 
presence of vesicular wall organelles called murosomes (Giesbrecht et al., 1997). The 
first mechanism involved continued lysis of the septum by murosomes while the 
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second involved the action of the splitting system as a mechanical aid to separation of 
the daughter cells by application of physical forces (Giesbrecht et al., 1997). Cell 
splitting in this manner could theoretically occur “suddenly” and the force used may 
force daughter cells to pop apart (Giesbrecht et al., 1997). Recent live-cell microscopy 
has shown that daughter cell separation does indeed occur on a millisecond timescale 
(Zhou et al., 2015). However, more recent EM work questioned the presence of a 
splitting system, although this does not negate the role of mechanical forces in the 
splitting of daughter cells (Giesbrecht et al., 1997; Matias and Beveridge, 2007). The 
growing septum was seen to consist of 5 distinct layers in EM, two high density zones 
(HDZ) sandwiched by low density zones (LDZ) i.e. membrane, LDZ, HDZ, LDZ, HDZ, LDZ, 
membrane (Matias and Beveridge, 2007). These LDZ’s were confirmed to be a 
“periplasmic space” and comprised of soluble components while the HDZ’s were that 
of the peptidoglycan cell wall (Matias and Beveridge, 2007). This firstly confirmed the 
existence of a periplasmic space within Gram positive bacteria and secondly proposed 
that the septum existed as 2 separate entities prior to cell separation (Matias and 
Beveridge, 2006, 2007). This suggests that the newly synthesised septum is rapidly 
separated into two separate parts due to autolysis activity, indeed many peptidoglycan 
hydrolases, not just Atl, have been localised to the septum of S. aureus (Frankel and 
Schneewind, 2012). 
Cell splitting has been shown to be due to the action of hydrolases. Null mutants of atl 
and sle1, an N-acetylmuramyl-ʟ-alanine amidase, produce clusters of cells that have 
failed to separate, suggesting the role of these enzymes in daughter cell separation 
(Kajimura et al., 2005; Takahashi et al., 2002). Additionally, using fluorescence 
microscopy, Atl amidase and glucosaminidase proteins have been localised to the 
septum, in particular in association with a raised architectural feature that surrounds 
the nascent septum known as the piecrust (Chapter 1.10.6.1)(Kent, 2013). This may 
implicate Atl in the hydrolysis of this feature required for cell splitting to take place. As 
in E. coli, the deletion of two putative lytic transglycosylases from S. aureus, IsaA and 
SceD caused impaired cell separation (Stapleton et al., 2007). 
 Septum expansion in S. aureus 
Nascent cell wall exposed on cell splitting was found to be stiffer than the rest of the 
cell wall, and this stiffness was seen to decrease as the expansion of the cell wall 
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occurred (Bailey et al., 2014). S. aureus has characteristic short glycan chains, average 
6 disaccharides long, which have been processed to give reducing terminal N-acetyl 
glucosamines (Boneca et al., 2000). This explains the need for glucosaminidase activity 
in the growth of S. aureus (Wheeler et al., 2015). The S. aureus genome contains 4 
putative glucosaminidases; atl, sagA, scaH, sagB (Wheeler et al., 2015). The 4 encoded 
proteins are synthetically lethal and cells that lack all four, due to the use of a 
conditional mutant, were seen to have a defect in cell expansion, increased surface 
stiffness and increased glycan chain length. Interestingly despite redundancy in 
glucosaminidases, SagB is the most dominant enzyme with important roles in both cell 
stiffness and glycan chain length (Wheeler et al., 2015). The nascent cell wall 
expansion due to hydrolysis of glycan strands & concomitant decrease in stiffness 
apparently accounts for the growth mode of S. aureus (Bailey et al., 2014; Wheeler et 
al., 2015). 
1.10 Peptidoglycan architecture 
While the chemical structure of peptidoglycan has been well studied it is only recently 
that we have had the techniques available to begin to understand the 3D architecture 
of the peptidoglycan sacculus. A number of architectural models have been proposed 
concerning glycan strand orientation. In addition recent applications of electron cryo 
tomography (ECT) and atomic force microscopy (AFM) have revealed large scale 
architectural features of peptidoglycan across species (Amako et al., 1982; Andre et al., 
2010; Hayhurst et al., 2008; Plomp et al., 2007; Touhami et al., 2004; Turner et al., 
2010a, 2013; Wheeler et al., 2011). 
 Models of peptidoglycan architecture 
 Planar vs. scaffold model of glycan chains 
Glycan strand orientation modelling has proposed two opposing ideas; the planar and 
scaffold models (Figure 1.13 A & B). In the planar model glycan chains are orientated 
parallel to the cytoplasmic membrane (Koch, 1998a). The planar model, within Gram 
negative bacteria would consist of a single stress bearing layer with newly synthesised 
material on the innermost side and mostly degraded material on the outermost side 
both loosely crosslinked to the stress bearing layer (Figure 1.13 B)(Dmitriev et al., 
2003). These glycans were thought to be arranged circumferentially first due to EM 




Figure 1.13. Models of peptidoglycan architecture. (A) Scaffold model. (B) Planar 
Model. (C) Helical glycan strands. (D) Tessera structure. Adapted from (Koch, 1998b; 




showed sacculi to be less elastic in the circumferential direction compared with the 
longitudinal direction (Koch, 1998a; Yao et al., 1999). Glycan chains form an extended 
helix with peptides extending in a clockwise manner, perpendicular to each other 
(Figure 1.13 C) (Vollmer and Höltje, 2004). Therefore, in a theoretically perfect 
monolayer would be 50% crosslinked, close to the 40-50% crosslinked experimental 
value. A modification of this model proposed by Koch (1998b) suggested that glycans 
would follow a zig-zag as opposed to a straight line forming small pores in the sacculus 
known as tessera (Figure 1.13 D)(Koch, 1998b).  Since glycan strands are often shorter 
than the dimensions of the cell and the percentage crosslinks is lower than the 
theoretical value, holes or slits are thought to exist within the sacculus formed of fused 
hexagonal tessera (Vollmer and Höltje, 2004). If these are distributed across the 
peptidoglycan layer it is not thought that the presence of such holes will decrease 
overall peptidoglycan stability. In Gram positive bacteria the peptidoglycan layer is 
thought to consist of several layers of peptidoglycan in this formation linked to one 
another (Dmitriev et al., 2003). 
An alternative model for glycan chain orientation was proposed by Dmitriev et al 
(2003) where glycan strands are arranged perpendicular to the cytoplasmic membrane 
(Figure 1.13 A). Glycans extend vertically from the cytoplasmic membrane and 
crosslinked by peptides parallel to the surface. The peptidoglycan would be highly 
crosslinked near the cytoplasmic membrane and have reduced crosslinking at the 
outer membrane (Dmitriev et al., 2003). This model was also later applied to Gram 
positives in the form of S. aureus where it could account for high cross-linking as well 
as division on consecutive planes (Dmitriev et al., 2004). The planar model of division 
was thought to result in sectors of peptidoglycan with glycan chains running in 
multiple directions and would require consecutive turns of the biosynthetic machinery 
whereas the scaffold model poses a simpler system (Dmitriev et al., 2004). While the 
short glycan chains of S. aureus would permit the scaffold architecture, sacculi of E. coli 
are thin and for the scaffold model to exist glycan chains would have an average length 
of 2.5 saccharides and a maximum length of 7 disaccharides (Vollmer and Höltje, 
2004). However, in reality E. coli has an average glycan chain length of 25-30 
disaccharides with a high proportion over 30 disaccharides, which would not fit a 
scaffold model of arrangement. Additionally, even if was assumed that peptidoglycan 
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with vertically orientated glycan strands were to exist entirely in the maximally 
stretched conformation there is not enough peptidoglycan material in the E. coli 
sacculus to cover the entire cell surface (Vollmer and Höltje, 2004). This makes it 
unlikely that the scaffold model exists in Gram negative bacteria. 
 New models of peptidoglycan architecture 
Recent work, mainly using EM and AFM, has revealed a number of different 
architectural features of peptidoglycan. While these have been useful in determining 
small scale features of peptidoglycan it has not yet been possible to confirm 
visualisation of glycan stands and crosslinks within sacculi (Turner et al., 2014).  
 Models of peptidoglycan architecture in Gram negative bacteria 
Electron cryo tomography (ECT) of sacculi from both E. coli and C. crescentus revealed 
a mostly single layer of peptidoglycan although in some parts this extended up to three 
layers thick (Gan et al., 2008). In addition, thin “tubes” of electron density were 
observed in the plane of the peptidoglycan and mostly perpendicular to the long axis 
of the cell. These were attributed to single glycan chains (Gan et al., 2008). This 
showed that the scaffold model is indeed not possible in Gram negative bacteria. The 
architecture of the glycan strands were uniform across the sidewall, indicating a lack of 
growth zones however they were irregularly spaced and not perfectly parallel, 
although a mostly circumferential organisation was observed (Gan et al., 2008). More 
recently AFM was used on Gram negative sacculi which revealed features in the plane 
of the sacculus however in many directions in relation to the axis of the cell (Turner et 
al., 2013). In addition, bands were seen to run approximately circumferential to the 
long axis (Figure 1.14 A), however these were too large to account for individual glycan 
strands. High resolution AFM showed these bands to contain pores and form a lattice 
like structure (Figure 1.14 A), however these pores were too large to be compatible 
with tessera (Koch, 1998b; Turner et al., 2013; Vollmer and Höltje, 2004). Additionally, 
hydrolase digestion of these features showed that glycans have little or no general 
orientation. This architectural landscape was common to all Gram negative species 
tested (E. coli, C. crescentus, Pseudomonas aeruginosa & Campylobacter jejuni)(Turner 





Figure 1.14. Model of Gram negative peptidoglycan architecture. (A) Model of 
architecture including randomly oriented glycan strands and bands of porosity 
circumferential to long axis. (B) “Architecture -regulated” model of growth. Adapted 




These architectural features in addition to super-resolution observations of insertion 
patterns (Chapter 1.9.1) has led to a model of “architecture-regulated” growth  
(Turner et al., 2013). Insertion of peptidoglycan into areas that already contain higher 
peptidoglycan levels would result in dense, thick peptidoglycan that was unable to 
expand (non-permissive architecture). The new model proposes that insertion would 
occur primarily in areas with the most pores (permissive architecture), likely directed 
by LpoA, the outer membrane protein required for synthesis as it would span the 
peptidoglycan in areas where the pores exist (Figure 1.14 B). The mechanism of growth 
for elongation occurs when the areas with higher peptidoglycan content are 
hydrolysed and stretched due to turgor pressure to become permissive (Turner et al., 
2013). 
 Models of peptidoglycan architecture in Gram positive rods 
Organisation of peptidoglycan in Gram positive rods, particularly B. subtilis have long 
been thought to also have a layered architecture however composed of multiple layers 
to explain peptidoglycan thickness. AFM observations of Lactobacillus helveticus 
revealed ~26 nm thick twisted fibres within the cell wall, this was attributed to glycan 
strands however this is not unequivocal due to limitations in the nanosurgery 
technique used (Firtel et al., 2004). Alternatively B. subtilis sacculi had a striated 
appearance perpendicular to the short axis in EM images which was thought to be due 
to glycan strands (Verwer and Nanninga, 1976). The glycan strands were proposed to 
be organised in an irregular pattern but predominantly tangentially.  
A more recent AFM study of B. subtilis revealed a number of features in the 
peptidoglycan. Firstly B. subtilis was shown to have exceedingly long glycan chains 
(Hayhurst et al., 2008). Approximately 25% of glycan material was found to be over 
500 disaccharides in length and some were measured to be of up to 5 µm in length, 
corresponding to 5,000 disaccharides. The inner surface of the peptidoglycan sacculus 
was shown to have a regular macrostructure with ~50 nm wide cables running across 
the short axis (Figure 1.15 A) (Hayhurst et al., 2008). This architecture was also 
maintained in the septum. The proposed model is that during biosynthesis a 
peptidoglycan rope is formed from the polymerisation and crosslinking of a small 




Figure 1.15. Peptidoglycan architecture of B. subtilis. (A) AFM phase images of cell 
wall features, outer vs. inner leaflet and possible twisted cables. (B) Model of 




cable which is inserted into the cell wall via crosslinks with 2 existing cables (Figure 
1.15 B). The interface is cleaved by hydrolases and flattened due to turgor which 
allows for growth (Hayhurst et al., 2008). This model not only allows for the long 
glycan chains but predicts that the cell wall is composed of one intact cable with 
partially hydrolysed cables present externally, explaining why the architecture is only 
observed on the inner leaflet (Hayhurst et al., 2008; Smith et al., 2000). Both E. coli and 
B. subtilis have been shown to twist during growth, albeit in a different direction, this 
suggested that helical peptidoglycan insertion may contribute to peptidoglycan 
architecture by chiral self-organization of the peptidoglycan network (Wang et al., 
2012b). 
Beeby et al. (2013) were unable to discern a structure representing the coiled cable 
architecture using ECT. Instead peptidoglycan was seen to be uniformly dense with the 
inner surface smooth and flush with the inner membrane (Beeby et al., 2013). During 
sporulation B. subtilis was shown to produce a thin “Gram negative” style 
peptidoglycan. The authors therefore rejected the coiled coil model since the uniform 
density does not allow for hollow cables. Additionally, the modification of 
peptidoglycan thickness during sporulation, in other species and due to the 
environment is unlikely to be possible with the cabled conformation (Beeby et al., 
2013; Cheng and Costerton, 1977; Hanaki et al., 1998; Tocheva et al., 2013). Instead a 
model of circumferentially arranged glycan chains in multiple layers was posed, similar 
to a suggested model for Gram negative bacteria which would be assembled from 
inside to out due to deposition of material at the inner membrane and degradation of 
the outer layer (Beeby et al., 2013). This can then be “thinned” by hydrolase activity. 
However this interpretation comes from ECT where signal:noise ratio limitations can 
make internal structure difficult to discern. In addition, the proposed model does not 
appear to accommodate the AFM data from Hayhurst et al (2008) in particular the long 
glycan chains. It is possible that the observed thinner peptidoglycan may have a 
different architecture, particularly as these observations were made during either 
different growth phases or in different species. Unlike Gram negative bacteria, a 
number of different architectural features have been seen among Gram positive 
species (Chapter 1.10.5 & 1.10.6). 
47 
 
 Models of peptidoglycan architecture in ovococci 
Unlike “true” cocci such as S. aureus which have an apparent “spherical” shape, 
ovococci are slightly elongated (Zapun et al., 2008a). Examples of ovococci include S. 
pneumoniae, Enterococcus faecalis and Lactococcus lactis. Using AFM Wheeler et al. 
(2011) determined the architectural features of ovococci peptidoglycan. Glycan 
strands were found to be preferentially orientated circumferentially and parallel to the 
short axis of the cell. Distinct ring structures were associated with growth and division 
from septa and equatorial rings were also observed (Wheeler et al., 2011). A single 
growth annulus was seen in L. lactis and E. faecalis, however up to three were 
observed in S. pneumoniae. Parallel bands of material attributed to several intertwined 
glycan bands were seen in S. pneumoniae but not in L. lactis or E. faecalis, probably 
due to the overlapping rounds of division in S. peumoniae. This showed that ovococci 
have a peptidoglycan architecture distinct from that of other Gram positive species (B. 
subtilis and S. aureus) as well as variation between ovococci species, though to be due 
to differences in spatial and temporal regulation of the cell cycle. 
 Models of peptidoglycan architecture in S. aureus 
Atomic force microscopy (AFM) has been applied to both whole cells and extracted 
peptidoglycan sacculi to determine the surface architecture of S. aureus (Touhami et 
al., 2004; Turner et al., 2010a). The mature peptidoglycan surface within whole cells 
were shown to have both contoured and smooth structures with different adhesive 
properties (Touhami et al., 2004). At higher resolution this peptidoglycan has been 
proposed to have a network or honeycomb-like structure (Figure 1.16 A) (Giesbrecht et 
al., 1998; Touhami et al., 2004; Turner et al., 2010b). However, these were not visible 
in extracted sacculi suggesting that the other components of the cell wall, proteins, 
teichoic acids etc., may contribute to these structures (Turner et al., 2010a).  Instead 
older cell wall was seen to have a knobbly architecture (Figure 1.16 B)(Turner et al., 
2010a). The knobbly architecture was thought to occur due to rearrangement of the 
nascent peptidoglycan architecture through the action of hydrolases. 
New cell wall material visualised just after cell separation was seen to consist of 
concentric surface rings and a central depression consistent with previous SEM (Figure 
1.16 B &C) (Amako et al., 1982; Touhami et al., 2004). In addition, AFM on sacculi 




Figure 1.16. Peptidoglycan architecture of S. aureus. (A) High resolution AFM of 
mature cell wall. (B) Mature and nascent peptidoglycan architecture in sacculi. (C) 
Nascent septum architecture. (D) Piecrust feature under AFM. Adapted from (Touhami 




peptidoglycan layer (Figure 1.16 D)(Turner et al., 2010a). This band, known as the 
piecrust, is proposed to denote the division planes (Chapter 1.10.6.1). Since this 
feature was seen surrounding incomplete septa it was proposed that this was 
synthesised prior to the rest of the septum. Spacing between the rings on the newly 
exposed septa were seen to vary from 13-25 nm on average although some longer 
spacings were also present (Touhami et al., 2004). As the rings were positioned closer 
to the centre of the septum the height increased from ~1 nm to ~2 nm (Touhami et al., 
2004). The central depression had a depth of at least 30 nm, the presence of this 
depression is likely due to the completion of the septal plate, an important step where 
peptidoglycan alignment and bonding is subtly different from normal peptidoglycan 
(Matias and Beveridge, 2007; Touhami et al., 2004). It is very rare for both the ring and 
knobbly architectures to occur in the same areas of the peptidoglycan sacculi suggests 
that the rings are remodelled into knobbles, likely by discontinuous autolysis of the 
peptidoglycan rings (Turner et al., 2010a). 
 Model of specification of division planes by recognition of specific 
architectural features 
On division of S. aureus, the piecrust architectural feature is split and each daughter 
cell receives half. This led to the proposal of a model of specification of division planes 
by architectural features (Turner et al., 2010a). Indeed, bands less distinct than the 
piecrust, known as ribs, were observed and understood to be remnants of the piecrust. 
When more than one band was present on a sacculi fragment they were 
approximately perpendicular and formed cross or T-junctions. A model of how the 
piecrust feature is inherited over several generations was proposed (Figure 
1.17)(Turner et al., 2010a). Immediately after division a cell contains a whole rib 
derived from the piecrust that marks the plane of division that had just taken place. On 
division in the next plane, the rib will be bisected by the new piecrust such that each 
daughter cell will receive half the rib, in addition to a new whole rib. Cross junctions 
occurred when a piecrust intersected a rib, once the cells split at the piecrust, these 
cross junctions become T-junctions (Turner et al., 2010a). This process will repeat on 
the third division plane resulting in daughter cells with a whole rib, a half rib and a 
quarter rib. At this point the next division plane will be the same as the first division 




Figure 1.17. Model of specification of division plane by architectural features in S. 
aureus. Note that although the piecrust and rib features are shown on the outer 
surface these would in fact be present on the inner leaflet of the cell wall. Adapted 




of the quarter rib and form a piecrust in this plane. Therefore, S. aureus can faithfully 
divide in 3 orthogonal planes. 
1.11  Methods of peptidoglycan analysis 
Peptidoglycan has been analysed on three levels; peptidoglycan chemistry by high 
performance liquid chromatography (HPLC), architecture by EM and AFM and 
subcellular localisation of features by fluorescence microscopy. HPLC muropeptide 
analysis has been beneficial in determining the chemical composition of both the 
muropeptide building block but also how these are assembled including glycan chain 
length and mechanism of crosslinking (Boneca et al., 2000; Desmarais et al., 2013; 
Glauner et al., 1988; Harz et al., 1990; Snowden and Perkins, 1990). This could also be 
applied to determine mechanisms of actions of numerous peptidoglycan interacting 
enzymes through a combination of HPLC with genetic mutations or recombinant 
enzyme digestion (Atrih et al., 1996, 1999; Snowden and Perkins, 1990). HPLC relies on 
the extraction of vast quantities of peptidoglycan which are then solubilized and 
pumped through a column such that fragments are separated based on their chemical 
properties (Desmarais et al., 2013). Therefore, this is a population average method and 
may disguise individual differences. It is also currently impossible to determine the 
muropeptide profile of subcellular compartments, for example is the septum more or 
less crosslinked than the rest of the cell wall? 
In order to determine both the overall morphology of the cell wall and the subcellular 
architectural features, various imaging techniques have been applied, namely EM and 
AFM. Since peptidoglycan has a high degree of heterogeneity it is not easily applied to 
methods that require a high degree of order such as X-ray diffraction. However, certain 
aspects of the architecture of muropeptides have been revealed using nuclear 
magnetic resonance (NMR)(Kim et al., 2013, 2014; Romaniuk and Cegelski, 2015). 
Electron microscopy uses electrons instead of light to produce an image, therefore has 
a greater resolving power than light. Peptidoglycan has been studied using both 
transmission and scanning EM methods as well as electron cryo tomography (ECT) in 
more recent years (Beeby et al., 2013; Gan et al., 2008; Popham, 2013). In ECT, 
samples are plunge frozen in liquid ethane & propane so that the water molecules do 
not have time to rearrange into crystalline ice therefore the cellular structure is 
preserved in vitreous ice. Samples are then imaged using transmission EM as they are 
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tilted in order to produce of 3D tomogram (Gan and Jensen, 2012). Another common 
method of architecture determination is the use of atomic force microscopy (AFM) a 
high resolution form of scanning probe microscopy that can achieve resolution up to 
fractions of a nanometre. AFM uses a sharp tip that scans the sample. The deflection 
of the tip is translated into a topological image, in addition phase shift of the tip can be 
converted into information concerning chemical and mechanical properties of the 
sample. 
While EM and AFM can both produce images with greater resolution than microscopy 
techniques based on light, the resulting images do not contain any information on the 
identification of the structures observed. In conjunction with chemical probes and 
reporter proteins fluorescence microscopy is able to localise structures to subcellular 
localisations. This has been particularly useful with fluorescent proteins (Hu and 
Lutkenhaus, 1999; Pinho and Errington, 2005). However conventional microscopy is 
limited by the resolution limit of light (~250 nm)(Huang et al., 2010). Therefore, new 
microscopy techniques have been developed that allow this resolution limit to be 
passed, including the use of structured illumination microscopy (SIM) and stochastic 
optical reconstruction microscopy (STORM) (Chapter 3.1.2). In recent years these have 
begun to be applied to microbiological samples, in particular to the study of 
peptidoglycan and cell division dynamics (Turner et al., 2013; Wheeler et al., 2011). 
1.12 Staphylococcus aureus 
Staphylococci are Gram positive, non-motile, facultative anaerobes. They are roughly 
spherical in shape with diameter of 0.7-1.2 µm. Taxonomically Staphylococci lie within 
the Firmicutes, within the Bacillales order due to ribosomal RNA sequences (Kuroda et 
al., 2001). The genome of S. aureus is AT rich, with a GC content of ~30% (Wang et al., 
2012a). Staphylococci are important human and animal opportunistic pathogens, in 
particular Staphylococcus epidermidis and Staphylococcus aureus are important human 
pathogens. 
 S. aureus is the most prevalent staphylococcal human pathogen. It is characterised by 
the gold pigmentation of its colonies due to the production of carotenoids including 
staphyloxanthin and its production of coagulase, a blot clotting factor (Marshall and 
Wilmoth, 1981). S. aureus is a commensal organism the resides primarily in the 
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anterior nares, the channels of the nose i.e. the nostrils. Approximately 20% of the 
population are permanent carriers of S. aureus while a further 30% are transitory 
carriers (Wertheim et al., 2005). It is unsurprising therefore that it is the most common 
cause of hospital-acquired infections. 
S. aureus can cause a large number of nosocomial and community-acquired infections. 
These generally occur via a breach in an outer barrier, skin or mucosal surface, that 
allows access of S. aureus to soft tissue and the bloodstream. S. aureus infections can 
range in severity from simple skin infections, boils and impetigo to more serious, even 
life threatening infections including bacteraemia, pneumonia, endocarditis and septic 
arthritis. In 2014, there were 9,100 reported cases of S. aureus bacteraemia in the UK, 
a reduction of 40% from 2004 (Public Health England, 2015). Of these 9.4% were due 
to MRSA. Intravenous catheters and other surgical implants are prone to S. aureus 
infections since they are rapidly coated in serum constituents such as fibrinogen and 
fibronectin allowing S. aureus adherence. 
There are many virulence factors expressed by S. aureus including surface proteins that 
play a role in adhesion, host immune system inhibition and toxins. Adhesion proteins 
are able to mediate host colonisation and infection by binding to the extracellular 
matrix mediated by MSCRAMMs (microbial surface components recognising adhesive 
matrix molecules)(Foster and Hook, 1998). S. aureus also excretes a number of 
enzymes thought to play a role in virulence and infection progression including 
catalase, coagulase, proteolytic enzymes and lipases. Staphylococci also produce a 
number of different toxins including cytotoxins, haemolysins and leukotoxins to lyse 
host cells and superantigens which bind MHC (major histocompatibility complex) Class 
II proteins causing over activation of the host immune system and host mediated cell 
damage, particularly from cytokine release (Llewelyn and Cohen, 2002). 
1.13 Antibiotic resistance 
As rapidly as new antibiotics have been introduced to combat S. aureus infections 
strains have arisen that have reduced susceptibility to the antimicrobial agents. 
Resistance to penicillin was seen almost immediately after penicillin was first used in 
1941. Resistance was caused by the expression of a β-lactamase that degrades 
penicillin and related antibiotics. Additionally, staphylococcal isolates were found that 
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were resistant to numerous other antimicrobial agents targeting different systems. 
Mechanisms of resistance include inactivation of antimicrobials by destruction or 
modification, prevention of access to target due to permeability, presence of efflux 
pumps or alteration of targets (Neu, 1992). The synthetic antibiotic methicillin was a 
promising antibiotic until the emergence of methicillin resistant S. aureus (MRSA) 
strains. These strains acquired an extra PBP known as MecA/PBP2A which has a low 
affinity for all β-lactams including methicillin (Neu, 1992; Zapun et al., 2008b). This 
problem is aggravated since many MRSA strains are also resistant to other antibiotics. 
Therefore, vancomycin and other glycopeptides have become the drugs of last resort. 
Inevitably resistance to vancomycin has also risen in S. aureus with the appearance of 
vancomycin-intermediate (VISA) and vancomycin-resistant (VRSA) strains. The 
mechanism of VISA is thought to be due to an increased cell wall thickness thereby 
restricting access of vancomycin to its target at the septum, combined with a reduction 
in PBP4 activity to increase levels of ᴅ-ala-ᴅ-ala, the target for vancomycin (Howden et 
al., 2010). VRSA is due to the acquisition of the vanA gene which allows the 
incorporation of ᴅ-lactate in the terminal peptide position of the pentapeptide of the 
peptidoglycan precursor thereby preventing vancomycin binding (Courvalin, 2006; 
Holmes et al., 2012).  
1.14 Project Aims 
Previous work has determined the architectural features of S. aureus peptidoglycan as 
well as the dynamics of synthesis using conventional fluorescence microscopy. 
However, this information is limited in resolution due to the use of diffraction limited 
microscopy. Recent developments in new probes to label peptidoglycan synthesis, 
based on fluorescent derivatives of ᴅ-amino acids (FDAAs), allow synthesis to be 
investigated for the first time in greater detail (Kuru et al., 2012).These new probes not 
only allow direct labelling of new peptidoglycan but also allow dynamics to be 
investigated by using probes with different spectral properties as a virtual time-lapse.  
The aim of this study was to apply novel probes and super-resolution microscopy to 
determine the insertion and dynamics of nascent peptidoglycan in S. aureus at the 
molecular level. This was achieved through a number of different objectives: 
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 Determine the ability of FDAAs to label peptidoglycan synthesis in S. aureus and 
ascertain the mechanism of labelling. 
 Establish methods of super-resolution microscopy in S. aureus using synthetic 
dyes. 
 Combine FDAA labelling and super-resolution microscopy to determine the 
localisation of peptidoglycan synthesis at the molecular level. 
 Investigate the effect of FtsZ depletion on peptidoglycan synthesis localisation. 
 Determine the dynamics of peptidoglycan synthesis during a single division 
cycle and inheritance of material over multiple cycles. 
These have informed new models of peptidoglycan synthesis in S. aureus as well as 
providing further insight into the cell growth and division process of this bacterium. 
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Chapter 2  
Materials and Methods 
2.1 Media 
All media was prepared using distilled water (dH2O) and sterilised by autoclaving at 
121°C, 15 pounds per square inch for 20 mins. 
 Brain Heart Infusion (BHI) 
Brain Heart Infusion (Oxoid/Fluka)      37 g l-1 
Bacteriological Agar (VWR) was added at 1% (w/v) to produce BHI Agar. 
 Chemically defined media (CDM) 
All glassware was acid washed & autoclaved before use in CDM preparation. 
 Solution 1 
Sodium phosphate dibasic (Na2HPO4.2H2O)     7 g l-1 
Potassium phosphate monobasic (KH2PO4)     3 g l-1 
ʟ-Aspartic Acid        0.15 g l-1 
ʟ-Alanine         0.1 g l-1 
ʟ-Arginine         0.1 g l-1 
ʟ-Cysteine         0.05 g l-1 
Glycine         0.1 g l-1 
ʟ-Glutamic Acid        0.15 g l-1 
ʟ-Histidine         0.1 g l-1 
ʟ-Isoleucine         0.15 g l-1 
ʟ-Lysine         0.1 g l-1 
ʟ-Leucine         0.15 g l-1 
ʟ-Methionine         0.1 g l-1 
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ʟ-Phenylalanine        0.1 g l-1 
ʟ-Proline         0.15 g l-1 
ʟ-Serine         0.1 g l-1 
ʟ-Threonine         0.15 g l-1 
ʟ-Tryptophan         0.1 g l-1 
ʟ-Tyrosine         0.1 g l-1 
ʟ-Valine         0.15 g l-1 
Solution 1 was adjusted to pH 7.2 prior to autoclaving or mixing to produce CDM. 
 Solution 2 (1000x) 
Biotin          0.02 g 
Nicotinic Acid         0.4 g 
ᴅ-Pantothenic Acid        0.4 g 
Thiamine HCl         0.4 g 
Pyridoxal HCl         0.8 g 
Pyridoxamine di-HCl        0.8 g 
Riboflavin         0.4 g 
Chemicals were dissolved in 140 ml dH2O and filter sterilised to produce a 1000x 
solution. This was diluted in dH2O to make a 1x solution just prior to use in CDM. 
 Solution 3 
Adenine Sulphate        0.4 g l-1 
Guanine HCl         0.4 g l-1 
Solution 3 was prepared in 0.1 M HCl. 
 Solution 4 
Calcium Chloride Hexahydrate (CaCl2.6H2O)     1 g l-1 
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Ferrous Ammonium Sulphate ((NH4)2Fe(SO4)2.H2O)    0.6 g l-1 
Solution 4 was prepared in 0.1 M HCl. 
 Solution 5 
Glucose         100 g l-1 
Magnesium sulphate Heptahydrate (MgSO4.7H2O)    5 g l-1 
 Preparation of CDM 
Solution 1         700 ml 
Solution 3         50 ml 
Solution 4         10 ml 
This mix of solutions was autoclaved under normal conditions. Once cooled to 50°C, 
100 ml of Solution 2 at 50°C and 100 ml of solution 5 at 50°C were added to the 
autoclaved mix. 
2.2 Antibiotics 
All Antibiotics used are listed in Table 2.1. For antibiotics prepared in dH2O stock 
solutions were filter sterilized (0.22µm pore size) and stored at -20°C. When antibiotics 
were added to agar for plates, agar was cooled to below 50°C prior to addition of the 
antibiotic. 
2.3 Buffers & Solutions 
Stock solutions were prepared in dH2O unless otherwise stated and sterilised by 
autoclaving whenever required for microbiological work. 
 Phosphate Buffered Saline 
Phosphate Buffered Saline Tablets (Sigma)     5 tablets l-1 
 Borate Buffer 
Boric Acid (H3BO3)        0.5M 











5 100% (v/v) Ethanol 5 
Lincomycin (Lin) 25 50% (v/v) Ethanol 25 
Spectinomycin 
(Spec) 
50 dH2O 100 
Table 2.1 Antibiotics used in this study.  
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 HPLC buffers 
All HPLC buffers were made with Milli-Q filtered water and filtered (0.2 µm pore size) 
prior to use. 
 Buffer A – 10 mM Ammonium Phosphate containing 5 mM sodium azide 
Ammonium Phosphate (2.5 M)      4 ml l-1 
Sodium Azide (10% (w/v) stock)      3.27 µl l-1 
Buffer was adjusted to pH 5.6. 
 Buffer B – 10 mM Ammonium Phosphate containing 30% (v/v) Methanol 
Ammonium Phosphate (2.5 M)      4 ml l-1 
Methanol         30% (v/v) 
Buffer was adjusted to pH 5.6 prior to addition of methanol. 
 Fixative preparation 
 Preparation of 16% (w/v) paraformaldehyde 
100mM sodium phosphate buffer (pH 7.0) was prepared as follows: 
Na2HPO4 (1M)         57.7 ml 
NaH2PO4 (1M)         42.3 ml 
Final volume was adjusted to 1 l. 
For 16% (w/v) paraformaldehyde: 
100 mM sodium phosphate buffer (pH 7.0)     50 ml 
Paraformaldehyde        8.0 g 
The solution was heated to 60°C with stirring for 20mins. Maintaining heat and 
agitation NaOH (≥ 5M) solution was added drop wise until the solution cleared. The 
solution was stored at 4°C for up to 3 months. 
 Fixative 
16% (w/v) Paraformaldehyde       0.5 ml 
PBS          2 ml 
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 Click-iT® reaction buffer mix 
All buffer components were made up as per instructions from Molecular Probes. 
 Click-iT® cell reaction buffer       440 µl 
Copper (II) sulphate (100 mM)      10 µl 
Click-iT® cell buffer additive       50 µl 
 STORM imaging buffers 
 50 mM Tris buffer containing 10 mM NaCl (pH 8.0) 
Tris base         6.057 g l-1 
NaCl          584.4 mg l-1 
The pH was adjusted to 8.0 prior to autoclaving. 
 MEA 
Mercaptoethylamine (MEA)       77.15 g l-1 
MEA was dissolved in 50 mM Tris containing 10 mM NaCl to produce 1M MEA stock. 1 
M MEA was diluted 1:10 to 100 mM for normal working concentration in 50 mM Tris 
containing 10 mM NaCl. Stock was stored for up to 1 month at -20°C, once diluted it 
was kept for up to 6 hours on ice. 
 GLOX 
Glucose oxidase stock        5 mg ml-1 
Catalase stock         4 mg ml-1 
To 100 mg glucose 100 µl glucose oxidase stock (0.5 mg ml-1) and 10 µl catalase stock 
(40 µg ml-1) were added and the volume made up to 1ml with 50 mM Tris buffer 
containing 10 mM NaCl (pH 8.0). GLOX buffer lasts for approximately 2 hours before 
efficiency reduced. 
 GLOX MEA 
MEA was added to GLOX (Chapter 2.3.6.3) at either 10 or 100 mM. GLOX MEA buffer 
lasts for 2 hours before efficiency reduced. 
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 Tris/EDTA/NaCl Buffer (TES) 
Tris Base         2.42 g l-1 
EDTA          1.86 g l-1 
NaCl          5.84 g l-1 
The pH was adjusted to 8.0 before autoclaving 
2.4 Bacterial strains and growth 
Staphylococcus aureus strains used in this study are listed in Table 2.2. Strains were 
grown on BHI Agar plates, containing antibiotics where necessary to maintain selection 
markers. For short-term storage strains were stored on agar plates at 4°C and for 
longer-term storage strains were stored on Microbank Beads at -80°C. 
Standard growth in liquid culture was aerobic growth at 37°C. A single colony was used 
to inoculate 10ml liquid BHI in a sterile 25ml universal tube, and grown overnight at 
37°C with shaking at 250 rpm. This was then used to inoculate fresh media in a sterile 
conical flask at an OD6oo of ~0.05. Cultures were typically grown to mid-exponential 
phase (OD600 0.3-0.8) at 37°C, 250 rpm. 
2.5 Chemicals & enzymes 
All chemicals were of analytical grade and are shown in Table 2.3. 
2.6 Centrifugation 
A number of different centrifuges were used in the course of this study, their details 
are shown in Table 2.4. 
2.7 Determination of bacterial cell density 
 Optical density measurements 
To determine the bacterial yield of a culture spectrophotometric measurements were 
taken at 600 nm (OD600). Measurements were taken using a Biochrom WPA Biowave 





Strain Genotype Source 
SH1000 Functional rsbU+ derivative 
of 8325-4 
(Horsburgh et al., 2002) 
Sa113ΔdltA Sa113 with dltA gene 
replaced by spectinomycin 
resistance gene, SpecR 
(Peschel et al., 1999) 
Sa113ΔtagO tagO::Ery Andreas Peschel 
JE2 MRSA - Parental strain of 
Nebraska Mutant Library. 
Also known as USA300 JE2 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
NE267 Transposon insertion 
mutant in SAUSA300_1676 
(sgtA) 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
NE596 Transposon insertion 
mutant in SAUSA300_1855 
(mgt) 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
NE1598 Transposon insertion 
mutant in SAUSA300_2040 
(homologous to FtsW, 
member of FtsW, RodA, 
SpoVE family - rodA) 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
NE420 Transposon insertion 
mutant in SAUSA300_1512 
(pbp3) 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
NE679 Transposon insertion 
mutant in SAUSA300_0629 
(pbp4) 
Centre for Staphylococcal Research, 
University of Nebraska Medical Centre 
4421 (pbp3) NE420 transduced into 
SH1000 
Kasia Wacnik 





SH1000 with both pbp3 
and pbp4 contain 
transposon insertion 
Kasia Wacnik 
FtsZ-eYFP SH1000 PSpac-ftsZ-eYFP Christa Walther 




Stock Solution Concentration Dissolved in Storage 
Lysostaphin 2 mg ml-1 20mM Sodium acetate 
(pH 4.6) 
-20°C 
Mutanolysin (Sigma) 1 mg ml-1 25mM sodium 
phosphate containing 
0.1mM MgCl2 (pH 5.7) 
-20°C 












100 mM DMSO -20°C, in dark 
ADA (3-azido-ᴅ-alanine) 
(Iris Biotechnology) 
100 mM DMSO -20°C 
Dipeptide (3-azido-ᴅ-
alanine-ᴅ-alanine) 
100 mM DMSO -20°C 
Alkyl Dyes (Molecular 
Probes) 
0.5 mg ml-1 DMSO -20°C, in dark 
Vancomycin 100mM DMSO -20°C 
NHS-647 (Molecular 
Probes) 
4mM DMSO -20°C, in dark 
NHS-Cy3b (GE 
Healthcare) 
2mM DMSO -80°C long 
term, -20°C 
short term, in 
dark 
ᴅ-serine (Sigma) 2.5M dH2O Room 
temperature 
Wheat germ agglutinin, 
Alexa Fluor® 488 
conjugate (Molecular 
Probes) 
1 mg ml-1 PBS -20°C in dark 
IPTG (Isopropyl-ᴅ-1-
thiogalactopyranoside) 
1 M dH2O -20°C 





Centrifuge Max Volume Max Speed 
Eppendorf Centrifuge 5424 2 ml 14,680 rpm 
Sigma Centrifuge 4K15C 50 ml 5,100 rpm 
Table 2.4 Centrifuges used in this study. 
 
Antibiotic Minimum inhibitory concentration 
(MIC) 
ᴅ-Cycloserine 50 µg ml-1 
Penicillin G 0.5 µg ml-1 
Moenomycin 0.5 µg ml-1 
PC190723 1 µg ml-1 




2.8 Antibiotic minimum inhibitory concentration (MIC) determination 
S. aureus overnight culture was used to inoculate a series of Universal tubes at an 
OD600 of 0.05. Universals contained 10ml liquid media plus a serial dilution of antibiotic 
concentration. Tubes were incubated at 37°C with aeration at 250 rpm for 24h. The 
MIC was determined as the lowest concentration which prevented growth, judged by 
OD 600 values, in comparison to an antibiotic-free control tube. Determined MIC for 
antibiotics used are shown in Table 2.5. 
2.9 Growth of S. aureus with antibiotic treatment 
An overnight culture of S. aureus was used to inoculate a conical flask containing 
sterile BHI liquid media at an OD600 of ~ 0.05. This was incubated at 37°C, 250 rpm for 
90 min to reach an OD600 of ~ 0.3. Antibiotics were then added at required 
concentration, generally 10 x MIC. Cultures were then continued to be incubated at 
37°C, 250 rpm while samples were taken for further analysis. 
2.10 Labelling peptidoglycan 
 Labelling with fluorescent ᴅ-amino acids (FDAAs) 
Non-commercially available FDAAs were synthesised by members of Dr. Simon Jones’ 
group from the Chemistry Department, University of Sheffield as per the methods 
described previously (Kuru et al., 2012, 2015). 
To label inserted peptidoglycan with FDAAs, S. aureus cultures were grown to mid-
exponential phase (as described in Chapter 2.4). 1ml aliquots were then added to 
FDAA at the appropriate concentration (generally 500 µM unless otherwise stated). 
Samples were incubated at 37°C for the required labelling time. Cells were harvested 
by centrifugation and the pellet washed once in PBS prior to further use. 
 Click-iT® reaction 
For FDAAs that contain an azide group rather than an intrinsic fluorophore the Click 
reaction is required to add alkyne containing fluorescent dyes in order to visualise 
FDAA localisation. The Click reaction was carried out on samples fixed as described 
below (Chapter 2.12.1). Cells were incubated with 0.5ml Click-iT reaction buffer mix 




 Labelling the cell surface with NHS-ester dyes 
A 1ml sample of S. aureus was centrifuged and the pellet resuspended in 250 µl PBS 
containing 1 µl NHS ester stock. Sample was incubated for 5 mins at room temperature 
on a rotator for mixing. Labelled cells were then collected by centrifugation and fixed 
using the method described in Chapter 2.12.1. 
 Vancomycin labelling 
 Production of fluorescent vancomycin 
To produce fluorescent vancomycin a 1:1 mix of 2 mM NHS ester fluorescent dye (e.g. 
Alexa Fluor dyes) and 2mM vancomycin was created and 5 µl triethylamine added to 
200 µl of the mix. This was incubated on a rotator at room temperature for 24 h. The 
resultant mix was left in open air to evaporate any excess trimethylamine before 800 
µl 1M Tris-HCl (pH 7.0) was added to react with any remaining NHS groups within the 
Alexa Fluor Dye. This method is modified from Daniel and Errington (2003). 
 Labelling peptidoglycan with fluorescent vancomycin 
Fluorescent vancomycin was used to label either live or fixed cells, the procedure 
remained the same. 1 ml culture or cell pellet re-suspended in 1 ml PBS was incubated 
with 10 µl fluorescent vancomycin for 30 min at room temperature with mixing. 
Labelled cells were then collected by centrifugation and fixed if required.                                                            
2.11 Labelling Protocols 
 Labelling 5 minutes peptidoglycan synthesis with FDAAs for diffraction limited 
microscopy & STORM 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and FDAA added at a concentration of 500 µM (1 mM for dipeptide). Samples were 
then incubated at 37°C on a rotary shaker for mixing for 5 minutes. Cells were then 
pelleted by centrifugation and fixed as per Chapter 2.12.1. For cells labelled with azide 
containing FDAAs the alkyne fluorophore was added to the FDAA via the Click reaction 
(Chapter 2.10.2) on fixed cells. 
 Labelling 5 minutes peptidoglycan synthesis with FDAAs for SIM 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
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and FDAA added at a concentration of 5 mM. Samples were then incubated at 37°C on 
a rotary shaker for mixing for 5 minutes. Cells were then pelleted by centrifugation and 
fixed as per Chapter 2.12.1 
 Labelling 2 minutes peptidoglycan synthesis with FDAAs for STORM 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and FDAA added at a concentration of 500 µM. Samples were then incubated at 37°C 
on a rotary shaker for mixing for 2 minutes. Cells were then pelleted by centrifugation 
and fixed as per Chapter 2.12.1. For cells labelled with azide containing FDAAs the 
alkyne fluorophore was added to the FDAA via the Click reaction (Chapter 2.10.2) on 
fixed cells. 
 Labelling peptidoglycan synthesis during antibiotic treatment 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.4. A 1ml sample was taken 
for labelling prior to addition of required antibiotic to the culture.  1 ml samples were 
taken at 5 minute intervals and FDAA added at a concentration of 500 µM (1 mM for 
dipeptide). Samples were then incubated at 37°C on a rotary shaker for mixing for 5 
minutes. Cells were then pelleted by centrifugation and fixed as per Chapter 2.12.1. 
For cells labelled with azide containing FDAAs the alkyne fluorophore was added to the 
FDAA via the Click reaction (Chapter 2.10.2) on fixed cells. 
 Labelling nascent peptidoglycan synthesis with vancomycin 
To label newly inserted peptidoglycan with fluorescent vancomycin a S. aureus 
overnight was created in BHI containing 0.125M ᴅ-serine. This was used to inoculate a 
conical flask containing BHI with 0.125M ᴅ-serine at an OD600 of ~0.05. This was 
incubated at 37°C, 250 rpm for 90 min to reach an OD600 of ~0.3, samples were 
centrifuged and re-suspended in BHI lacking excess ᴅ-serine. Samples were allowed to 
grow for the required labelling time before samples were taken and labelled with 
fluorescent vancomycin as per previous method (Chapter 2.10.4.2). 
 Labelling whole peptidoglycan with vancomycin 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were 
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harvested by centrifugation and fixed as per Chapter 2.12.1. The fixed cell pellets were 
then resuspended in 1ml PBS and labelled with fluorescent vancomycin at 1 mM 
(Chapter 2.10.4.2). 
 Dual labelling with dipeptide & vancomycin 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and dipeptide added at a concentration of 1 mM. Samples were then incubated at 
37°C on a rotary shaker for mixing for 5 minutes. Cells were then pelleted by 
centrifugation and fixed as per Chapter 2.12.1. The Click reaction was then carried out 
to link the alkyne-containing fluorophore (5 µg ml-1). Following completion of the Click 
reaction cells were pelleted by centrifugation and resuspended in 1 ml PBS and 
labelled with fluorescent vancomycin at 1 mM (Chapter 2.10.4.2). 
 Chemical treatment of labelled samples 
Cells were labelled with FDAAs for 5 minutes as per Chapter 2.11.1 including the 
fixation step. Samples were then treated with chemicals to remove portions of the cell 
wall.  
 Non-covalently bound proteins – resuspended in 5 % (w/v) SDS & boiled for 15 
minutes. Sample was washed multiple times to remove excess SDS. 
 Covalently bound proteins – resuspended in 1 ml 50mM Tris-HCl (pH 7.5) 
containing 2 mg ml-1 pronase & incubated for 90 mins at 60°C. 
 Reducing termini – resuspended in borate buffer (Chapter 2.3.2) and 
approximately 5 mg ml-1 sodium borohydride was added. Sample incubated for 
15 min & the reaction haklted by addition of phosphoric acid to reduce the pH. 
 Teichoic Acids – resuspended in 250 µl 48% (w/v) Hydrofluoric acid for 48 h at 
4°C. 
 Labelling mutant strains to determine off-septal percentage 
Overnight cultures were used to inoculate 50 ml BHI at OD600 of 0.05 and grown at 
37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5 for each strain. 1 ml aliquots were 
taken and FDAA added at a concentration of 500 µM (1 mM for dipeptide). Samples 
were then incubated at 37°C on a rotary shaker for mixing for 5 minutes. Cells were 
then pelleted by centrifugation and fixed as per Chapter 2.12.1. For cells labelled with 
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azide containing FDAAs the alkyne fluorophore was added to the FDAA via the Click 
reaction (Chapter 2.10.2) on fixed cells. 
Samples were then imaged ensuring the same conditions across the strains. To 
determine % off-septal fluorescence average intensity projections of the stacks were 
created & portions of the cells highlighted and the CTCFs calculated. 
 Using the FtsZ-eYFP strain to determine the effect of PC190723 
 Growth of FtsZ-eYFP strain 
The FtsZ-eYFP is under the control of an IPTG inducible promoter. Therefore, within 
the overnight culture and growth culture IPTG was added at 200 µM. 
 Treatment of FtsZ-eYFP strain with PC190723 
An SH1000 overnight culture was used to inoculate 50 ml BHI containing 200 µM IPTG 
at an OD600 of 0.05 and grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.4. 
PC190723 was then addedto the culture at 10 µg ml-1.  
 Labelling FtsZ-eYFP with FDAAs 
1 ml samples were taken and HADA was added at a concentration of 500 µM. Samples 
were then incubated at 37°C on a rotary shaker for mixing for 5 minutes. Cells were 
then pelleted by centrifugation and fixed as per Chapter 2.12.1. Cells were only 
labelled with HADA as fluorescent proteins are not compatible with the Click reaction 
as the presence of copper renders them incapable of fluorescence.  
 Dual Labelling 
 2h followed by 5min with FDAAs 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and initial FDAA added at a concentration of 5 mM. Samples were then incubated at 
37°C on a rotary shaker for mixing for 2 hours. Cells were then pelleted by 
centrifugation and resuspended in 1 ml pre-warmed BHI containing the second FDAA 
at 5 mM and incubated at 37°C on a rotary shaker for mixing for 5 minutes. Cells were 
then harvested by centrifugation and fixed as per Chapter 2.12.1. 
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 Sequential 5 minute labelling 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and FDAA added at a concentration of 5 mM. Samples were then incubated at 37°C on 
a rotary shaker for mixing for 5 minutes. Cells were then pelleted by centrifugation and 
resuspended in 1 ml pre-warmed BHI containing the second FDAA at 5 mM and 
incubated at 37°C on a rotary shaker for mixing for 5 minutes. This was then repeated 
a third time for labelling with the third FDAA. Cells were then pelleted by 
centrifugation and fixed as per Chapter 2.12.1. 
 Sequential 30 minute labelling 
Prior to this experiment a growth curve of SH1000 growth was determined and the 
generation time calculated to be 30 minutes under conditions used. 
An SH1000 overnight culture was used to inoculate 50 ml BHI at OD600 of 0.05 and 
grown at 37°C, 250 rpm for 90 mins to an OD600 of ~0.3-0.5. 1 ml aliquots were taken 
and FDAA added at a concentration of 500 µM. Samples were then incubated at 37°C 
on a rotary shaker for mixing for 30 minutes(single generation time). Cells were then 
pelleted by centrifugation and resuspended in 1 ml pre-warmed BHI containing the 
second FDAA at 500 µM and incubated at 37°C on a rotary shaker for mixing for 5 
minutes. This was then repeated a third time for labelling with the third FDAA. Cells 
were then pelleted by centrifugation and fixed as per Chapter 2.12.1. For cells labelled 
with azide containing FDAAs the alkyne fluorophore was added to the FDAA via the 
Click reaction (Chapter 2.10.2) on fixed cells 
2.12 Preparation of samples for fluorescence microscopy 
 Fixation 
Collected cell pellets were re-suspended in 0.5 ml dH2O and 0.5 ml fixative (Chapter 
2.3.4) for 30 min at room temperature on a rotator for mixing. Fixed cells were then 
washed in dH2O and the pellet collected by centrifugation. 
 Sample preparation for diffraction limited microscopy 
An approximate sample dilution was made of fixed cells in dH2O and 5 µl was applied 
gently to a poly-ʟ-lysine slide (Sigma) and left to air dry. The slide was then washed 
with dH2O and dried with Nitrogen. A coverslip was then mounted with 5 µl imaging 
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buffer and sealed with clear nail polish. Typical imaging buffers used were SlowFade 
Gold antifade mountant (Molecular Probes) or water (LC-MS CHROMASOLVE®, Fluka). 
 Sample preparation for STORM 
 Preparation of coverslips 
High-precision coverslips (No. 1.5H, 22 x 22mm, 170±5 µm, Marienfeld) were cleaned 
by sonicating in 1M KOH for 20 min. The KOH was then rinsed off and the coverslips 
covered by 2 ml poly-ʟ-lysine (0.01% w/v in H2O, Sigma) and incubated for 30 min at 
room temperature. Coverslips were then washed and dried with nitrogen before being 
mounted with a bacterial sample 
 Preparation of sample for BigSTORM 
To a prepared coverslip (Chapter 2.12.3.1) 5 µl of a 1:1000 dilution of TetraSpeckTM 
(0.1 µm, blue/green/orange/dark red, Molecular Probes) were applied and dried with 
Nitrogen.  An appropriate sample dilution was made of fixed cells in HPLC grade water 
(LC-MS CHROMASOLVE®, Fluka) and this was applied to the coverslip on top of the 
TetraSpeckTM and dried with nitrogen. The coverslip was then washed with dH2O and 
dried with nitrogen. The coverslip was mounted in the centre of a poly-ʟ-lysine slide 
with 5 µl STORM imaging buffer (Chapter 2.3.6) and sealed with clear nail polish. 
 Preparation of sample for N-STORM 
An appropriate sample dilution was made of fixed cells in HPLC grade water (LC-MS 
CHROMASOLVE®, Fluka) and 5 µl added to a prepared coverslip (Chapter 2.12.3.1). The 
sample was dried by nitrogen gas, washed in dH2O and dried once again with nitrogen. 
Coverslip was mounted on depression slides (76 x 26 x 1.35 mm, 90° ground edges, 1 
cavity, 15-18 mm, depth 0.6-0.8 mm, Marienfeld) with approximately 100 µl STORM 
Imaging Buffer (Chapter 2.3.6) and sealed with clear nail polish just prior to imaging. 
 Preparation of calibration slide for N-STORM 
TetraSpeckTM (0.1 µm, blue/green/orange/dark red, Molecular Probes) were diluted 
1:1000 in 1 x PBS (1 X PBS pH 7.4, Life Technologies), approximately 100 µl was added 
to a depression slide (76 x 26 x 1.35 mm, 90° ground edges, 1 cavity, 15-18 mm, depth 
0.6-0.8 mm, Marienfeld), covered with High-Precision coverslip (No. 1.5H, 22 x 22mm, 
170±5 µm, Marienfeld) and sealed with clear nail polish. 
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 Sample preparation for SIM 
An appropriate sample dilution was made of fixed cells in HPLC grade water (LC-MS 
CHROMASOLVE®, Fluka) and 5 µl added to a High-Precision coverslip prepared as per 
Chapter 2.12.3.1. The sample was dried by nitrogen gas, washed in dH2O and dried 
once again by Nitrogen. The coverslip was mounted in the centre of a poly-ʟ-lysine 
slide with 5 µl SlowFade® Diamond Antifade Mountant (Molecular Probes) and sealed 
with clear nail polish. 
2.13 Fluorescence microscopy 
 DeltaVision microscopy 
Fluorescence Microscopy was carried out using a DeltaVision deconvolution 
microscope (Applied Precision) equipped with filters required for imaging of 
fluorophore used in this study (Table 2.6 ). Objective used was a UplanSApo 100x oil 
(NA 1.4) and images were detected using a Photometrics CoolsnapHQ CCD camera. 
When required images were deconvolved using Softworx and all images were 
processed using Fiji processing package (v 1.50). 
 Nikon dual-camera microscopy 
Following acquisition of a Nikon dual-cam microscope all standard resolution 
microscopy was carried out using this microscope. Microscopy was carried out on a 
Nikon Ti inverted microscope fitted with a Lumencor SpectraX light engine (395 nm, 
440 nm, 470 nm, 508 nm, 561 nm, 640 nm) and Emission filters for DAPI, GDP, RFP, 
Cy5 and Quad(DAPI/GFP/RFP/Cy5). Single emission filters were used whenever 
possible. Images were using a 100x PlanApo (1.4 NA) oil objective using 1.518 RI oil and 
detected by an Andor Zyla sCMOS camera. Images were acquired using NIS Elements 
software including deconvolution where required. 
 OMX microscopy 
Widefield deconvolution and structured illumination microscopy (SIM) was carried out 
using a GE Healthcare Life Sciences DeltaVision OMX Blaze microscope. 
  Widefield microscopy 
For widefield microscopy samples were illuminated using a 6 colour solid state 
illuminator (LED) with standard filters (Table 2.7). Objective was a 60x 1.42 oil 
planapochromat lens. Focus was controlled using a UltimateFocus hardware Autofocus 
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Module. Z-stacks taken using a fast piezo -z-axis system on the nanomotion sample 
stage. Microscope was controlled and images deconvolved using DeltaVision OMX 
SoftWoRx 6.1.3. 
 Structured illumination microscopy 
SIM samples were illuminated using laser illumination (Table 2.8). Objective and filters 
were the same as for widefield microscopy. For each z slice, samples were imaged in 5 
phase shifts and 3 angles of the illumination pattern, z steps were 0.125 nm. 
Images were reconstructed using SoftWoRx version 6.1.3 and optical transfer functions 
(OTFs) were made according to GE recommendations for image reconstruction. 
 Image rendering 
All diffraction-limited and OMX images were processed and rendered using Fiji, an 
ImageJ based image processing software. Where 2 or more channels were used each 
channel was false coloured. When colours overlap usually an intermediate colour is 
shown, however when this overlap occurs at an area of high intensity or saturation this 
area was depicted as white. All intensity calculations were carried out using tools 
within Fiji on z-projections in single channels. Cell size was determined using DIC 
images and Fiji measurement tool calibrated by image pixel/mm ratio. 
 Stochastic optical reconstruction microscopy (STORM) 
 BigSTORM 
  Hardware setup 
Direct STORM localisation microscopy imaging was used (Heilemann et al., 2008). 
Lasers were focussed onto the back-plane of a 60⨯ 1.4 NA oil immersion objective 
mounted in an Olympus IX71 inverted optical microscope (Table 2.9). A filter cube 
containing an appropriate long-pass dichroic filter and band-pass emission filter was 
inserted. A piezoelectric motor (Physik Instrumente) was used to adjust focus. An 
image expander comprising a 35 mm and a 100 mm lens was used to project the image 
onto a Hamamatsu ImagEM camera. A 1 m focal length cylindrical lens was inserted 
between the image expander lenses to allow for compensation of drift perpendicular 
to the focal plane (Huang et al., 2008). Focus was maintained by repeatedly localising a 
fiducial particle and adjusting the objective position using the piezo to maintain a 
constant ratio of the fitted full-width half maxima (FWHM) in perpendicular directions. 
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Laser power was adjusted to maximize signal without saturating the charge-coupled 
device. The camera and piezo were controlled using Labview. 
  Image reconstruction 
Image processing was conducted using localization microscopy methodology as 
previously described (Huang et al., 2008). Data were processed by fitting Gaussian 
functions to individual molecule fluorescence using Matlab. Drift in the focal plane was 
corrected retrospectively by tracking a fiducial particle throughout the acquisition 
sequence and offsetting localizations against its position.  
  Image rendering 
Images were rendered using ThunderSTORM ImageJ/Fiji plugin (Ovesný et al., 2014). 
Data points were plotted on a 256 x 256 pixel area histogram with 100 nm z steps from 
-500 nm to 500 nm. For 2D projections, maximum intensity projections were created. 
For 3D data, points were false coloured according to their z step prior to creation of a 
maximum intensity projection. 
 N-STORM 
N-STORM was carried out using a Nikon Ti-NS N-STORM version 1 with 3D capability. 
Objective used was a SR Apo TIRF 100x and images detected using EM-CCD (Andor DU-
897) camera. Microscope control is via the NIS elements software with the N-STORM 
module. 
  Calibration 
A sample of fluorescent beads (See Chapter 2.12.3.4) was imaged over an 800 nm shift 
in z using the 3D calibration tool in the software. The shape of the beads was then 












DAPI HADA 360/40 457/50 
mRFP TADA, TMR, 
Amersham Cy3B 
580/20 630/60 
Cy5 AlexaFluor647 640/20 685/40 
Table 2.6 DeltaVision Filters 




638/40 Alexa Flour 647 
Table 2.7 OMX Filters 
Laser Line Compatible Fluorophores 
445 nm HADA 
488 nm NADA 
568 nm TADA 
642 nm Alexa Flour 647 
Table 2.8 OMX SIM Laser Lines 













OBIS 405 50 NA NA NA 
Sapphire 514 75 514 542 (27) YFP 
Sapphire 561 75 561 593 (40) Tetramethyl-
rhodamine (TMR) 
OBIS 647 120 662 676 (29) Alexa Flour 647 
Table 2.9. Details for Laser lines used in BigSTORM.  
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 Data acquisition 
Data was acquired for ~80,000 frames and focus was kept using the Nikon perfect 
focussing system. Imaging lasers used were 647 nm for Alexa Fluor 647 at 100% and 
568 nm for Amersham Cy3B at ~50%. The 405 nm laser was used for activation and 
adjusted according to the number of events per frame either manually or using the 
AutoLP function. The N-STORM filter-cube was used for single colour experiments, 
collecting light above 675 nm. For dual colour the red/far red cube was used collecting 
575-625 nm and above 660 nm and images were taken by consecutive switching 
between the two channels which is the standard multicolour imaging mode in N-
STORM imaging. 
  Data processing 
Localisation of events was carried out by the N-STORM module of the Nikon NIS 
elements software version 4.20.02 using default settings for screening minimum and 
maximum height. Images were rendered using the same system as BigSTORM (Chapter 
2.13.5.1.3) 
2.14 Purification of cell walls 
 Extraction of cell walls 
An overnight culture was used to inoculate a conical flask containing liquid BHI to an 
OD600 of ~0.05. This was incubated at 37°C, 250 rpm until required OD600 was achieved 
(generally OD600 ~ 0.6). Cultures were then boiled for 10 min to kill the cells before 
being collected by centrifugation. Pellets were re-suspended in 5% (w/v) SDS at 55°C 
and boiled for 30 min to remove non-covalently bound cell wall components. Cells 
were collected by centrifugation and re-suspended in 4% (w/v) SDS and boiled for 15 
min. Material was then washed six times in dH2O at 60°C and collected by 
centrifugation to remove excess SDS. Pellets were re-suspended in 50 mM Tris-HCl (pH 
7.5) containing 2 mg ml-1 pronase and incubated at 60°C for 90 min to remove 
covalently attached proteins. Additional cell wall polymers were removed by 
incubation in 250 µl 48% (w/v) hydrofluoric acid (HF) at 4°C for 48 h. The purified 
peptidoglycan was washed at least six times in dH2O and once in Tris-HCl (pH 7.5) until 
the pH decreased beyond 5.0. Purified sacculi were stored as pellets at -4°C. 
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 Breaking cells for imaging 
When broken cells were required for imaging of sacculi breakage occurred 
immediately following the first boiling step (Chapter 2.14.1). Cells were broken by 
FastPrep. Thick suspensions of boiled cells were added to lysing matrix tubes 
containing 0.1 mm silica spheres (Lysing Matrix B, MP Biomedicals). These samples 
were mechanically sheared six times at 6.0 m s-1 for 30 s using an MP Biomedicals 
FastPrep 24 Homogeniser at 4°C, ensuring samples did not over heat. Amount of 
breakage was assessed by microscopy and further mechanical shearing was carried out 
if required. Cells were recovered by centrifugation for 30 s at 1000 rpm to remove 
beads from the cell suspension. 
2.15 Preparation of cell walls for biochemical analysis 
 Preparation of fluorescently labelled sacculi 
Overnight cultures were used to inoculate conical flasks containing liquid BHI to an 
OD600 of 0.05 and were grown at 37°C, 250 rpm until exponential phase (OD600 ~0.3-
0.4). HADA was added to cultures at 1mM and cultures were incubated for 30 min at 
37°C, 250 rpm. Peptidoglycan was then extracted as described in Chapter 2.14. 
 Digestion of peptidoglycan to produce soluble muropeptides 
Fluorescently labelled & unlabelled peptidoglycan was freeze dried. Peptidoglycan 
(~1mg) was then re-suspended in 250 µl mutanolysin (1 mg ml-1) made up to 1 ml with 
25 mM sodium phosphate buffer containing 0.1 mM MgCl2 (pH 5.7). This was 
incubated at 37°C for 18h and was boiled for 5 min to stop the reaction. The soluble 
peptidoglycan was collected by centrifugation and collection of the supernatant. To 
this was added 40 µl lysostaphin (2 mg ml-1) and 20 µl 1M Tris HCl (pH 8.3) to adjust pH 
to 7. This was incubated at 37°C overnight and was boiled for 5 min the stop the 
reaction. 
 Sodium borohydride reduction of soluble peptidoglycan material 
The resolution of HPLC separation is reduced in the presence of - and - anomers of 
peptidoglycan. Following solubilisation reduction of peptidoglycan with sodium 
borohydride was carried out. The pH of soluble peptidoglycan was raised by addition 
of borate buffer (Chapter 2.3.2) and approximately 10 mg ml-1 sodium borohydride 
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was added. The sample was incubated for 15 min at room temperature and the 
reaction halted by adjusting the pH to pH 4 using phosphoric acid. 
 HPLC separation of muropeptides 
The pH of solubilised peptidoglycan samples was adjusted to pH 5.6 and samples were 
filtered (0.2 µm, Spartan 13/0.2, GE Healthcare). A Thermo Scientific Hypersil GOLD aQ 
column (250 x 4.6 mm, 3 µm particle size) was pre-equilibrated with Buffer A (Chapter 
2.3.3.1) in a Waters HPLC system. Muropeptides were eluted at a flow rate of 0.5 ml 
min-1, using a linear gradient 0-100% Buffer B (Chapter 2.3.3.2) containing 30% (v/v) 
methanol over 140 min. Elution of muropeptides was detected by monitoring 
absorbance at 202 nm and fluorescence (Excitation 360 nm, Emission 457 nm for 
HADA). Peaks were collected manually for further analysis. 
2.16 Incorporation of 14C-labelled N-acetylglucosamine into cell wall peptidoglycan 
The rate of peptidoglycan synthesis was determined by measuring incorporation of 
14C-GlcNAc (Maki et al., 2001). S. aureus was grown overnight in CDM and used to 
inoculate fresh CDM to an OD600 of 0.05 and grown to early exponential phase.  At this 
point 5 µM 14C-GlcNAc (45 µCi mmol-1) was added to cultures as supplied. At 30 min 
intervals 0.5 ml samples were transferred to a microfuge tube containing 0.5 ml ice-
cold 10 % (w/v) Trichloroacetic acid (TCA) and incubated at 90°C for 15 mins and 
placed on ice for 30 min. Samples were then filtered on Glass Microfibre filters 
followed by 5% (w/v) TCA washing. Filters were then immersed in 10 ml Ultima GoldTM 
(Perkin Elmer) and radioactivity was counted with a liquid scintillation analyser 
(Packard Liquid Scintillation Analyzer Model Tri-Carb 31007R) using direct 
disintegrations per minute (DPM) counts with a count time of 10 min per sample.
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Chapter 3  
Use of fluorescent ᴅ-amino acids to analyse peptidoglycan synthesis 
in Staphylococcus aureus  
 
The work in this chapter was carried out in collaboration with Stéphane Mesnage 
(biochemical analysis of muropeptides) and Christa Walther & Robert Turner (STORM 
& SIM microscopy). 
3.1 Introduction 
 Labelling peptidoglycan synthesis 
Investigation into the localisation of peptidoglycan synthesis within bacteria has been 
limited by the availability of labelling tools (Daniel and Errington, 2003). Initial studies 
into peptidoglycan synthesis used electron microscopy (EM) to localise synthesis 
within extracted cell walls. This was achieved either by autoradiography of 
radiolabelled sacculi or uranyl acetate staining of thin sections (Merad et al., 1989; de 
Pedro et al., 1997). However, these methods are limited since they can be used on 
sacculi only and topology of insertion can therefore be difficult to assess (Daniel and 
Errington, 2003). 
More recently a method was developed that utilizes the ability of bacteria, such as      
E. coli to incorporate a variety of ᴅ-amino acids into the peptide sidechain of 
peptidoglycan (de Pedro et al., 1997). Media supplemented with ᴅ-cysteine allows for 
the exchange of the terminal ᴅ-amino acid via a reaction within the periplasm. The 
thiols within ᴅ-cysteine can be detected using immuno-detection and labels 
compatible with either fluorescence or electron microscopy.  This method is limited to 
use with sacculi and, at concentrations above 1 mg ml-1, ᴅ-cysteine is toxic to bacteria. 
To overcome problems from both these methods Daniel and Errington developed a 
labelling method using a fluorescent derivative of vancomycin (Daniel and Errington, 
2003). Vancomycin is a glycopeptide antibiotic that binds tightly to the terminal ᴅ-ala-
ᴅ-ala in the peptidoglycan peptide side chain (Sheldrick et al., 1978). In most cases the 
terminal ᴅ-ala-ᴅ-ala in bacteria is protected from binding by rapid processing either 
82 
 
into peptidoglycan crosslinks or hydrolysis, therefore vancomycin is thought to 
specifically bind to nascent peptidoglycan (Daniel and Errington, 2003). However S. 
aureus has naturally low carboxypeptidase activity, hence in order to use fluorescent 
vancomycin, S. aureus must be incubated in excess ᴅ-serine (Scheffers and Pinho, 
2005). ᴅ-serine is incorporated into the terminal stem peptide position and is not 
recognised by fluorescent vancomycin. A short pulse of growth with ᴅ-ala allows new 
peptidoglycan synthesised during the pulse to be labelled by vancomycin (Scheffers 
and Pinho, 2005). While labelling with fluorescent vancomycin has allowed greater 
insight into localisation of peptidoglycan synthesis, a probe that allowed direct 
labelling of new peptidoglycan and would be usable in live cells was still necessary. 
In 2012 Michael VanNieuwenhze and colleagues developed fluorescent derivatives of 
ᴅ-alanine as labels of nascent peptidoglycan. Small fluorophores were attached to ᴅ-
alanine to produce fluorescent ᴅ-amino acids (FDAAs) which were found to label the 
peptidoglycan of a variety of bacterial species (Kuru et al., 2012). This labelling was 
found to require viable cells & the ᴅ-enantiomer suggesting active incorporation into 
the peptidoglycan. Chemical analysis of muropeptides suggested that incorporation 
was via periplasmic exchange reactions into position 4 of Gram negative bacteria and 
position 5 of Gram positive bacteria (Kuru et al., 2012). FDAAs provide a tool for the 
labelling of peptidoglycan synthesis sites in a wide variety of bacteria that is applicable 
with any fluorescence detection technique, particularly fluorescence microscopy. 
 Super resolution microscopy 
 Fluorescence microscopy 
Fluorescence is the emission of photons by atoms or molecules following excitation of 
electrons following absorption of energy, usually in the form of an absorbed photon. 
When a photon of an appropriate wavelength is absorbed by a fluorescent molecule 
an electron is excited to a higher energy state and almost immediately falls back to the 
ground state. In this process the energy is released as a photon, but given some energy 
will be lost from this system the released photon is generally of a longer wavelength 
(Murphy and Davidson, 2013). This process can be visualised using a Jablonski diagram 




Figure 3.1. Jablonski diagram showing energy levels occupied by an excited electron 
within a fluorescent molecule. Adapted from (Murphy and Davidson, 2013). 
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wavelength, that is a wavelength that will be absorbed by the fluorescent molecule 
used, this is usually selected by an excitation filter that removes all other wavelengths 
from the excitation light (Figure 3.2). This is then directed through the objective and 
onto the sample. This is different to light microscopy where the light is transmitted 
through the sample to the objective. The released fluorescent signal from the sample 
is then collected by the objective and sent to the camera detector. 
 The diffraction limit 
When light is focussed it does not converge to an infinitely sharp point rather a blurry 
focal spot occurs due to diffraction. In a similar fashion a single point emitter, such as a 
fluorescent molecule, appears as a blurry spot with a finite size (Huang et al., 2010). 
This defines the point spread function (PSF) of the microscope and if two emitters are 
localised within a distance of half the point spread function then they will appear as if 
they were a single object. This resolution limit was recognised by Ernst Abbe and is 
defined by the wavelength of light used (λ) and the numerical aperture of the objective 
used (NA) (Rego et al., 2012). This gives a resolution limit of ~250 nm in x & y and ~ 550 
nm in z given a high NA objective (Huang et al., 2010). Many subcellular functions fall 
within this size limit and so if these are to be imaged a way to circumvent this limit was 
required. 
 Super-resolution microscopy 
A wide range of instruments and methods have been introduced in order to improve 
the spatial resolution of fluorescence microscopy, these fall mainly into two classes. 
1. Patterned illumination to spatially modulate the behaviour of molecules 
2. Single molecule imaging due to stochastic activation of individual molecules 
(Huang et al., 2010). 
 Patterned illumination 
When a patterned light field is applied to a sample it manipulates the fluorescence 
emission. Positive patterned illumination occurs when the light field used for imaging 
is itself patterned while negative patterned illumination uses an additional patterned 









Structured illumination microscopy (SIM) uses a positive pattern of light to illuminate 
the sample, this is typically a sinusoidal pattern created from the combination of two 
light beams. Using such a patterned light source means that an image of the sample is 
taken only of the illuminated subsection of the field and the resultant image is 
composed of both the sample structure and the patterned light structure (Huang et al., 
2010). By taking multiple images using the patterned light by both scanning and 
rotating the light source additional spatial resolution can be acquired (Chapter 3.2.3.2; 
Gustafsson, 2000). In practise this means that for each slice in z, images are taken for 5 
lateral shifts and 3 angles resulting in 15 images per slice. While in theory any 
fluorophore is compatible with the system since no special photophysics are required, 
stable bright fluorophores are advantageous as bleaching during the acquisition 
process can interfere with the reconstruction algorithm (Huang et al., 2010). SIM is still 
limited by diffraction therefore only a doubling of resolution is possible, however using 
the saturated response of fluorophores, it has been possible to achieve resolutions of 
50 nm using saturated SIM (SSIM) (Gustafsson, 2005).  
In contrast stimulated emission depletion (STED) uses negative patterned illumination 
(Hell and Wichman, 1994). A secondary light source, the depletion light, brings an 
excited electron back down to the ground state without the emission of a photon (i.e. 
fluorescence) (Figure 3.1). The depletion light surrounds the focal spot of the 
excitation laser reducing the size of illuminated region of molecules. By scanning this 
sharpened focal spot across the sample and image of greater resolution can be 
acquired without any post acquisition processing (Huang et al., 2010). The depletion 
light is created by diffraction limited optics therefore enhancement is in theory limited. 
However, STED uses the same saturated response of fluorophores as Saturated SIM i.e. 
the number of fluorophores that are capable of generating fluorescence approaches 
zero once the depletion laser intensity is above the saturation level (Murphy and 
Davidson, 2013). When a ring-shaped depletion light above the saturation level is 
applied to the sample only a very small region of the sample near the centre of the ring 
can generate a fluorescent signal (Huang et al., 2010). 
 Single-molecule localisation microscopy 
Problems arise from the diffraction limit due to overlapping emission from multiple 
fluorophores such that they cannot be distinguished from one another. By controlling 
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emission such that only one molecule is emitting at a time it is possible to achieve 
higher resolution than with standard fluorescence microscopy (Betzig et al., 2006). In 
2006, two separate techniques were developed which used this principle to image at 
higher resolutions; photoactivated localisation microscopy (PALM) was developed 
using fluorescent proteins (Betzig et al., 2006), while stochastic optical reconstruction 
microscopy (STORM) was developed for synthetic fluorescent dyes (Rust et al., 2009). 
However this difference in probes initially used is the only major difference in the two 
techniques such that they are generally referred to as PALM/STORM microscopy 
(Murphy and Davidson, 2013). PALM/STORM images are constructed from a series of 
imaging cycles where in each cycle only a subset of molecules are switched on. This 
requires the use of lasers of power 50 to 200 milliwatts (mW) to provide sufficient 
energy to induce single-molecule photoswitching (Murphy and Davidson, 2013).  
PALM imaging uses continuous excitation by a laser of wavelength near excitation 
maximum for the photoactivatable fluorescent protein used. Whenever the proportion 
of single molecules within the field is reduced a pulse of light from a second laser, 
often at 405 nm, is capable of activating inactive fluorescent proteins to increase the 
density of activated fluorescent proteins but still at a resolvable level (Betzig et al., 
2006). This cycle is repeated to create thousands of imaging frames. 
STORM was first used with a Cy3-Cy5 dye pair. Red laser light produces fluorescent 
emission from Cy5, forming a stable dark state while green laser light converts Cy5 
back to a potential fluorescent state at a higher efficiency in the presence of Cy3 (Rust 
et al., 2009). Under conditions where single molecule detection can occur this switch 
can be cycled hundreds of times before permanent photobleaching occurs (Rust et al., 
2009). A version of STORM is known as dSTORM (direct STORM) where single 
fluorescent dyes can be driven into the photoswitchable states with reducing reagents 
under oxygen depletion (Murphy and Davidson, 2013). In this case single fluorophores 
can be switched between the states through the use of a single laser. This requires the 
use of a single fluorescent dye and therefore simplifies the process. 
Following acquisition of several thousand images the precise localisation of each of the 
fluorophores is determined. Each single molecule produces a blurry fluorescent spot. 
By statistical fitting of an ideal PSF to this spot the centre of the detected emission 
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light can be determined giving the precise localisation of the molecule (Betzig et al., 
2006). Once this has been done for each of the frames the image can be reconstructed 
through combination of the frames to produce a high resolution plot of fluorophore 
localisation. 
Due to the requirements of STORM, there is a limit to the fluorescent dyes & proteins 
that are compatible with this technique. Probes require three properties to be a 
suitable STORM fluorophore. Firstly they must have both a “light” and “dark” state 
where at a specific range of wavelengths light is only emitted in the light state (Huang 
et al., 2010). Secondly they must be able to emit a high number of photons before 
becoming dark in order to achieve high resolution. And finally, a low spontaneous 
activation is also advantageous, this reduces the likelihood of more than one 
fluorophore being in the “light” state within a single diffraction limited area (Huang et 
al., 2010). 
Blinking of fluorophores is achieved through the cycling of the fluorophore between a 
number of different energetic states (Figure 3.1). Stochastic photoswitching is 
achieved when a fluorophore cycles between photon emission state transitions (i.e. 
cycling between ground and singlet excited state) and temporary arrest in the triplet 
state (T) (Henriques et al., 2011). At this point fluorophores are sensitive to permanent 
photobleaching if exposed to molecular oxygen, therefore oxygen is depleted in 
imaging samples e.g. by the use of enzyme catalysed oxygen scavenging buffers. 
Recovery of ionized fluorophore to allow continued photoswitching is often achieved 
by the addition of millimolar concentrations of reducing agents into the buffer 
(Henriques et al., 2011). 
In order to achieve 3D STORM single molecules must be accurately localised in the 
axial plane in addition to the lateral plane (Huang et al., 2010). This is achieved through 
the application of astigmatism, whereby light propagating from different planes has 
different focal points. A cylindrical lens inserted into the imaging path causes a shape 
change in the detected light. It is possible to determine the lateral position from the 




 Aims of the chapter 
1. To establish fluorescent ᴅ-amino acid labelling of peptidoglycan insertion in S. 
aureus. 
2. To determine the mechanism of FDAA labelling in S. aureus. 
3. To establish super-resolution microscopy for the analysis of peptidoglycan 
synthesis. 
3.2 Results 
 Fluorescent ᴅ-amino acid labelling in S. aureus 
 Fluorescent ᴅ-amino acids 
Fluorescent ᴅ-amino acids (FDAA) used within this thesis were synthesised by Dr Simon 
Jones’ group (University of Sheffield, Department of Chemistry) when unavailable 
commercially.  
The FDAA’s used fall largely into two groups; FDAAs that were intrinsically fluorescent 
and those that contained azide groups for attachment of fluorophores following 
insertion into peptidoglycan. All FDAAs used can be seen in Figure 3.3. The FDAAs with 
intrinsic fluorophores used were HADA, NADA and TADA (Figure 3.3 A-C) which have 7-
hydroxycoumarin-3-carboxylic acid (emission 450 nm), 4-chloro-7-nitrobenzofurazan 
(emission 538 nm) and tetramethylrhodamine (emission maximum 576 nm) 
fluorophores respectively (Kuru et al., 2012).  
The azide containing FDAAs (Figure 3.3 D&E), also known as “clickable” ᴅ-amino acids 
allow the use of fluorophore not compatible with labelling, e.g. due to size/charge to 
be used as peptidoglycan labels. Alkyne containing fluorophores (Figure 3.3 F & G) can 
be attached to azido-FDAAs via copper catalysed azide-alkyne cycloaddition (Baskin 
and Bertozzi, 2007). An azide containing dipeptide FDAA was also utilised (Figure 3.3 
E). This is a conjugated azido ᴅ-alanine and a second unlabelled ᴅ-alanine with the 
labelled ᴅ-alanine in position 1, therefore the fluorophore is proposed to label position 
4 within the peptide sidechain. 
 Determining concentration of FDAAs required for S. aureus labelling 
Prior to use of FDAAs for peptidoglycan labelling it was important to determine the 




Figure 3.3. Chemical structures of FDAAs & Alkyne Dyes. (A) HADA, (B) NADA, (C) 
TADA, (D) ADA, (E) dipeptide. Coloured portions represent the fluorophores or reactive 
groups while black represents the ᴅ-amino acid backbone and linker structure. (F) 
Tetramethylrhodamine alkyne dye structure. (G) Alexa Fluor 647 structure. Exact 
structure of alkyne derivative not known.  
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achieved by addition of FDAA’s into growth media at a concentration of 0.25-1 mM 
(Kuru et al., 2012). Concentrations of 100 µM – 1mM were tested for each of the 
FDAA’s available ( Figure 3.4 - Figure 3.9) and it was determined that a concentration 
of 500 µM was optimal for each of the FDAAs. This was determined as the lowest 
concentration of FDAA that gave a good fluorescence signal across the different labels. 
The concentration of alkyl dye used within the “click” reaction was also examined 
(Figure 3.8). The Click reaction was carried out following incorporation of the azide 
containing into the peptidoglycan. A concentration of 5 µg ml-1 dye was sufficient for 
azide FDAA labelling within diffraction limited (Figure 3.8) and STORM microscopy 
(data not shown).  The optimal concentration of labelling was also tested for the 
dipeptide label; this was found to be 1 mM (Figure 3.9). 
 Pattern of FDAA labelling over time 
S. aureus was incubated with FDAAs for various times (5 – 30 min) to assess their 
ability to label synthesis of peptidoglycan (Figure 3.10). At 5 min incubation, clear 
division septa are labelled by the FDAAs showing septal rings and plates. This pattern 
continues on increased time incubation however there is also an increase in labelling 
throughout the cell wall suggesting that material remains labelled and that 
concentrations used is sufficient for labelling of synthesis over longer periods. This 
pattern was consistent across all FDAAs used (Appendix I). 
 Mechanism of FDAA labelling in S. aureus 
  Fluorescent ᴅ-amino acids label peptidoglycan 
FDAAs have been shown to label peptidoglycan covalently within both B. subtilis and E. 
coli through retention of fluorescence in purified sacculi of labelled cells (Kuru et al., 
2012). To ensure that this was also the case within S. aureus, peptidoglycan was 
extracted from FDAA labelled cultures and counterstained with Wheat Germ 
Agglutinin(WGA) Alexa Fluor 488 conjugate, a lectin that binds GlcNAc molecules 
(Figure 3.11) (Wheeler et al., 2015). A strong fluorescence signal from the FDAA label 
was present and it was also possible to identify some features of septal labelling such 





Figure 3.4. Testing increasing concentrations of HADA to determine optimal labelling 
conditions. All S. aureus samples were labelled for 5 minutes an analysed by 
fluorescence microscopy. (A) 100 µM HADA, (B) 200 µM HADA, (C) 500 µM HADA, (D) 1 




Figure 3.5. Testing increasing concentrations of NADA to determine optimal labelling 
conditions. All samples were labelled for 5 min. (A) 100 µM NADA, (B) 200 µM NADA, 




Figure 3.6. Testing increasing concentrations of TADA to determine optimal labelling 
conditions. All samples were labelled for 5 min. (A) 100 µM TADA, (B) 200 µM TADA, 




Figure 3.7. Testing increasing concentrations of ADA to determine optimal labelling 
conditions. All samples were labelled for 5 min and a post-fixation click reaction was 
carried out with alkyne Alexa Fluor 647 at 5 µg ml-1. (A) 100 µM ADA, (B) 200 µM ADA, 




Figure 3.8. Testing increasing concentrations of alkyne Alexa Fluor 647 in the click 
reaction with ADA at 500 µM to determine optimal conditions for labelling. (A) 0.5 µg 




Figure 3.9. Testing increasing concentrations of dipeptide to determine optimal 
conditions for labelling peptidoglycan insertion. All samples were labelled for 5 
minutes and post-fixation click reaction was carried out with alkyne Alexa Fluor 647 at 
5 µg ml-1. (A) 500 µM dipeptide, (B) 1 mM dipeptide, (C) 1.5 mM dipeptide, (D) 2 mM 




Figure 3.10. Incorporation of ADA over time. (A) 5 min, (B) 10 min, (C) 15 min, (D) 20 







Figure 3.11. Labelling of peptidoglycan sacculi. Peptidoglycan was extracted from ADA 
labelled S. aureus SH1000 (5 minutes labelling at 500 µM). Following extraction, the 
click reaction with Alexa Fluor 647 and counter staining with WGA Alexa Fluor 488 





 Active growth is required for labelling 
To determine that FDAAs were actively incorporated during peptidoglycan synthesis 
rather than labelling through other means, cells in stationary phase were labelled for 5 
min with ADA (Figure 3.12). In order to visualise cells samples were counterstained 
with WGA-488. These cells were seen to have no fluorescence signal from the FDAA, 
showing that active synthesis of new peptidoglycan is required for FDAA labelling of 
peptidoglycan within S. aureus. 
 Effect of peptidoglycan synthesis antibiotics on labelling 
Peptidoglycan biosynthesis is an important target for a number of antibiotics such as 
penicillin (Bugg et al., 2011). Using these antibiotics, it is possible to investigate the 
incorporation pathway of FDAAs through inhibition of individual steps. 
The most common peptidoglycan biosynthesis targeted antibiotics are β-lactam 
antibiotics. This class of antibiotics covalently bind the serine residues within the 
transpeptidase active sites of penicillin binding proteins (PBPs), thereby preventing the 
assembly of the peptidoglycan layer (Jovetic et al., 2010). During treatment of S. 
aureus with 10 x minimum inhibitory concentration (MIC) penicillin G, peptidoglycan 
synthesis was labelled with HADA (Figure 3.13) and dipeptide (Figure 3.14) for 5 
minutes. Even at 30 minutes post treatment incorporation occurs with the same 
pattern for both HADA and dipeptide however with a decreased level of labelling. 
Transglycosylation reactions in the assembly of the peptidoglycan cell wall are 
inhibited by moenomycin (Braddick et al., 2014). Moenomycin binds the 
transglycosylase active site of PBPs where the elongating glycan chain would normally 
bind (Rebets et al., 2013). Treatment of S. aureus with 10 x MIC moenomycin, while 
peptidoglycan insertion was labelled for 5 minute intervals with HADA, showed no 
change to insertion pattern over 30 minutes suggesting that blocking 
transglycosylation has no effect on the insertion of FDAAs (Figure 3.15). When labelling 
peptidoglycan synthesis with the dipeptide label there is a reduction in signal following 






Figure 3.12. FDAA labelling requires active growth. S. aureus SH1000 in stationary 
phase was labelled with ADA for 5 min (500 µM) and click labelled to Alexa Fluor 647 





Figure 3.13. Labelling peptidoglycan synthesis in S. aureus SH1000 with HADA (500 
µM) during treatment with 10 x MIC penicillin G (5 µg ml-1). Labelling was carried out 
for 5 minutes during treatment. (A) No penicillin G, (B) 0-5 min treatment, (C) 5-10 min 
treatment, (D) 10-15 min treatment, (E) 15-20 treatment, (F) 20-25 min treatment, (G) 





Figure 3.14. Labelling peptidoglycan synthesis in S. aureus SH1000 with dipeptide (1 
mM) during treatment with 10 x MIC penicillin G (5 µg ml-1). Labelling was carried out 
for 5 minutes during treatment. (A) No penicillin G, (B) 0-5 min treatment, (C) 5-10 min 
treatment, (D) 10-15 min treatment, (E) 15-20 treatment, (F) 20-25 min treatment, (G) 




Figure 3.15. Labelling peptidoglycan synthesis in S. aureus SH1000 with HADA (500 
µM) during treatment with 10 x MIC moenomycin (5 µg ml-1). Labelling was carried 
during treatment. A) No moenomycin, (B) 0-5 min treatment, (C) 5-10 min treatment, 
(D) 10-15 min treatment, (E) 15-20 treatment, (F) 20-25 min treatment, (G) 25-30 min 





Figure 3.16. Labelling peptidoglycan synthesis in S. aureus SH1000 with dipeptide (1 
mM) during treatment with 10 x MIC moenomycin (5 µg ml-1). Labelling was carried 
out for 5 minutes during treatment. (A) No moenomycin, (B) 0-5 min treatment, (C) 5-
10 min treatment, (D) 10-15 min treatment, (E) 15-20 treatment, (F) 20-25 min 




ᴅ-cycloserine is an inhibitor of the alanine racemase and ᴅ-alanine-ᴅ-alanine ligase 
(Ddl) thus blocking synthesis of the peptidoglycan precursors (Liechti et al., 2013). 
Treatment of S. aureus with 10 x MIC ᴅ-cycloserine while concurrently labelling 5 
minutes of peptidoglycan synthesis with HADA shows labelling is inhibited at 5 minutes 
incubation with ᴅ-cyloserine (Figure 3.17). Conversely labelling with the dipeptide 
probe, which should enter the cytoplasmic steps of synthesis after the inhibited 
processes, continues as normal until 20 minutes incubation (Figure 3.18). At 20 
minutes post-treatment the toxic effects of ᴅ-cycloserine are apparent. Concentrations 
of dipeptide used are not sufficient to restore growth, therefore changes in labelling 
pattern at later stages are likely an effect of the bactericidal drug action as opposed to 
inhibition of labelling. 
 Biochemical analysis of labelled peptidoglycan 
Peptidoglycan from S. aureus labelled with HADA for 30 min was compared to 
unlabelled peptidoglycan to further characterise FDAA labelling of peptidoglycan. Prior 
to analysis via reverse phase C18 HPLC, peptidoglycan was digested with mutanolysin 
and lysostaphin to produce soluble muropeptides. Muropeptides were separated by 
HPLC and the elution monitored by absorbance at 202 nm for the presence of 
muropeptides and fluorescence for the presence of HADA. Comparison of profiles 
obtained through absorbance monitoring showed no discernible difference between 
the unlabelled and HADA labelled peptidoglycan (Figure 3.19 A). This is likely due to 
the small percentage of total peptidoglycan labelled, approximately 0.2-2.8% of total 
peptidoglycan (Kuru et al., 2012). However, analysis of the fluorescence trace indicated 
the presence of additional HADA labelled muropeptides within the peptidoglycan, of 
note a single peak with a fluorescence value of 4 x 105 counts (retention time = 19.7 
mins) (Figure 3.19 B). Both the labelled and unlabelled were analysed by Mass 
Spectrometry (MS) however it was not possible to identify the fluorescently labelled 
muropeptide and therefore the position of HADA. 
 Using STORM in Staphylococcus aureus 
 Selecting imaging conditions for STORM in S. aureus 
In order to utilise STORM with S. aureus a number of different dyes that have been 
used previously for STORM were tested within available systems. Initial tests were 




Figure 3.17. Labelling S. aureus SH1000 peptidoglycan synthesis with HADA (500 µM) 
during treatment with ᴅ -cycloserine at 10 x MIC (500 µg ml-1). Labelling was carried 
out for 5 minutes during treatment. (A) No ᴅ -cycloserine, (B) 0-5 min treatment, (C) 5-
10 min treatment, (D) 10-15 min treatment, (E) 15-20 treatment, (F) 20-25 min 





Figure 3.18. Labelling S. aureus SH1000 peptidoglycan synthesis with dipeptide (1 
mM) during treatment with ᴅ -cycloserine at 10 x MIC (500 µg ml-1). Labelling was 
carried out for 5 minutes during treatment. (A) No ᴅ -cycloserine, (B) 0-5 min 
treatment, (C) 5-10 min treatment, (D) 10-15 min treatment, (E) 15-20 treatment, (F) 




Figure 3.19.  Biochemistry of FDAA labelling of S. aureus peptidoglycan. Reverse 
phase C18 HPLC Traces of SH1000 peptidoglycan (Black) and 30 min HADA (500 µM) 
labelled SH1000 peptidoglycan (Blue) following digestion with mutanolysin and 
lysostaphin A) UV absorbance at 202 nm, B) fluorescence value (Excitation 360 nm, 








Figure 3.20. Testing fluorescent dyes in STORM. (A) Tetramethylrhodamine (TMR) 
(Linked to ADA labelled S. aureus via Click reaction, 5 minutes labelling with ADA at 500 
µM). (B) Alexa Fluor 647 (NHS-ester labelled S. aureus, 8 µM). (C) Alexa Fluor 647 
vancomycin at 1 mM (GLOX 100 mM MEA). (D) Alexa Fluor 647 vancomycin at 1 
mM(GLOX 10 mM MEA) (E) Amersham Cy3B (NHS-ester labelled S. aureus, 16 µM). 





dSTORM (Jones et al., 2011). TMR was attached to the S. aureus cell wall via click 
reaction to ADA and imaged by dSTORM (Figure 3.20 A). Despite investigation with a 
number of different buffer conditions (50mM Tris containing 10 mM NaCl (pH 8.0), 100 
mM MEA, GLOX, GLOX containing 100 mM MEA) imaging with TMR could not be 
improved from the example shown. Another well studied group of dyes for use in 
STORM include cyanine based dyes such as Alexa Fluor 647 (Henriques et al., 2011; 
Jones et al., 2011). Using an Alexa Fluor 647 NHS ester to label the cell surface, S. 
aureus cells were imaged using the NSTORM system (Figure 3.20 B). With this dye it 
was possible to achieve good resolution in both lateral and axial dimensions. Previous 
work had shown optimal imaging conditions in GLOX buffer containing 10mM 
mercaptoethylamine (MEA) (Dempsey et al., 2011). When Alexa Fluor 647 was used 
within some labelling systems, such as when Click labelled to FDAAs and in use as an 
NHS ester it was beneficial to increase MEA concentration to 100 mM. Conversely 
when AlexaFluor 647 was linked to vancomycin image reconstruction was improved 
with the lower MEA concentration (Figure 3.20 C & D). 
In order to explore dual colour STORM it was necessary to have a second STORM 
compatible dye spectrally compatible with Alexa Fluor 647 and functional in GLOX MEA 
buffer. One of the possible compatible dyes was Amersham Cy3B. When testing the 
NHS ester version of this dye to label the bacterial cell surface, it was possible to 
achieve good resolution and image reconstruction within GLOX 100 mM MEA (Figure 
3.20 E). Therefore, in dual colour STORM experiments Amersham Cy3B and Alexa Fluor 
647 were used as the two dyes. 
 Controls for STORM 
With a sensitive microscopy technique such as STORM it is important to determine the 
presence and contribution of localisations in the absence of the imaging label so that 
they may be taken into account when analysing data. To determine the presence of 
autofluorescence at imaging wavelengths, S. aureus that was not labelled with any 
fluorophores were imaged under the same imaging conditions as in other experiments 
(Figure 3.21). The number of identified autofluorescence molecules were for Alexa 
Fluor 647 imaging <500 and for Amersham Cy3B imaging ~3,000. Those within 
Amersham Cy3B were found to be cell associated. However, this signal was 






Figure 3.21. Autofluorescence detection in STORM. SH1000 without attached 
fluorescence were imaged using imaging conditions for both (A) Alexa Flour 647 and 
(B) Amersham Cy3B. Number of molecules detected were 388 and 3941 respectively. 




The amount of cross talk for each of the dyes used was determined by imaging NHS 
ester-Cy3B or Vancomycin-Alexa Fluor 647 labelled cells under standard imaging 
conditions for both 538 nm and 647 nm (Figure 3.22). The cross talk seen was cell 
associated however, was not deemed to be significant enough to cause 
misinterpretation during dual colour STORM experiments. Another source of non-
specific localisations within STORM samples could come from binding of the Alexa 
Fluor dyes to S. aureus during the click reaction used to attach STORM dyes to FDAAs. 
To determine any background pattern S. aureus that was not labelled with any FDAAs 
was click labelled with Alexa Fluor 647 and STORM imaged using normal imaging 
conditions. The resultant plot showed that while there is fluorescent signal associated 
with the cells there is no pattern of labelling (Figure 3.23). 
 Using SIM in Staphylococcus aureus 
 Testing FDAAs in SIM 
The synthetic fluorescent dyes attached to FDAAs are promising SIM compatible dyes 
however when S. aureus labelled with FDAAs at normal labelling conditions (from 
Chapter 3.2.1.2) were imaged using SIM the samples bleached before acquisition of 
the z-stack was completed. This prevents the processing algorithm from reconstructing 
images that accurately represent the sample.  Since FDAAs are apparently non-toxic to 
cells labelling was carried out with increased concentrations of FDAAs and imaged 
using SIM. It was found that labelling for 5 minutes with FDAAs at 10 x normal labelling 
conditions (i.e. 5 mM) allowed for reconstruction of images within SIM (Figure 3.24). 
This was true for the three FDAAs with intrinsic fluorophores however was not the 
case for Alexa Fluor 647 (Figure 3.24 D). It would be possible to use the ADA or 
dipeptide labels and attach a different fluorophore however since a fourth label was 
not required this was not pursued further. 
 The problem with SIM 
While in theory SIM increases resolution by a factor of 2 and therefore can increase 
the spatial information we can gain from microscopy images, when interpreting 
structures close to the resolution limit it is important to be aware of the appearance of 
artefacts within the image (Georgieva and Nollmann, 2015; Gustafsson, 2005).  In 
particular, the appearance of a residual stripe pattern originating from the illumination 




Figure 3.22. Determining crosstalk of Alexa Fluor 647 and Amersham Cy3B. S. aureus 
labelled with either NHS ester-Cy3B (16 µM, Top Row) or Vancomycin-647 (1 mM, 
bottom row) were imaged under normal conditions for both 538 nm (left hand 
column) and 647 nm (right hand column). Numbers in the top left hand side of each 




Figure 3.23. STORM of SH1000 labelled by the Click reaction in the absence of Click 





Figure 3.24. Testing peptidoglycan labels in structured illumination microscopy. 
Images are shown as maximum intensity projections A) HADA at 5 mM, B) NADA at 5 
mM, C) TADA at 5 mM, D) 0.1 µM vancomycin-647. Scale bar 5 µm. 
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pattern within an image, such as that derived from illumination, is to carry out a 
Fourier transform of an image. Fourier transforms plot sample structure in reciprocal 
space. Therefore in resultant Fourier transformed images low resolution information is 
plotted close to the origin and higher resolution information is plotted further away 
(Gustafsson, 2000). For example, when a Fourier transform of a diffraction limited 
image is taken this is plotted as a circle of the observable region in reciprocal space 
(Figure 3.25 A). However, when structured illumination is used the Fourier transform 
image has a petal shape for this observable region (Figure 3.25 C). This is because the 
lateral shifts of the grating result in moiré fringes of the circle from diffraction limited 
(Figure 3.25 B) and this is repeated for each angle. Therefore, information has been 
gathered for a region double the size of what can be gathered from a diffraction 
limited image, hence the increase in resolution. Within these transformed images it is 
possible to see any underlying structure within the image. For example, the Fourier 
transform of the HADA labelled sample from Figure 3.24 is shown in Figure 3.25 D-F. 
While the Fourier transform of the middle of the z-stack (Figure 3.25 D) shows limited 
structure, Fourier transforms from the bottom (Figure 3.25 E) and Top (Figure 3.25 F) 
show more distinct patterns such as lines and repeating dots in imaging angles. This 
suggests an underlying pattern and therefore caution must be used in analysis of this 
data. For all SIM data found in this thesis corresponding Fourier transforms can be 
found in Appendix II. In practice therefore SIM can be used to crisp up diffraction 
limited images however should not be used to determine any new biology, particularly 
regarding an underlying pattern of fluorescent signal. 
3.3 Discussion 
 Labelling peptidoglycan synthesis in S. aureus 
Since the development of FDAAs in 2012 they have been found to be a useful tool in 
the field of bacterial cell wall research. Compared to previous techniques FDAAs 
provide a direct and covalent means of labelling peptidoglycan synthesis (Kuru et al., 
2012). Unlike ᴅ-cysteine or fluorescent antibiotic labelling of peptidoglycan synthesis, 
FDAAs are compatible with live cell labelling since fixation is not required for imaging. 
Also of advantage is the application of different coloured FDAAs in virtual time-lapse 
since the addition of each new probe indicates the location of peptidoglycan synthesis 







Figure 3.25. Fourier transforms can detect underlying structure in SIM images. 
Schematic of Fourier transforms of (A) a diffraction limited image, (B) Moiré fringes 
due to shifting of the grating pattern and (C) the petal pattern resulting from the use of 
3 angles during image acquisition. Adapted from (Gustafsson, 2000). Fourier transform 
of the z-stack of the HADA labelled sample shown in Figure 3.24 A, from the middle 
(D), bottom (E) and top (F) of the stack.  
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can now be assessed over much longer periods of time than previously possible as well 
as in detail at shorter timescales. 
Taxonomically diverse bacteria have been shown to have tolerance for the 
incorporation of FDAAs, therefore FDAAs have been used across bacterial species to 
investigate new features of peptidoglycan synthesis. For example, application of FDAAs 
and 3D SIM in Streptococcus pneumoniae discovered a new mode of peptidoglycan 
synthesis within elongation (Cadby and Lovering, 2014). Peripheral synthesis in S. 
pneumoniae is different from that in rod shaped organisms as it has been shown to 
occur at the pinched site near the septum. Using FDAAs within S. pneumoniae at the 
mid-to-late stage of cell division peptidoglycan synthesis was located to an outer ring 
and an inner spot of synthesis with the inner spot associated with PBP2x activity (Tsui 
et al., 2014). 
Another example of FDAAs being used to investigate peptidoglycan within bacterial 
species has been in the application of FDAAs to the so-called “chlamydial anomaly” 
(Liechti et al., 2013; Pilhofer et al., 2013). Chlamydial species have been known to 
contain peptidoglycan synthetic genes within their genomes and are susceptible to cell 
wall targeting antibiotics (e.g. ᴅ-cycloserine and penicillin) however peptidoglycan has 
not previously been found within Chlamydia. Using single amino acids FDAAs it was not 
possible to detect PG, however the development of a ᴅ-alanyl-ᴅ-alanine dipeptide 
probe allowed replicating chlamydiae to be labelled, presumably via incorporation into 
peptidoglycan (Kuru et al., 2015; Liechti et al., 2013). 
However, despite the applications of FDAAs in peptidoglycan synthesis labelling, a 
consensus is yet to be reached concerning the labelling mechanism. The promiscuity of 
peptidoglycan metabolic enzymes across bacterial species to the incorporation of both 
natural and unnatural ᴅ-amino acids is well known (Cava et al., 2011; Shieh et al., 
2014). Non-canonical ᴅ-amino acids (NCDAAs) are produced by bacteria in stationary 
phase and their incorporation into peptidoglycan is thought to be important in the 
control of cell wall metabolism (Lam et al., 2009). Control of peptidoglycan metabolism 
is proposed to occur via both their incorporation into the peptidoglycan peptide stem 
and via regulation of peptidoglycan modification enzymes. There are two distinct 
processes by which NCDAAs (and therefore FDAAs) may incorporate into 
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peptidoglycan; either by periplasmic editing of mature peptidoglycan or via 
incorporation into peptidoglycan subunits in the cytosol (Cava et al., 2011). NCDAAs 
have been found in both position 4 and 5 in the peptide stem of peptidoglycan via 
HPLC, the two different positions suggest different incorporation pathways. Formation 
of NCDAAs in position 4 is dependent upon ʟ,ᴅ-transpeptidase reaction in multiple 
Gram negative species. However NCDAAs were not found in position 4 in Gram 
positive species tested but instead in position 5 (Cava et al., 2011). For position 5 
incorporation within B. subtilis the process was determined to be via an 
extracytoplasmic process catalysed by a ᴅ-ᴅ-peptidyl transferase. Within the tested 
Gram negative species formation of NCAAs in position 5 was found to likely occur via 
peptidoglycan precursors. Since other Gram positive species were not tested it is not 
possible to determine whether this mechanism is specific to B. subtilis or more 
general, especially since Ddl and MurF are conserved among bacteria suggesting this 
difference may be attributed to transport mechanisms as opposed to ability of 
cytoplasmic proteins to incorporated NCDAAs (Cava et al., 2011).  
There have been several reported mechanisms for the labelling of peptidoglycan with 
ᴅ-amino acid derivatives. FDAAs were found to incorporate in position 4 in E. coli and 
Agrobacterium tumefaciens and in position 5 in B. subtilis (Kuru et al., 2012). 
Comparing this with previous work on NCDAAs it was hypothesized that FDAAs label 
via extracytoplasmic reactions mediated by ʟ,ᴅ-transpeptidases (Ldts) in Gram 
negatives and PBPs in Gram positives. At the same time as FDAAs were developed, a 
second group utilised ᴅ-amino acids functionalised with azide and alkyl groups to label 
peptidoglycan in vivo (Siegrist et al., 2013). They postulated that these ᴅ-amino acids 
were incorporated via the biosynthetic pathway with the same two possible pathways 
as hypothesized for NCDAAs. They determined that the pathway used would 
determine the position that ᴅ-amino acid reporters would be located on the peptide 
sidechain; periplasmic editing of mature peptidoglycan would result in labelling in 
either the 4th or 5th position while cytosolic incorporation into precursors would result 
in labelling in position 5 only (Siegrist et al., 2013). Since in many bacteria the 5th 
position is rapidly processed, the presence of labelled ᴅ-amino acids in position 5 is 
presumed to be labelling of new peptidoglycan irrespective of the labelling 
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mechanism. However since S. aureus has low carboxypeptidase activity the picture is 
not as clear (Scheffers and Pinho, 2005; Siegrist et al., 2013).  
In this thesis I was unable to identify the position of FDAAs within the S. aureus 
peptidoglycan despite identification of a fluorescent peak during HPLC analysis. This is 
most likely due to the low abundance of material. It is presumed that FDAAs will label 
only a small proportion of the peptidoglycan, particularly since the presence of such a 
big additional group is likely to interfere with the processing of peptidoglycan. There 
are a number of different approaches to take in order to resolve this including 
increasing the portion of labelled material by incubating S. aureus cultures with a 
saturating concentration of HADA. In addition, this could be done in the presence of a 
ᴅ-alanine racemase inhibitor or a mutant strain however, this may prove toxic to the 
cells. Other approaches include using different enzymes for peptidoglycan digestion or 
the use of a radioactive derivative of HADA as detection and quantification of 
radioactivity is easier than the detection of fluorescence using the analysis systems 
available. It may also be possible to increase the amount of labelling in a mutant strain 
that had increased labelling for example an autolysin mutant or strain with decreased 
crosslinking. However, a strain with increased FDAA labelling has not yet been 
identified. 
The complete blockage of FDAA labelling by antibiotics that inhibit the early stages of 
peptidoglycan synthesis (ᴅ-cycloserine) while treatment with antibiotics that inhibit 
the extracytoplasmic assembly enzymes (penicillin) allows a mechanism of FDAA 
labelling in S. aureus to be proposed. The majority of peptidoglycan labelling is due to 
synthesis of precursors, the single FDAA is joined into a dipeptide by the ᴅ-alanine-ᴅ-
alanine ligase (Ddl) and then attached to the precursor via MurF. This MurF step is also 
the proposed incorporation step of the dipeptide label. However, one cannot rule out 
the possibility of FDAA labelling occurring via an extracytoplasmic exchange reaction 
catalysed by the PBPs (Kuru et al., 2012, 2015; Qiao et al., 2014). The dipeptide label 
has to be incorporated by synthesis, while single FDAAs may be incorporated by both 
pathways (Liechti et al., 2013). Complete removal of labelling by ᴅ-cyloserine suggests 
that the single FDAA does indeed insert via the cytoplasmic steps, however since ᴅ-
cyloserine is a substrate analog it is also possible that its presence can inhibit any 
potential exchange reaction. The decrease in signal from dipeptide labelling during 
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moenomycin treatment, while fluorescence is maintained with the HADA label 
suggests that insertion of the dipeptide label requires transglycosylase action whereas 
HADA incorporation does not. Once moenomycin is added, the transglycosylase 
reaction will be inhibited and the rest of the synthesis pathway will also stop to 
prevent build-up of excess lipid II, preventing dipeptide incorporation. However, HADA 
will be free in the periplasm where it can be incorporated via the exchange reaction. 
This suggests that even with the inhibition of synthesis the level of labelling is 
maintained due to an increase in exchange reaction.  
There are 4 PBPs in S. aureus, with PBP4 being the most plausible candidate for ᴅ-
amino acid exchange. PBP4 is a low molecular weight PBP, however surprisingly it has 
transpeptidase activity both in vitro and in vivo (Qiao et al., 2014). It is a promiscuous 
enzyme that can interact with both new peptidoglycan and lipid II monomers, 
suggesting a biological role in incorporating additional crosslinks to increase rigidity, 
indeed peptidoglycan from a strain lacking PBP4 has reduced crosslinking (Curtis et al., 
1980; Qiao et al., 2014). Both in vivo and in vitro studies show that PBP4 can use both 
lipid II and peptidoglycan as a substrate for FDAA probes (Qiao et al., 2014). It is 
possible to suggest that both cytoplasmic incorporation of FDAAs and extracytoplasmic 
exchange mediated by PBP4 are involved in FDAA peptidoglycan labelling in S. aureus. 
This poses the question, do FDAAs still label peptidoglycan synthesis within S. aureus? 
Since PBP4 was shown to bind and activate nascent peptidoglycan and lipid II it is 
reasonable to assume that all labelling mediated by PBP4 occurs only at the sites of 
new peptidoglycan therefore all detected fluorescent signal from FDAA labelling can be 
attributed to the location of peptidoglycan synthesis (Qiao et al., 2014). 
One approach to avoiding any complications from multiple labelling mechanisms is to 
use a label which solely labels via the cytoplasmic labelling pathway. The ᴅ-alanyl-ᴅ-
alanine dipeptide probe developed by Kuru and colleagues can be used as a synthesis 
only label (Kuru et al., 2015). The dipeptide probe bypasses the Ddl enzyme and enters 
the cytoplasmic pathway via MurF (Liechti et al., 2013). By comparing labelling 
patterns of cells labelled with single FDAAs and with dipeptide it is possible to 
determine if there are any additional patterns that do not arise from peptidoglycan 
synthesis during. This is of particular use since currently the dipeptide is only available 
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with functionalized groups and therefore does not have as widespread an application 
as the single FDAAs. 
A further approach to deciphering labelling mechanisms is to use an in vitro analysis to 
assess the ability of enzymes within the peptidoglycan biosynthesis pathway to use 
FDAAs as substrates. Thereby it may be possible to determine the ability of PBP4, Ddl 
and MurF from S. aureus to use FDAAs without the complexity of whole cell systems. 
Looking at the in vitro ability of purified systems to incorporate labels into 
peptidoglycan can unravel mysteries surrounding incorporation pathways as well as 
informing future development of peptidoglycan labels (Lebar et al., 2014).  
Following the success of FDAAs in labelling peptidoglycan synthesis it is wise to 
question whether there are any other means of labelling peptidoglycan synthesis. 
Particularly by using a similar approach i.e. fluorescent or functionalised derivatives of 
components of bacterial muropeptides. Due to the presence of ʟ-amino acids in a large 
number of structures labelling any ʟ-enantiomers in the peptide sidechain would lead 
to high background labelling of proteins and other structures. The same is true for 
labelling of the peptide crossbridge, which in S. aureus is attached to the muropeptide 
before it traverses the membrane by the Fem system (Münch et al., 2012). This leaves 
the ᴅ-glutamic acid in position 2 as a possible site for labelling. However, this amino 
acid is amidated at the α-carboxyl to produce ᴅ-iso-glutamine by the essential 
GatD/MurT enzyme complex suggesting that labelling at this position may prove lethal 
(Figueiredo et al., 2012; Münch et al., 2012). 
The other structure which can be probed for peptidoglycan synthesis is the sugar 
backbone. This repeating GlcNAc-MurNAc structure is produced via the same process 
across bacterial species (Typas et al., 2012) suggesting that sugar labelling would be a 
universal peptidoglycan synthesis probe. However, during the synthesis of 
peptidoglycan GlcNAc goes through a number of different reactions limiting the sites 
at which a functionalised group can be added (Navarre and Schneewind, 1999). Other 
possibilities include labelling of MurNAc either on the sugar or within the lactyl group, 
however there is unlikely to be a transport protein that will allow the ingress of these 
labels into the cytoplasm. In the same manner, feeding cells with labelled lipid II is 
unlikely to lead to labelled peptidoglycan. Despite the many possible limitations, these 
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sugar-based probes should not be dismissed out of hand. An azide derivative of GlcNAc 
(GlcNAz) has been successfully used to label S. aureus (Memmel et al., 2013). However, 
this probe has the ability to label glycoproteins, glycolipids and extracellular 
polysaccharides in addition to peptidoglycan and the specificity of labelling from this 
probe has not yet been determined. 
 Using super-resolution microscopy in S. aureus 
Due to the small size of bacterial cells, super-resolution techniques have proved 
particularly powerful. Light microscopy is limited by resolution which restricts 
localisation within bacterial cells. Electron microscopy has been able to increase 
resolution due to the subnanometre wavelength of electrons however identification of 
specific structures (e.g. individual proteins) is not always possible and EM is not 
compatible with live cells (Coltharp and Xiao, 2012). Recent advances in super-
resolution microscopy techniques have achieved resolutions of 10-50 nm while taking 
advantage of labelling specificity and live cell compatibility that is possible with light 
based microscopy techniques. 
The first developed super-resolution microscopy technique was stimulated-emission-
depletion microscopy (STED) (Hell and Wichman, 1994). A depletion pattern surrounds 
the excitation laser, bringing excited fluorophores to ground state before it can emit 
fluorescence thereby reducing the area of molecules that can fluoresce (Hell and 
Wichman, 1994). In theory this system has unlimited resolution however aberrations in 
optics, scattering from the sample and photostability of fluorophores means that the 
current maximum achieved resolution is 6 nm. However, this occurred studying 
fluorescent defects in diamonds, a process with minimal photobleaching. In biological 
samples the best resolutions achieved are 20 nm with organic dyes and 50-70 nm with 
fluorescent proteins (Huang et al., 2010). A further advantage of STED is the 
application with live samples, especially when sample size is small for example imaging 
bacteria. S. aureus labelled with any of the FDAAs would be ideal samples for STED 
however since complex instrumentation is required it was not possible to test this. 
Structured illumination microscopy (SIM) also uses patterned illumination to achieve 
super-resolution however it uses a positive pattern of illumination (Huang et al., 2010). 
Patterned light is passed across the sample so that each point on the sample is 
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illuminated, with multiple images taken per slice. The resultant images are processed 
via a reconstruction algorithm to produce an image of the sample with greater 
resolution. The advantage of SIM is that no special photophysics are required for 
fluorescent probes and similarly to diffraction limited microscopy, it is easily applicable 
to live cell microscopy (Huang et al., 2010). Despite this it is important to note that 
most practical applications of SIM suffer from the introduction of artefacts into images 
(Schaefer et al., 2004). Often these artefacts take the form of residual stripe patterns 
from the illumination and if not recognised they can influence analysis of images. With 
SIM it is often not possible to use it to discover new biology however images can make 
features seen in diffraction limited microscopy clearer. 
The third super-resolution technique uses single molecule localisation technology. 
There are two main types: photoactivation localisation microscopy (PALM) and 
stochastic optical reconstruction microscopy (STORM). Probes cycle between a dark 
and light state such that in each frame only a subset of molecules are in a light state, 
allowing the centre of molecules to be precisely localised and a resolution of ~25 nm in 
the lateral dimension is therefore achievable (Jones et al., 2011). The advantage of 
such high resolution is that processes can be localised to within molecular resolution, 
however due to the high number of frames required for this high resolution it is limited 
in its application with live cells and therefore in the dynamics of structures (Coltharp 
and Xiao, 2012). Recent developments in reconstruction software and camera sensors 
allow for high throughput STORM by reducing image acquisition time and increasing 
fields of view suggest that live cell STORM may be more widely applicable in the future 
(Almada et al., 2015). Another limitation in the application is the availability of dyes 
and proteins compatible with STORM/PALM since they must be able to undergo 
special photophysics in order to be compatible (Henriques et al., 2011). This is 
particularly problematic within fluorescent proteins. However, there are currently a 
number of synthetic dyes compatible with STORM that can be used in conjunction with 
cell wall labelling.  
Future development of super-resolution microscopy is currently focussed on the 
development of correlative light and EM or AFM microscopy, such that the advantages 
of protein/structure localisation of super-resolution microscopy can be applied to the 
high-resolution images possible with EM and AFM (Coltharp and Xiao, 2012; Watanabe 
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et al., 2011). This has already been applied to EM where both STED and PALM 
microscopy has been correlated with EM within a number of different eukaryotic cell 
types (Watanabe et al., 2011). The application of correlative microscopy would be 
particularly advantageous in the investigation into the architecture of bacterial 
peptidoglycan to link what is known about the synthesis and chemistry of 




Chapter 4  
Analysis of the pattern of peptidoglycan synthesis in Staphylococcus 
aureus 
 
The work in this chapter was carried out in collaboration with Christa Walther & 
Robert Turner (STORM & SIM microscopy). 
4.1 Introduction 
 Cell wall architecture in S. aureus 
Peptidoglycan architecture is important in maintaining cell morphology and viability 
(Wheeler et al., 2011). While the biochemical composition of peptidoglycan is well 
understood, it is only in recent years that the architecture and dynamics of the cell wall 
have begun to be resolved. 
Traditionally peptidoglycan architecture was thought of in terms of glycan strand and 
peptide side chain orientation. Two opposing models were proposed; the first layered 
model (and modifications of that model) suggested that glycan strands were arranged 
parallel to the cytoplasmic membrane (Koch, 1998a; Verwer et al., 1978), whilst the 
second (scaffold model) suggested glycan strands were arranged perpendicular to the 
membrane (Dmitriev et al., 2003). While there has been greater support of the layered 
model neither is perfect and in the light of recent high resolution techniques it is 
apparent that peptidoglycan architecture is diverse across bacterial species (Turner et 
al., 2014; Vollmer and Höltje, 2004). 
In Gram negative bacteria, particularly E. coli, the architecture of peptidoglycan was 
proposed to comprise of glycan strands parallel to the plasma membrane running 
circumferentially around the cell in a disorganised hoop-like fashion (Gan et al., 2008). 
More recently atomic force microscopy (AFM) studies has suggested that glycan 
strands are parallel to the cell surface but have no general orientation despite large 
scale circumferential organisation (Turner et al., 2013). This disordered architecture 
was found to appear in all tested Gram negative species, suggesting a common 
architecture throughout Gram negatives. 
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On the other hand Gram positive bacteria have been shown to have a number of 
different peptidoglycan architectures (Hayhurst et al., 2008; Turner et al., 2010a, 2014; 
Wheeler et al., 2011). AFM studies of B. subtilis peptidoglycan suggests the presence of 
~50 nm peptidoglycan cables that run across the short axis of the cell (Hayhurst et al., 
2008). Similar studies in ovococci bacteria showed that glycan strands preferentially 
orientate circumferentially, across the short axis and produce parallel bands of 
material, thought to be several intertwined glycan strands (Wheeler et al., 2011).  
S. aureus has a dynamic peptidoglycan architecture consisting of thick bands, rings and 
knobbles that change as cells progress through division cycles (Turner et al., 2010a). 
Thick bands of material, known as piecrusts, encircle intact cells on the inner surface of 
the peptidoglycan sacculus. These thickenings are formed prior to the centripetal 
assembly of the septal disk and are proposed to specify the siting of division planes 
(Turner et al., 2010a). The third architectural feature, knobbles, occur due to 
remodelling of the septal ring architecture through autolysis during cell spitting and 
expansion of new hemispheres. S. aureus peptidoglycan architecture is produced by 
the balance of peptidoglycan synthesis and hydrolysis (Turner et al., 2010a; Wheeler et 
al., 2015). 
Synthesis of new cell wall material in S. aureus has been shown to occur specifically at 
the cell division site, i.e. the septum (Pinho and Errington, 2003; Turner et al., 2010a). 
This synthesis occurs via the production of a ring of material (the piecrust) bisecting 
the cell, then the completion of the septal disk, associated with an apparent spiral 
septal architecture. In addition to AFM, transmission EM (TEM) of whole cells and 
extracted fragments has shown the progression of synthesis at the division septum to 
follow such a pattern (Matias and Beveridge, 2006, 2007). A thick peptidoglycan bridge 
is synthesised at the septum site in the mother cell wall, this is thought to correspond 
to the piecrust feature seen in AFM images (Turner et al., 2010). New peptidoglycan is 
added to the leading edge of the septum which appears to exist as two separate 
entities (Matias and Beveridge, 2007). As the septum growths in length it is also 
thickened by additional peptidoglycan synthesis or remodelling. 
Previous work on the synthesis has relied on diffraction-limited microscopy, and as 
such, any models may miss features of peptidoglycan synthesis. In E. coli the 
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application of stochastic optical reconstruction microscopy (STORM) to determine 
localisation of peptidoglycan synthesis revealed multiple distinct foci of peptidoglycan 
insertion spread over the cell cylinder in addition to septal peptidoglycan insertion 
(Turner et al., 2013). Such application of super-resolution microscopy to S. aureus may 
reveal additional features in peptidoglycan synthesis. 
 S. aureus divisome 
S. aureus is closely related to B. subtilis however, it has an apparently less complex 
mechanism of growth, in that it lacks an elongation phase. Therefore, while there will 
be conservation of the divisome, S. aureus is likely to be simpler with less redundancy. 
Homologs of genes essential in B. subtilis are putatively essential in S. aureus as well as 
some non-essential genes (Chaudhuri et al., 2009). This is likely due to the lack of 
genes with overlapping function in S. aureus. 
Compared with B. subtilis and E. coli, S. aureus has a minimal biosynthetic machinery, 
likely due to the apparent single mode of synthesis (Pinho and Errington, 2003). S. 
aureus has only 4 PBPs, of these only 2 have been shown to be essential; PBP1 & PBP2 
(Pereira et al., 2007; Pinho et al., 2001; Wada and Watanabe, 1998). PBP2 is a class A 
HMW PBP, with dual transglycosylase and transpeptidase activity while PBP1 is a 
transpeptidase only. Some evidence suggests that PBP1 essentiality is due only to the 
presence of the protein not necessarily its transpeptidase activity, however functional 
transpeptidation is required for normal growth (Pereira et al., 2009). As well as the 
PBPs, S. aureus encodes 4 other proteins with potential peptidoglycan biosynthetic 
roles: two monofunctional transglycosylases SgtA & MGT, and two auxiliary proteins 
FmtA & FmtB. All PBPs have been localised primarily to the septum as well as a 
number of other division proteins such as FtsZ, EzrA & GpsB (Pinho and Errington, 
2003, 2005; Scheffers and Pinho, 2005; Steele et al., 2011). In addition to the 4 native 
PBPs, MRSA strains contain an additional PBP, PBP2A/MecA (Zapun et al., 2008b). In 
the presence of β-lactam antibiotics MecA is induced and can act as the only 
transpeptidase as it has low affinity for the drug present. In this case PBP2 remains 
essential since the transglycosylase activity is required (Pinho and Errington, 2005). 
Even with such a simplified set of enzymes required for peptidoglycan synthesis S. 
aureus is capable of growth when only 2 of these are expressed (Reed et al., 2015). 
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These are the 2 essential PBPs and depletion of either of these in the minimal 
peptidoglycan synthesis strain (COL MIN) results in arrested growth. COL MIN was 
shown to grow and produce peptidoglycan as normal although response to changes in 
environment such as virulence and resistance was reduced (Reed et al., 2015). 
Additionally, the expression of other peptidoglycan interacting enzymes such as 
autolysins was modulated. While PBP1 and 2 are the only peptidoglycan biosynthetic 
enzymes required it is not clear what the minimum system of proteins are required for 
division to successfully take place. 
 Aims of the Chapter 
1. To determine the pattern of peptidoglycan synthesis in S. aureus. 
2. To determine the effect of FtsZ inhibition on peptidoglycan synthesis. 
 
4.2 Results 
 Localisation of peptidoglycan synthesis in S. aureus 
The localisation of peptidoglycan synthesis in S. aureus has been presumed to occur 
primarily, if not exclusively, at the septum (Pinho and Errington, 2003; Turner et al., 
2010a). However, this has been based on work using fluorescent vancomycin to label 
the ᴅ-ala-ᴅ-ala motif, associated with localisation of peptidoglycan synthesis (Daniel 
and Errington, 2003). S. aureus exhibits low carboxypeptidase activity therefore these 
residues are maintained in the mature peptidoglycan (Scheffers and Pinho, 2005). In 
order to label newly synthesised peptidoglycan with vancomycin, cultures must be 
grown in excess ᴅ-serine. Therefore, most dipeptide motifs contain ᴅ-serine, which is 
not recognised by vancomycin. Transient incubation in ᴅ-serine free media allows 
nascent peptidoglycan to be labelled by vancomycin (Scheffers and Pinho, 2005). Since 
the development of FDAAs it has been possible to label synthesis directly (Kuru et al., 
2012). Application of this technique in conjunction with super-resolution imaging 
techniques allows the localisation of peptidoglycan synthesis during division of S. 
aureus at the molecular level. 
Localisation of 5 minutes of peptidoglycan synthesis as labelled by both HADA and 
dipeptide fluorescent labels shows a pattern of peptidoglycan comparable to published 







Figure 4.1 Localisation of FDAA Incorporation over 5 minutes. Peptidoglycan synthesis 
labelled by FDAA incorporation shows a mainly septal localisation when labelled with 
FDAAs. Images taken using Nikon Dual Cam widefield system (Diffraction limited; A, B) 
or OMX (structured illumination; C) (A) Synthesis labelled with HADA (500 µM, Scale 
bar 5 µm, single slice). (B) Synthesis labelled with dipeptide label(1 mM) with Alexa 
Fluor 647(5 µg ml-1) (Scale bar 5 µm, single slice). (C) Structured illumination image of 




(Pinho and Errington, 2003; Turner et al., 2014).  Diffraction limited microscopy has a 
resolution of ~250 nm, given that S. aureus cells are ~1 µm in diameter it is not 
possible to learn any further details of peptidoglycan synthesis from previous work, 
even with the use of FDAA probes (Huang et al., 2010). SIM has increased resolution 
(to ~125 nm) however in practise this only crisps up diffraction limited images and it is 
often not possible to glean any new biology from these images (Huang et al., 2010). 
SIM images of 5 minutes of peptidoglycan synthesis labelled with HADA shows clear 
septal labelling, however there is also fluorescence outlining the surface of the entire 
cell (Figure 4.1 C). It is unclear from these images whether this fluorescence 
surrounding the cell is due to an artefact of SIM microscopy or is due to labelling with 
FDAAs (Chapter 3.2.3.2 & Appendix Figure 8). For this reason and also for the 
advantage of the increased resolution available, the pattern of peptidoglycan insertion 
was then investigated using STORM. 
STORM was carried out on mid-exponential phase S. aureus labelled for 5 minutes with 
ADA. Localisation of peptidoglycan synthesis was obtained through 3D imaging using a 
Nikon N-STORM commercial system and a non-commercial system, resulting in the 
same localisation patterns (Figure 4.2). There are four features of peptidoglycan 
synthesis that can be observed and will be discussed in further detail below. These can 
be identified within fields of cells however, individual cells best representing the 
features have been enlarged and represented as both 2D images and 3D projections to 
highlight these features in an easier to interpret form (Figure 4.3). The features are as 
follows: 
1. Peptidoglycan synthesis at the septum does not occur solely as a focus at the 
leading edge of the septum. 
2. Cells with incomplete septa have an apparent gap in peptidoglycan synthesis at 
the cross wall junction (Figure 4.3 A). 
3. Cells with completed septa prior to cell splitting show 2 separate regions of 
peptidoglycan synthesis suggesting the presence of two septal plates (Figure 
4.3 B). 
4. Contrary to previous models peptidoglycan synthesis is not limited to the 







Figure 4.2. Localisation of ADA incorporation over 5 minutes. Labelling shows both a 
septal and off-septal incorporation pattern. Probe used was ADA Alexa Fluor 647(ADA 
at 500 µM, Alexa Fluor 647 at 5 µg ml-1 in Click reaction). 3D localisation of synthesis is 
represented by colour table in 100 nm slices from 500 nm behind the plane of focus (-








Figure 4.3. 2D images and 3D projections of selected cells to highlight features of 
peptidoglycan incorporation.  Labelling with ADA (500 µM, Alexa Flour 647 at 5 µg ml-1 
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in Click reaction) for 5 minutes. (A) Two cells, both with incomplete septa. (B) Single 
cell with a completed septum, presumably just prior to cell splitting. In each case a 2D 
image and 3D contour plot are shown. 2D images are rendered using a 2D histogram 
with bin dimensions of 10 by 10 nm and number of localisations indicated by grey 
level. 3D renders are Matlab contour plots with a fixed number of 10 contours per 




The same labelling pattern was also seen in cells labelled with the dipeptide FDAA label 
(Figure 4.4) and with fluorescent vancomycin following incubation with excess ᴅ-serine 
(Figure 4.5). Quality of fluorescent vancomycin labelling is not of the same standard as 
those labelled with FDAAs however, the labelling pattern shows the same information. 
This lesser quality is plausibly due to attachment of Alexa Fluor 647 to vancomycin 
altering the photophysics of the fluorophore thereby reducing the number of 
localisable events during image acquisition. Identical labelling patterns with 3 different 
methods of labelling synthesis allows some assurance that observed pattern is due to 
peptidoglycan synthesis rather than an artefact of the labelling technique. 
 Peptidoglycan synthesis occurs as a zone at the septum 
Peptidoglycan synthesis was hypothesised to occur at the leading edge of the septum. 
However, labelling with ADA has demonstrated that this is not the case since synthesis 
appears to occur all across the new septum (Figure 4.3 A). Initial suggestions were that 
labelling 5 minutes of peptidoglycan synthesis was too long to catch insertion just at 
the leading edge since all peptidoglycan synthesised during the experiment would be 
labelled. When labelling time is reduced to 2 minutes the amount of labelling 
throughout the cell was reduced since less new peptidoglycan is synthesised yet the 
labelling pattern still suggests that peptidoglycan synthesis does not occur only at the 
leading edge (Figure 4.6). It is therefore postulated that peptidoglycan synthesis occurs 
as a zone at the septum.  
 Apparent splitting of septum prior to daughter cell separation 
The final stage of S. aureus cell division is the splitting into two daughter cells (Zhou et 
al., 2015). It is at this stage that the septum is split between the daughter cells, the 
connecting cross wall is broken and the septum expands to form daughter cells of the 
same shape as the mother cell (Matias and Beveridge, 2007; Wheeler et al., 2015; 
Zhou et al., 2015). Nascent peptidoglycan labelling reveals a split within the septum 
towards the mother cell wall edge. In many cases this can be seen to occur prior to 
completion of septation (Figure 4.3 A & Figure 4.7). It is unlikely that this lack of 
labelling is due to initiation of the separation process since the incomplete septa would 
render the cell prone to lysis. Therefore, this apparent gap is likely to be plugged with 
peptidoglycan and is due to the lack of synthesis of peptidoglycan in this region during 
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Figure 4.4. Localisation of dipeptide incorporation over 5 minutes. Dipeptide labelling 
shows both a septal and off-septal pattern.  Dipeptide at 1 mM, Alexa Flour 647 at 5 µg 
ml-1 in Click reaction. 3D localisation of incorporation is represented by colour table in 
100 nm slices from 500 nm behind the plane of focus (-500 nm, blue) to 500 nm in 









Figure 4.5. Fluorescent vancomycin labelling of nascent peptidoglycan following 
incubation in excess ᴅ-serine demonstrates septal and off-septal labelling.  Synthesis 
is labelled with vancomycin conjugated to Alexa Fluor 647 (1 mM) following 5 minutes 
incubation in ᴅ-serine free media to allow labelling of 5 minutes peptidoglycan 
synthesis. 3D localisation of synthesis is represented by colour table in 100 nm slices 
from 500 nm behind the plane of focus (-500 nm, blue) to 500 nm in front of plane of 









Figure 4.6. Reduced labelling time shows zone of synthesis at septum. Synthesis is 
labelled with (A) ADA (500 µM) and (B) dipeptide (1 mM) (Alexa Flour 647 at 5 µg ml-1 
in Click reaction). 3D localisation of synthesis is represented by a colour table in 100 
nm slices from 500 nm behind the plane of focus (-500 nm, blue) to 500 nm in front of 







Figure 4.7. Cells show gap in peptidoglycan synthesis labelling at septum & mother 
cell interface prior to cell splitting. Synthesis of peptidoglycan labelled for 5 minutes 
with (A) ADA (500 µM) and (B) dipeptide (1 mM) (Alexa Flour 647 at 5 µg ml-1 in Click 
reaction). Arrows indicate presence of the split at the mother cell edge of the septum. 
Z slices through the cell is shown in 100 nm segments showing gap at the outside edge 
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of the septum. Z projection with z indicated by colour table also shown for 




labelling. To determine the presence of peptidoglycan within the apparent gap cells 
were imaged with vancomycin to stain the cell wall. In the absence of incorporation of 
excess ᴅ-serine vancomycin can be used as a whole cell wall label in S. aureus. The split 
at the outside of the septum is not apparent in vancomycin labelled cells with both 
incomplete and completed septa suggesting that the split is filled with peptidoglycan 
(Figure 4.8).  
In order to show if the gap in FDAA labelling is in fact filled with peptidoglycan dual-
colour STORM was employed with peptidoglycan synthesis labelled with dipeptide and 
all the cell wall labelled with vancomycin conjugated to the fluorophore Amersham 
Cy3B. Cells with a gap in labelling with dipeptide have a continuum of peptidoglycan 
material labelled with vancomycin (Figure 4.9 & Figure 4.10). This shows that the gap is 
only in peptidoglycan synthesis. Where the septum and mother cell wall join there is a 
peptidoglycan plug (the piecrust) which remains in place with no further synthesis 
while the septum is being completed. 
In some cells with completed septa the septal plate could be viewed as two separate 
regions of peptidoglycan synthesis (Figure 4.3). There are a number of different 
explanations for this;  
 The septum is thickened following completion; this occurs only at the two 
cytoplasmic sides of the peptidoglycan therefore the gap is where the 
previously synthesised peptidoglycan is situated. 
 The septum is synthesized as two separate entities, one for each daughter cell. 
 The septum is synthesized as a single entity and then split due to autolytic 
activity prior to cell separation. 
By plotting a grey value profile for a line through the centre of a cell representing this 
“double septa” phenomenon the gap could be measured as ~ 25 nm (Figure 4.11). This 
distance is at the limit of resolution achievable by the STORM system. In addition, for 
the two regions to be visible the cell must be situated such that this gap is more or less 
parallel to the imaging plane. Therefore, it has not been possible to determine 












Figure 4.8. The gap in the septum is not apparent in cells when cell wall is labelled 
with vancomycin. Whole cell wall is labelled by vancomycin (1 mM). (A) Fields of cells 
labelled with vancomycin. Z- sectioning 800 nm in this example therefore 3D 
localisation of synthesis is represented by a colour table in 100 nm slices from 400 nm 
behind the plane of focus (-400 nm, blue) to 400 nm in front of plane of focus (400 nm, 
red). (Scale bar, 1 µm). (B) Selection of cells shown to highlight lack of gap in the 
septum in cells with both completed and incomplete septa prior to cell splitting. Z 
slices of 100 nm from bottom to top of cells shown along with a Z-projection image for 





















Figure 4.9. STORM of cells dual labelled with dipeptide and vancomycin. 
Peptidoglycan synthesis is labelled for 5 minutes with dipeptide (1mM) while the 
whole cell wall is labelled with vancomycin (1 mM). (A) Dipeptide and vancomycin 
labels shown separately as z projections with position of molecules in z represented by 
colour table in 100 nm slices. (B) Single 100 nm slice highlighting presence of 
peptidoglycan within gaps of peptidoglycan synthesis but not in the peptidoglycan 
layer (indicated by arrow), dipeptide coloured red & vancomycin coloured green. (C) Z-
sectioning of the two labels and the channels merged, split into 100 nm slices. (Scale 












Figure 4.10. STORM of dual dipeptide and vancomycin labelled S. aureus. 
Peptidoglycan synthesis is labelled for 5 minutes with dipeptide (1 mM) while the 
whole cell wall is labelled with vancomycin (1 mM). Dipeptide labelling shows a gap at 
both sides of the septum while vancomycin labelling does not. (A) Dipeptide and 
vancomycin labels shown separately as z projections with position of molecules in z 
represented by colour table in 100 nm slices. (B) Single 100 nm slice highlighting 
presence of peptidoglycan within gaps of peptidoglycan synthesis, dipeptide coloured 
red & vancomycin coloured green. (C) Z-sectioning of the two labels and the channels 





Figure 4.11. Measurement of gap between two areas of peptidoglycan synthesis.  A 
grey value profile was plotted for the line indicated. The gap between the 2 peaks was 




with FDAA and vancomycin or whether this phenomenon is present in cells with 
incomplete septa. 
 Peptidoglycan insertion is not confined to the septum 
Perhaps the most surprising observation was the presence of peptidoglycan synthesis 
labelling out with the septum as this would suggest that new peptidoglycan synthesis 
is not limited to septation as previously thought (Pinho and Errington, 2003; Turner et 
al., 2010a). Further investigation showed that this labelling is present in diffraction 
limited and SIM images (Figure 4.1). This non-septal peptidoglycan labelling, hereafter 
referred to as off-septal synthesis or labelling, offers a potential new mode of growth 
by S. aureus and provides further insight into the processes of growth and division in S. 
aureus. 
To determine the proportion of fluorescence not associated with septal peptidoglycan 
synthesis a modified corrected total cell fluorescence (CTCF) protocol was used to 
calculate the non-septal fluorescence in diffraction limited images (McCloy et al., 
2014). Corrected total cell fluorescence is calculated by the following equation: 
 CTCF = Integrated density - (area of selected cell x background mean fluorescence) 
The CTCF for both the total cell and the septum were calculated and the percentage 
non-septal fluorescence determined. These calculations were performed on z- 
projections of diffraction-limited images for ease and because neither SIM nor STORM 
data should be used for quantitative analysis due to the methods used in image 
reconstruction.  
Calculation for the S. aureus wildtype strain, SH1000, estimated non-septal 
fluorescence at 54 ± 7 %. Since there is limited cytosolic labelling with FDAAs this was 
attributed to off-septal labelling of the cell wall. Before the role of off septal synthesis 
in the growth of S. aureus could be assessed, it was first necessary to determine that 
the fluorescence signal was due to labelling of peptidoglycan synthesis rather than an 
artefact of the labelling process. 
Chemical treatment of S. aureus labelled with ADA-Alexa Fluor 647 to remove different 
components of the cell wall was carried out in order to determine whether the off-
septal incorporation was due to labelling of peptidoglycan or another structure (Figure 
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4.12). The treatments used were as follows; SDS to remove any non-covalently bound 
proteins, pronase to digest any covalently bound proteins, sodium borohydride to 
reduce the reducing termini of glycan strands and HF to remove teichoic acids. Off-
septal labelling remained following these chemical treatments, suggesting that the off-
septal labelling occurs in the peptidoglycan (Figure 4.12).  In both sodium borohydride 
and HF treated cells the normal labelling pattern was reduced, in the case of HF 
treated cells normal labelling was almost completely eliminated. This is most likely due 
to the harsh effects of chemical treatments on the fluorophore and may be eliminated 
by carrying out the click reaction following chemical treatment. Another means to 
determine the presence of off-septal labelling on peptidoglycan is the imaging of 
purified sacculi (Figure 3.11). However, due to cell breakage during the purification 
process it is difficult to distinguish between septal and off-septal peptidoglycan.  
Teichoic acids are decorated with ᴅ-alanine residues and therefore FDAAs may be able 
to label these structures (Brown et al., 2013). The dltA gene of S. aureus encodes a ᴅ-
alanine-ᴅ-alanyl carrier protein and the S. aureus dltA mutant completely lacks ᴅ-
alanine in either LTAs or WTAs (Peschel et al., 1999). Labelling the dltA mutant with 
HADA for 5 minutes resulted in similar off-septal labelling as SH1000 (Figure 4.13 A). 
Deletion of the WTA biosynthetic gene tarO produces a strain that is lacking in WTAs 
(Xia and Peschel, 2008). Once again labelling this mutant for 5 minutes with HADA 
resulted in no removal or reduction in off-septal labelling (Figure 4.13 A). Calculation of 
off-septal labelling using the modified CTCF described above determined off-septal 
labelling to be 57 ± 7 % and 67 ± 6 % for the dltA and tarO mutants respectively. This in 
fact represents a slight increase in off-septal labelling for these mutants, particularly 
for the tarO mutant (Figure 4.13 B). This increase was coupled with an increase in 
average CTCF for whole cells and may be due to PBP4 mislocalisation (Figure 4.13 
C)(Atilano et al., 2010). 
 Role of peptidoglycan synthesis enzymes in off-septal labelling of 
peptidoglycan 
Following the demonstration that the off septal labelling is due to peptidoglycan 
incorporation it was hypothesised that this may be the result of peptidoglycan 






Figure 4.12. Chemical treatment of S. aureus to investigate off-septal labelling. 
Diffraction limited images of SH1000 labelled with ADA (500 µM)(Alexa Flour 647 at 5 
µg ml-1 in Click reaction) for 5 minutes then treated with 5% (w/v) SDS for 15 min, 2 mg 
ml-1 pronase for 90 min, 5 mg ml-1 sodium borohydride for 15 min or 48% (w/v) 







Figure 4.13. Contribution of teichoic acids to off-septal labelling. (A) Diffraction 
limited images of SH1000, ΔdltA, ΔtarO labelled for 5 minutes with HADA (500 µM). 
(Scale bar 5 µm). (B) Box plot of % off-septal labelling in SH1000, ΔdltA, ΔtarO. Box 
extends from 25th to 75th percentiles and midline is plotted at the median. Whiskers 
are drawn down to the minimum value and up to the maximum value. P values are the 
result of Mann-Whitney tests comparing mutants with the wildtype (SH1000). (C) Box 




containing nearly 2,000 strains with non-essential genes disrupted (Fey et al., 2013).  
Included within this library are mutations in a number of genes coding for cell division 
and peptidoglycan synthesis components. The five most promising candidates along 
with the library parental strain, JE2, were labelled for 5 minutes with HADA and the 
amount of off septal incorporation assessed (Figure 4.14). The five genes chosen for 
study were the two non-essential PBPs (pbp3 & pbp4), the monofunctional 
transglycosylases (sgtA & mgt) and the FtsW homolog (rodA). The rodA mutant, 
NE1598, is attributed as a hypothetical protein with the transposon inserted into 
SAUSA300_2040. This was found to be a homolog of ftsW, the lipid II flippase, and has 
been assigned as rodA (http://aureowiki.med.uni-greifswald.de/SAUSA300_2040).   
The off-septal labelling of JE2 was found to be 43 ± 6 %, which is lower than that of 
SH1000. This indicates a degree of variation between the strains. The percentage off-
septal labelling for each of the transposon mutants was calculated and compared to 
JE2 (Figure 4.14 B). The % off-septal labelling for the mutants was not found to be 
significantly reduced compared to JE2, although there was an increase for the pbp3, 
sgtA, mgt and rodA mutants and a slight decrease for the pbp4 mutant. This decrease 
for the pbp4 mutant may suggest that PBP4 may play some role in the off-septal 
labelling, however, this small reduction in off-septal labelling is associated with a large 
reduction in CTCF (Figure 4.14 C). There is also a reduction seen in labelling with the 
mgt mutant. This suggests that both PBP4 and MGT may play a role in the insertion of 
FDAA labelled precursors into the cell wall rather than a specific role of PBP4 in off-
septal synthesis of peptidoglycan. 
 Role of penicillin binding proteins in synthesis of peptidoglycan 
The role of the PBPs in peptidoglycan synthesis was further assessed. The pbp3 and 
pbp4 mutants were transduced into the SH1000 background, to give strains 4421 and 
4425 respectively, and a pbp3pbp4 double mutant created (4424). These strains were 
produced and verified by Kasia Wacnik.  
Within the SH1000 background images of both the wildtype and PBP mutant strains 







Figure 4.14. Off-septal labelling in Nebraska library mutants. (A) Diffraction limited 
images of strains labelled for 5 minutes with HADA (500 µM). (Scale bar 5 µm). (B) Box 
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plot of % off-septal labelling for the tested strains. Box extends from 25th to 75th 
percentiles and midline is plotted at the median. Whiskers are drawn down to the 
minimum value and up to the maximum value. P values are the result of Mann-
Whitney tests comparing mutants with the parental strain (JE2). (C) Box plot of 






Figure 4.15. Role of PBP3 and PBP4 in off-septal labelling. Diffraction limited images 
of SH1000, 4421 (pbp3), 4425 (pbp4) & 4424 (pbp3pbp4) labelled with HADA (500 µM) 




is also seen in the double mutant. Quantification of the off-septal labelling gave 55 ± 6 
% for SH1000, 51 ± 6% for 4421 (pbp3), 34 ± 7 % for 4425 (pbp4) and 53 ± 7 % for 4424 
(pbp3pbp4) (Figure 4.16 A). The pbp3 mutant while having a lower mean value shows 
the same approximate minimum and maximum values for % off-septal labelling 
suggesting PBP3 does not have a significant role in off-septal labelling. The % off-septal 
value for 4425 (pbp4) is significantly lower than that of SH1000, however the double 
mutant is not significantly different from SH1000. It is unclear why this may be the 
case, but may reflect indirect effects of inactivation of both activities. The CTCF of 
these strains revealed that deletion of the non-essential PBPs results in a reduction in 
FDAA incorporation into the cell wall (Figure 4.16 B). In the case of the double mutant 
the CTCF was less than 10% of the SH1000 CTCF.  It was hypothesized that this 
decrease in fluorescence may be due to a reduction in synthesis of peptidoglycan 
during the labelling period. Comparison of growth rates of SH1000 and the three 
mutants showed no difference (Figure 4.16 C). Since growth rate is not a factor it may 
be that the pbp4 mutant synthesises peptidoglycan at a reduced rate. Peptidoglycan 
synthesis across the four strains was determined based on the rate of incorporation of 
14C GlcNAc over 180 mins. The rate was calculated as DPM per OD unit per minute 
while cells were growing at exponential phase (Figure 4.16 D). The rate of 14C GlcNAc 
incorporation whenever pbp4 was disrupted was not different from that of SH1000 
(1634 vs 1727 DPM OD600-1 min-1). The rate for 4421 pbp3 was higher than that of 
SH1000 (2124 DPM OD600-1 min-1) however this was not seen in the double mutant 
(1863 DPM OD600-1 min-1). This shows that the reduction in fluorescence is not due an 
alteration in peptidoglycan synthesis rather less incorporation of FDAAs when PBP4 is 
not present. It suggests that the previously mentioned exchange reaction for labelling 
is mediated by PBP4 (Chapter 3.3.1). 
The dipeptide label can only be inserted into peptidoglycan via the synthesis pathway 
(Liechti et al., 2013). Labelling the PBP mutants with dipeptide therefore would 
determine if the reduction of CTCF was due to the loss of labelling via the exchange 
reaction. Both SH1000 and the PBP mutants were labelled for 5 minutes with the 
dipeptide label and images showed no difference in labelling across the strains (Figure 







Figure 4.16. Quantification the role of PBP3 and PBP4. (A) Box plot of % off-septal 
labelling of 5 minutes HADA (500 µM) incorporation for the PBP mutants. Box extends 
from 25th to 75th percentiles and midline is plotted at the median. Whiskers are drawn 
down to the minimum value and up to the maximum value. P values are the result of 
Mann-Whitney tests comparing mutants with the wildtype. (B) Box plot of corrected 
total cell fluorescence (CTCF). Box and p values same as for off-septal fluorescence. (C) 
Growth curve of SH1000 and mutant strains in CDM. (D) Rate of 14C-GlcNAc 








Figure 4.17. Role of PBP3 and PBP4 in off-septal labelling measured via dipeptide 
incorporation. (A) Diffraction limited images of PBP mutant strains labelled for 5 
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minutes with dipeptide (1 mM)(Alexa Flour 647 at 5 µg ml-1 in Click reaction). (Scale bar 
5 µm). (B) Box plot of % off-septal labelling for PBP mutants. Box extends from 25th to 
75th percentiles and midline is plotted at the median. Whiskers are drawn down to the 
minimum value and up to the maximum value. P values are the result of Mann-
Whitney tests comparing mutants with the wildtype. (C) Box plot of corrected total cell 




mutant strains, in fact all three were slightly higher than that of SH1000 (Figure 4.17 
B). The CTCF for SH1000 and the PBP mutant strains showed a large range of values 
with 4421 (pbp3) showing values significantly higher than SH1000, 4425 (pbp4) 
showing values significantly lower than SH1000 while there was no significant 
difference in the double mutant 4424 (pbp3pbp4) (Figure 4.17 C). This variance is 
probably due to use of Alexa Fluor 647, an easily bleached fluorophore, within this 
experimental setup. Contrary to HADA, using dipeptide, PBP4 did not have such a 
striking role in the level of incorporation. 
To determine whether there were any further differences in peptidoglycan synthesis in 
the PBP mutants the strains were imaged using both SIM and STORM. SIM images of 
both 4421 (pbp3) and 4425 (pbp4) showed a similar labelling pattern to SH1000 
however the reduction in labelling of these strains made SIM more difficult (Figure 
4.18). The reduction in labelling of 4424 (pbp3pbp4) meant that reconstruction of 
images with any cell wall labelling was not possible (Figure 4.18 & Appendix Figure 12). 
Fourier transforms of SIM image of PBP mutants showed a periodic structure within 
the images, particularly repetitive dots and stripes in 3 angles, reminiscent of the 3 
angles used by the grating during image acquisition (Appendix Figure 9-Appendix 
Figure 12). To avoid issues with the use of SIM, the PBP mutants were labelled for 5 
minutes with ADA and imaged using STORM (Figure 4.19). Within these images the 
patterns of peptidoglycan synthesis identified previously were present within all 
strains (Chapter 4.2.1). In particular, the off-septal labelling pattern was seen in all the 
mutant strains. This result was repeated with 5 minutes labelling of peptidoglycan 
synthesis with dipeptide (Figure 4.20) thereby showing that these patterns are not due 
to any exchange reaction mediated by PBP4. 
 Effect of inhibition of FtsZ by PC190723 on peptidoglycan insertion 
 PC190723 
A group of small synthetic antimicrobials have been created with potent bactericidal 
activity against staphylococcal species and B. subtilis however not against other Gram 
positive and negative bacteria (Haydon et al., 2008). The lead component, PC190723 (
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Figure 4.21 A), has been shown to mislocalise FtsZ in B. subtilis and S. aureus (Haydon 





Figure 4.18. SIM of 5 minute HADA labelled PBP mutants. Each strain was labelled for 











Figure 4.19. STORM of ADA labelled PBP mutants. 5 minutes of peptidoglycan 
synthesis was labelled with with ADA (500 µM)(Alexa Flour 647 at 5 µg ml-1 in Click 
reaction) in each strain. 3D localisation of synthesis is represented by a colour table in 
100 nm slices from 500 nm behind the plane of focus (-500 nm, blue) to 500 nm in 











Figure 4.20. STORM of dipeptide labelled PBP mutants. 5 minutes of peptidoglycan 
synthesis was labelled with dipeptide (1 mM)(Alexa Flour 647 at 5 µg ml-1 in Click 
reaction) in each strain. 3D localisation of synthesis is represented by a colour table in 
100 nm slices from 500 nm behind the plane of focus (-500 nm, blue) to 500 nm in 




IC50 of 55ng ml-1.(Haydon et al., 2008) However, the exact mode of action of PC190723 
against the FtsZ protein is unclear. It may interact with the GTPase active site 
preventing GTP hydrolysis or may stabilize FtsZ polymers inducing filament assembly 
and preventing proper functioning (Andreu et al., 2010; Elsen et al., 2012; Haydon et 
al., 2008). However, PC190723 has poor drug-like and pharmacokinetic properties so 
subsequent 1st and 2nd generation pro-drugs have been created with enhanced 
pharmacokinetics and increased anti-staphylococcal activity in vivo (Kaul et al., 2015). 
Cell division inhibition by PC190723 in S. aureus was shown to lead to quick arrest of 
DNA replication initiation followed by complete arrest of cell growth (Arjes et al., 
2014). 
 In S. aureus the drug PC190723 has been shown to cause cell enlargement, typical of 
FtsZ depletion (Haydon et al., 2008). The localisation of FtsZ has previously been 
shown to form multiple rings and arcs however the consequent effects on 
peptidoglycan synthesis have not been studied in S. aureus (Tan et al., 2012). 
 Effect of PC190723 on growth & cell size of S. aureus 
The MIC of PC190723 for SH1000 was determined to be 1 µg ml-1 (Chapter 2.8) 
therefore all following growth and labelling experiments were carried out at 10 µg ml-1 
i.e. 10 x MIC. Following addition of 10 µg ml-1 the growth of S. aureus cultures was 




Figure 4.21 B). To determine the localisation of FtsZ, an FtsZ-eYFP fusion was 
introduced on a plasmid (13ADQETC) with FtsZ-eYFP expression under the control of 
an inducible promoter (PSpac) (C. Walther, unpublished results). While the MIC of this 
strain was not tested to determine whether the additional copies of FtsZ had an effect 
on tolerance to PC190723, addition of 10 µg ml-1 PC190723 to a growing culture of the 
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FtsZ-eYFP strain resulted in cessation of growth, as for SH1000 (
Figure 4.21 B). 
The average cell diameters of both SH1000 and the FtsZ-eYFP strain were monitored 
during treatment with PC190723 (
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Figure 4.21 C). To achieve this fixed cells were imaged using brightfield and the 
diameter of cells were measured using Fiji software. Since the diameter of cells will 
vary throughout the cell cycle at least 150 cells were measured to limit the effects of 
this variation. Treatment with 10 µg ml-1 PC190723   
202 
 
Figure 4.21. Effect of PC190723 on growth and cell diameter. (A) Structure of 
PC190723. (B) Growth curve in the presence of 10 µg ml-1 PC190723. (C) Average cell 




caused an increase in cell diameter from 1.48 ± 0.16 µm to 2.60 ± 0.35 µm after 125 
minutes treatment in SH1000. This pattern was repeated in the FtsZ-eYFP strain in the 
presence of IPTG with an increase in diameter from 1.45 ± 0.20 µm to 2.52 ± 0.26 µm 
in the same time period. 
 Effect of PC190723 on FtsZ localisation in S. aureus 
The effect of PC190723 on the FtsZ-eYFP strain was analysed by fluorescence 
microscopy (Figure 4.22). The localisation patterns of FtsZ were determined and 
quantified (Figure 4.23). Untreated cells show an FtsZ localisation pattern of rings at 
the midcell, this ring of different diameters depended on the stage of the cell cycle. 
After 10 minutes of PC190723 treatment cells began to lose the midcell localisation 
and FtsZ became localised to discrete foci and arcs, generally at the periphery of the 
cell. After 10 minutes the midcell localisation and discrete foci/arcs are at 
approximately 50:50 but by 15 minutes the majority of cells had FtsZ in discrete 
foci/arcs. This delocalised pattern remained until 95 minutes, over which time cells 
increase in diameter. At 95 minutes the fluorescent signal from the FtsZ-eYFP strain 
began to be distributed across the whole cell. The discrete foci of FtsZ is reminiscent of 
the pattern seen in B. subtilis (Haydon et al., 2008). 
 Effect of PC190723 on peptidoglycan synthesis localisation in S. aureus 
To determine the effect of PC190723 on peptidoglycan synthesis, FtsZ-eYFP was 
labelled with HADA (Figure 4.24). Quantification of labelling patterns shows that at the 
interval of 10-15 minutes treatment, insertion of HADA changed from the control 
synthesis patterns seen previously (e.g septal rings & plates with off septal labelling; 
Figure 4.1) to exclusive labelling of the peripheral cell wall (Figure 4.25). This change in 
labelling coincides with the change in FtsZ localisation from septal rings to discrete 
foci/arcs. At 90-95 minutes and 120-125 minutes HADA labelling in individual cells 
either remains as peripheral cell wall labelling, labelling is completely removed or the 
entire cytoplasm is labelled by HADA. 
Since the FtsZ-eYFP strain has an increased production of FtsZ, localisation of PG 
synthesis was also carried out in SH1000 (Figure 4.26). The same change in pattern of 









Figure 4.22. Effect of PC190723 on FtsZ localisation in S. aureus. FtsZ-eYFP was 




Figure 4.23. Quantification of localisation of FtsZ during PC190723 treatment. 
Frequency of FtsZ localisation pattern during treatment with 10 µg ml-1 PC190723. 












Figure 4.24. Effect of PC190723 on peptidoglycan synthesis in FtsZ-eYFP S. aureus. 
Peptidoglycan synthesis was labelled over 5 minute windows with HADA (500 µM) and 
FtsZ-eYFP localised during treatment with 10 µg ml-1 PC190723 over 125 minutes. 






Figure 4.25. Quantification of localisation of peptidoglycan synthesis during 
inhibition by PC190723 in the FtsZ-eYFP strain. 5 minutes peptidoglycan synthesis was 
labelled by HADA. The frequency of each HADA localisation pattern during treatment 
with 10 µg ml-1 PC190723 was determined. Table of frequencies shown in Appendix IV 











Figure 4.26. Effect of PC190723 on peptidoglycan synthesis in SH1000.  5 minute 
windows of peptidoglycan synthesis were labelled with HADA (500 µM) during 




synthesis pattern is lost at approximately 10 minutes after inhibition with PC190723 
and peptidoglycan synthesis occurs at the periphery of the cell only until 
approximately 90 minutes post treatment when cells begin to either entirely lose 
labelling with HADA or the HADA signal appears throughout the cell (Figure 4.27). To 
investigate peptidoglycan synthesis during PC190723 treatment in further detail, 
STORM was used (Figure 4.28). Images show a control phenotype of peptidoglycan 
synthesis immediately following PC190723 treatment (Figure 4.28 A &B). After 10-15 
minutes there is an increase in cells lacking a septum (as expected from the diffraction 
limited images) and also there are a few enlarged cells with an abnormal phenotype, 
such as the cell indicated in Figure 4.28 C. After 30 minutes of treatment with 
PC190723 peptidoglycan synthesis is exclusively at the peripheral cell wall only (Figure 
4.28 D &E). Peptidoglycan synthesis appears to occur in a uniform manner suggesting 
the discrete foci & arcs of FtsZ do not result in a punctate pattern of peptidoglycan 
synthesis.  
The effect of PC190723 on the % off-septal labelling of cells which had initiated 
septation was measured (Figure 4.29). There was a slight increase in % off-septal 
labelling (49% to 62%). Therefore, when cells are already septating the addition of 
PC190723 does not disrupt the pattern of peptidoglycan synthesis. 
 Effect of PBP deletion and PC190723 treatment on peptidoglycan 
biosynthesis 
Deletion of the non-essential PBPs (PBP3 & PBP4) has no effect on either growth or 
inhibition of growth by PC190723 (Figure 4.16 & 
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Figure 4.21). The effect of PC190723 on peptidoglycan synthesis in cells missing PBP3 
and/or PBP4 was measured. Imaging of peptidoglycan synthesis in 4421 (pbp3) (Figure 
4.30), 4425 (pbp4) (Figure 4.31) or 4424 (pbp3pbp4) (Figure 4.32) shows no apparent 
difference in progression of peptidoglycan synthesis or morphological changes 
compared to SH1000 (Figure 4.26). Due to the reduction in labelling intensity these 
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Figure 4.27. Quantification of localisation of PG synthesis during inhibition by 
PC190723 in SH1000. 5 minute windows of peptidoglycan synthesis labelled by HADA. 
Frequency of each HADA localisation pattern during treatment with 10 µg ml-1 












Figure 4.28. Localisation of peptidoglycan synthesis during PC190723 treatment. 5 
minutes peptidoglycan synthesis was labelled using ADA (500 µM)(Alexa Flour 647 at 5 
µg ml-1 in Click reaction) during treatment with 10 µg ml-1 PC190723. (A) No PC190723. 
(B) 0-5 minutes PC190723. (C)10-15 minutes PC190723 with cell of interest 
highlighted. (D) 30-35 minutes PC190723. (E) 60-65 minutes PC190723. 3D localisation 
of synthesis is represented by a colour table in 100 nm slices from 500 nm behind the 
plane of focus (-500 nm, blue) to 500 nm in front of plane of focus (500 nm, red). (Scale 




Figure 4.29. Quantification of off-septal labelling during the first 20 minutes of 
PC190723 treatment. Cells were measured wherever a clear septum was present. Box 
plot of % off-septal labelling of 5 minutes HADA (500 µM) incorporation. Box extends 
from 25th to 75th percentiles and midline is plotted at the median. Whiskers are drawn 
down to the minimum value and up to the maximum value. P values are the result of 
Mann-Whitney tests comparing with the control sample. N value for 15-20 minutes 









Figure 4.30. Effect of PC190723 on localisation of peptidoglycan synthesis in 4421 
(pbp3). 5 minute windows of peptidoglycan synthesis were labelled by HADA (500 µM) 







Figure 4.31. Effect of PC190723 on peptidoglycan synthesis in 4425 (pbp4). 5 minute 
windows of peptidoglycan synthesis were labelled by HADA (500 µM) during treatment 









4.3 Figure 4.32. Effect of PC190723 on peptidoglycan synthesis in 4424 (pbp3pbp4). 
5 minute windows of peptidoglycan synthesis were labelled by HADA (500 µM) 




 Model of septal peptidoglycan synthesis 
Features of peptidoglycan synthesis as determined by STORM of FDAA labelled cells 
allows us to propose a new model of peptidoglycan synthesis within S. aureus. 
Peptidoglycan synthesis was shown to occur as a zone of synthesis toward the leading 
edge of the septum as opposed to a focus at the leading edge (Chapter 4.2.2). This is in 
agreement with previous cryo-EM on cell wall fragments that showed the septum 
flared towards the cross wall (Figure 4.33 A)(Matias and Beveridge, 2007). The septum 
is synthesised by insertion of new peptidoglycan primarily at the leading edge, 
however also along the length of the growing septum to produce a complete septum 
of an appropriate thickness (Figure 4.33 B). The peptidoglycan synthesis enzymes 
within the divisome are proposed to exist as a gradient around the peptidoglycan 
synthesis zone denoted by the purple dots within the model (Figure 4.33 B). Indeed, a 
number of division proteins including FtsZ and EzrA have been shown to have such a 
localisation (Kasia Wacnik, unpublished results). Eventually the nascent growing 
septum will reach a cross-section such that its innermost layer can no longer interact 
with the synthetic machinery. This is also the case at the piecrust where the thick band 
of peptidoglycan prevents access to the biosynthetic machinery. This does not indicate 
splitting of the cell prior to completion of the septum as the piecrust at the mother cell 
wall – septum intersect remains intact. This allows the dividing cell to withstand turgor 
pressure. 
Before or during separation of daughter cells the septum must be split in half such that 
each daughter cell receives part of the septum as a new hemisphere of cell wall. The 
intricacies and dynamics of how this happens remains unclear, particularly as this 
appears to occur at length scales shorter than the resolution of super-resolution 
microscopy (Zhou et al., 2015). Data from my study shows two separate areas of 
peptidoglycan synthesis, suggesting 2 separate entities. However, there remains two 
issues with this model which must be assessed. Firstly, it is possible that the septum 
exists as a single entity with synthesis occurring at the outer edge of the septal plate 
thereby leaving a plate of peptidoglycan that is inaccessible to new peptidoglycan 
synthesis, much like the split that was seen at the cross wall. However, while the split 





Figure 4.33. Peptidoglycan synthesis occurs as a zone at the septum. (A) TEM of cell 
wall fragments showing septum flared towards outer cell wall (Matias and Beveridge, 
2007). (B) Model of peptidoglycan synthesis at the septum. Red indicates zone of 
synthesis primarily at the leading edge but also along the length of the growing 
septum. Cell division machinery (purple dots) also occurs as a gradient. 
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not possible to resolve the presence or absence of peptidoglycan within the gap 
between the 2 presumed septal plates. Secondly even if the septum exists as 2 septal 
plates it is not clear whether the peptidoglycan is synthesized as two separate entities 
or whether the single septum can be hydrolysed into two, even prior to completion of 
septal synthesis. Previous work by Matias & Beveridge using cryo-EM showed that the 
S. aureus septum is made of five distinct zones (Matias and Beveridge, 2007). It was 
suggested that there were two peptidoglycan structures running along the septum 
with a periplasm-like area between them (Matias and Beveridge, 2007). This provides 
further evidence that the septum is produced as two entities prior to completion of 
septation & cell splitting, however it is still not possible to dissect the events that occur 
at the point of synthesis. 
 Contribution of off-septal synthesis to growth in S. aureus 
Unlike rod shaped bacteria S. aureus was proposed to only have one mode of growth 
that is peptidoglycan synthesis during division (Pinho and Errington, 2003). However, 
labelling peptidoglycan synthesis with FDAAs revealed off-septal labelling which has 
been attributed to synthesis of peptidoglycan at the peripheral cell wall. Using both 
chemical and genetic tools it has not been possible to remove or significantly reduce 
this off-septal labelling as calculated using CTCF values. 
The method used for calculation of off-septal labelling results in a wide range of %. 
This is partially due to difficulties in quantification of subcellular features and variation 
in the overall labelling between strains. Loss of PBP3, PBP4 and a range of 
peptidoglycan biosynthetic components did not greatly alter the level of off-septal 
labelling compared to overall incorporation. This suggests that there is no separate 
peptidoglycan synthesis machinery responsible for off-septal labelling comparable to 
the elongasome in rod-shaped organisms. Thus off-septal synthesis is likely carried out 
by the same machinery as septal synthesis, in particular by PBP2. However, there are a 
number of additional auxillary proteins involved in peptidoglycan synthesis that could 
have a role. Of particular interest is FmtA which has been suggested to have weak ᴅ-
Ala-ᴅ-Ala carboxypeptidase activity.  
Should off-septal labelling be due to the action of PBP1 and PBP2 there remains a 
question as to what is the role of this synthesis? Recent work, during the last 12 
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months, has shown that S. aureus is not a true sphere as has been previously 
suggested but produces an ellipsoidal shape during the cell cycle (Monteiro et al., 
2015; Zhou et al., 2015). It is possible that the off-septal synthesis of material may play 
a role in this shape change. However, it will prove difficult to investigate, as both PBP1 
and PBP2 are essential for growth. Conditional lethal expression constructs could allow 
titration of PBP levels for analysis of their role in off septal labelling. 
 Response to treatment of S. aureus with FtsZ inhibitor PC190723 
PC190723 has been shown to stabilize FtsZ polymer formation in vitro as well as 
allowing FtsZ polymers to assemble at lower than normal concentrations (Andreu et 
al., 2010; Elsen et al., 2012). This prevents the in vivo function of FtsZ and thereby 
poses a means of inhibition of the division process (Andreu et al., 2010). However the 
mechanism behind cytokinesis inhibition and bactericidal action of PC190723 is not 
clear (Tan et al., 2012).  
Previous work in MRSA has shown PC190723 at 10 x MIC levels to cause an FtsZ-CFP 
strain to show mislocalisation of FtsZ into multiple rings and arcs (Tan et al., 2012). 
Within my study a FtsZ-eYFP strain was shown to mislocalise FtsZ into discrete foci and 
arcs. Strain variation is likely to be the reason for this slightly different pattern. It is 
unclear why these different strains would produce different localisation patterns. The 
strains both encode extra copies of fluorescent FtsZ under the control of an inducible 
promoter. It may be that there is a lower copy number of Ftsz-eYFP than FtsZ-CFP 
thereby masking multiple rings in addition to the arcs seen. It has proven difficult to 
substitute the native FtsZ with a fluorescently tagged version.  
Imaging of both FtsZ and peptidoglycan synthesis localisation after PC190723 
treatment allows its effects to be evaluated. PC190723 promotes FtsZ polymerisation 
within S. aureus cells causing FtsZ to localise to discrete foci & arcs at the periphery of 
the cell. In turn this causes peptidoglycan synthesis to be recruited to the peripheral 
cell wall. Insertion of newly synthesised peptidoglycan into the peripheral cell wall 
without concurrent division causes the characteristic increase in S. aureus cell 
diameter (Pinho and Errington, 2003). This continues until a point at which cells can no 
longer expand and they die and/or lyse. Without live cell microscopy of cells 
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undergoing treatment it is unclear whether cells continue expansion until lysis or 
whether growth will arrest and death eventually occurs via lysis. 
The maintenance of control off-septal labelling percentage in cells with a septum 
suggests that transition to peripheral synthesis is not gradual. In conjunction with the 
presence of septating cells after the majority of cells altered to a peripheral synthesis 
pattern suggests that FtsZ mislocalisation by PC190723 only prevents continued 
cytokinesis before a certain point in the cell cycle. Once cells have passed this point cell 
division appears to continue however, the next round of division is not possible. This 
may suggest that FtsZ is only required for the initial stages of cell division and that the 
process is driven by a separate factor during the later stages, possibly by peptidoglycan 
synthesis itself. It has been postulated that there is a DivIB checkpoint at the transition 
between piecrust and septal plate synthesis which may play a role (Bottomley et al., 
2014).  
It would be interesting to determine the subsequent effect of FtsZ mislocalisation on 
other proteins within the divisome. For example, EzrA, the negative regulator of FtsZ, 
was also found to lose its localisation quickly and end up distributed in foci around the 
cell membrane (K. Wacnik, unpublished results). Another important divisome protein 
that has been shown to be mislocalised during treatment with PC190723 is PBP2 which 
localises to broad patches following 30 minutes treatment with PC190723 (Tan et al., 
2012). This is particularly important since mislocalisation of PBP2 in MRSA strains can 
restore sensitivity to β-lactams as the transglycosylase activity of PBP2 is required even 
in the presence of PBP2A (Pinho and Errington, 2005; Tan et al., 2012). It has been 
shown that PC190723 can act synergistically with β-lactams therefore PC190723 and 
other divisome inhibiting compounds may potentiate β-lactam drugs as therapeutics 
(Tan et al., 2012). 
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Chapter 5  
Dynamics of peptidoglycan insertion in Staphylococcus aureus 
 
The work in this chapter was carried out in collaboration with Christa Walther (SIM 
microscopy). 
5.1 Introduction 
It has been challenging to determine peptidoglycan dynamics at the subcellular level 
within bacteria due to the lack of tools to easily visualise peptidoglycan synthesis. 
However, in recent years the development of FDAA probes has begun to open up this 
area (Kuru et al., 2012; Siegrist et al., 2013).  
Using ᴅ-cysteine labelling in conjunction with immunodetection of thiol groups on 
Gram negative sacculi the dynamics of peptidoglycan insertion was determined (de 
Pedro et al., 1997). For E. coli, the transition of elongation to septation is correlated 
with a modification of peptidoglycan insertion pattern. Elongation is associated with 
diffuse and “random” incorporation of precursors over the cylindrical portion of the 
sacculus (de Pedro et al., 1997). On initiation of septation, insertion changes to 
localised insertion at the preseptal area. Additionally, it was determined that following 
completion of the septa and cell separation the new cell poles (old septa) become 
metabolically inert suggesting a stable peptidoglycan configuration with neither 
hydrolysis or synthesis occurring (Vollmer and Bertsche, 2008). In C. crescentus the 
shift from swarmer to stalked phase is coupled with a change to the peptidoglycan 
insertion pattern. Initial diffuse incorporation of precursors during most of the cell 
cycle is relocated to the future division site prior to cell constriction, unlike in E. coli 
where constriction is apparent at the shift in incorporation pattern (Aaron et al., 2007; 
Vollmer and Bertsche, 2008). This pre-septal growth from the midcell contributes to 
cell elongation prior to cell division. 
Rod-shaped organisms, such as B. subtilis have two modes of peptidoglycan synthesis, 
during septation and elongation (Szwedziak and Löwe, 2013). Previous work has 
concentrated on the dynamics of synthesis proteins as opposed to the dynamics of 
actual peptidoglycan insertion. Using fluorescent vancomycin, peptidoglycan insertion 
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in B. subtilis was shown to occur in broad bands at division sites as well as on the 
cylinder of the rod-shape (Daniel and Errington, 2003). The cylinder labelling 
localisation was reminiscent of the helical pattern previously found for the actin-like 
proteins MreB and Mbl (Jones et al., 2001). Investigation into the peptidoglycan 
architecture of both the new septum and wall cylinder suggested a mechanism of 
insertion of helical cables within the cylinder and in producing the septum as a spiral 
(Hayhurst et al., 2008). However, both these approaches were limited to static 
snapshots. 
The two modes of peptidoglycan insertion in rod-shaped bacteria are mediated by 
related but distinct protein complexes; the divisome and elongasome. The divisome is 
almost universal in bacteria and is responsible for cell division, while the elongasome 
directs lateral insertion and is a modified version of the divisome, without the FtsZ ring 
and associated machinery (Szwedziak and Löwe, 2013). The divisome and elongasome 
are bound to the membrane via actin-like protofilaments FtsA and MreB respectively. 
Dynamics of the divisome have often concentrated on the dynamics of FtsZ, a tubulin 
homolog that organises peptidoglycan synthesis and remodelling at the mid-cell 
(Szwedziak and Löwe, 2013). FtsZ filaments are also thought to produce the force 
required for cell constriction during division (Mingorance et al., 2010). The localisation 
and dynamics of the z-ring was limited by conventional fluorescence microscopy and 
EM due to the diffraction limit and labelling difficulties (Jennings et al., 2011). Despite 
this FtsZ has been localised to a band at the mid-cell in a ring-like structure that is 
dynamic in nature (Romberg and Levin, 2003). More recently the localisation of FtsZ 
has been determined at higher resolution by super-resolution microscopy techniques 
(Biteen et al., 2012; Holden et al., 2014; Strauss et al., 2012). Initial studies using 3D 
SIM showed that the z-ring of B. subtilis has a heterogeneous distribution of FtsZ with 
a possible discontinuous structure due to the presence of “gaps”, areas of the z-ring 
with little or no visible fluorescence (Strauss et al., 2012). Time-lapse microscopy 
showed that the distribution and position of FtsZ rapidly changed, however this 




Two variations of PALM have been applied to the analysis of FtsZ from Caulobacter 
crescentus, resulting in different models of FtsZ localisation (Biteen et al., 2012; Holden 
et al., 2014). The first produced images of z-rings that span the cells diameter and were 
of a thickness to suggest either a compressed helix or similar structure consisting of a 
high number of FtsZ protofilaments (Biteen et al., 2012). Conversely, Holden et al. 
found FtsZ to form a patchy ring at the mid-cell (Holden et al., 2014). Using high 
throughput 3D-PALM and a synchronised population of bacteria, patterns of FtsZ 
localisation throughout the cell-cycle were determined. Continuous rings were a rare 
event and although the proportion increased in late-stage division they were never the 
dominant morphology (Holden et al., 2014). It remains unclear what the shorter 
timescale dynamics of a patchy z-ring may be. Both a continuous and patchy ring can 
be modelled to allow FtsZ to produce a force capable of influencing constriction. 
However, whether force generation is required in vivo is still unclear, particularly how 
it may be linked to peptidoglycan remodelling (Sundararajan et al., 2015). EM 
tomography of FtsZ indicates a continuous, closed ring formed by overlapping short 
filaments (Chapter 1.7.1; Szwedziak et al., 2014). It is suggested that the non-
continuous rings found by Holden et al. (2014) may be due to the use of tagged 
proteins since there may be non-functional GTP fusions or that the punctate pattern is 
an artefact of overexpression (Szwedziak et al., 2014). Additionally, low signal-to-noise 
may cause overlapping regions of filaments to be over emphasised. 
The location and dynamics of the z-ring does not necessarily directly correspond to the 
synthesis, one way of determining localisation of synthesis is to locate the main 
peptidoglycan synthesis enzymes, PBPs (Scheffers and Pinho, 2005). Localisation of 
nearly all the PBPs within B. subtilis vegetative cell division and elongation shows there 
are 3 main patterns (Scheffers and Pinho, 2005; Scheffers et al., 2003);  
1. Dispersed localisation at the peripheral cell wall 
2. Specific localisation to division septum 
3. Localisation to distinct spots at the periphery – sometimes resolved in short 
arcs. 
However, in recent years there has been limited new insights into the localisation and 
dynamics of PBPs, in particular those which are located to the septum. In addition, it is 
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not known which PBPs are actively inserting peptidoglycan at any time. This remains a 
promising avenue of research, one that would be aided by the use of FDAAs to label 
new peptidoglycan insertion. 
The elongasome-linked actin homolog, MreB, is essential for the maintenance of the 
rod-shape (van Teeffelen et al., 2011). It contains a canonical actin fold and produces 
protofilaments (Szwedziak and Löwe, 2013). The dynamics of the elongasome have 
been determined through the analysis of fluorescently tagged MreB (Domínguez-
Escobar et al., 2011; Garner et al., 2011; van Teeffelen et al., 2011). Initial studies on 
MreB suggested localisation in helical filaments that encircled the cytoplasm and were 
flexible and highly dynamic (Carballido-López, 2006). More recently MreB has been 
shown to rotate around the long axis in a manner dependent upon peptidoglycan 
synthesis as opposed to its own polymerization (van Teeffelen et al., 2011). This has 
been shown in E. coli (van Teeffelen et al., 2011) and B. subtilis (Domínguez-Escobar et 
al., 2011; Garner et al., 2011). Within B. subtilis MreB filaments exist in shorter 
fragments or patches that have continuous movement in both directions. The 
discontinuous nature means that MreB cannot function as a “cell-spanning” structure 
but may act as a scaffold for peptidoglycan synthesis or to control the mobility of the 
elongasome (Domínguez-Escobar et al., 2011). Similarly to FtsZ, knowledge of MreB 
dynamics is only suggestive of where peptidoglycan synthesis is taking place. In order 
to determine the localisation of peptidoglycan synthesis both at the septum and within 
the periphery, FDAAs could be used to label peptidoglycan insertion.  
Apparently spherical bacteria, such as S. aureus lack MreB homologs and have been 
previously thought to have only one mode of peptidoglycan insertion, septation (Pinho 
and Errington, 2003; Scheffers and Pinho, 2005). All the major cell division proteins 
(FtsZ, PBP1, PBP2 & 2A, EzrA) have been localised to the septum during division 
although evidence of dynamics is limited (Jorge et al., 2011; Pereira et al., 2007; Pinho 
and Errington, 2003, 2005; Steele et al., 2011). PBP2 was shown to produce a ring at 
the future division plane and as the septum closes the localisation of PBP2 changes to 
a disk co-localised with the septum, this remains throughout cell division even as 
daughter cells begin to separate (Pinho and Errington, 2005). Using 3D-SIM, PBP2 was 
found to have a similar localisation pattern to FtsZ, namely a heterogeneous bead-like 
distribution (Strauss et al., 2012).  
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There exists a model of peptidoglycan dynamics within S. aureus informed by 
architectural features determined by AFM and vancomycin labelling of nascent 
peptidoglycan. AFM determined the presence of thick bands (“piecrusts”) of material 
that encircles cells and surrounded any incomplete septa found (Turner et al., 2010a). 
These piecrusts are thought to be formed before the centripetal assembly of the septal 
disk occurs. Vancomycin labelling appears to corroborate this since nascent 
peptidoglycan appears as a ring or disk in the plane of the septum, with brighter 
fluorescence indicating the piecrust in some cells. Following the synthesis of the 
septum, pairs of daughter cells were seen to partially separate before synthesis of 
orthogonal new growth occurred (Figure 5.1). The stage between septum completion 
and cell splitting is brief (Turner et al., 2010a). 
Due to division of S. aureus on 3 sequential and orthogonal planes peptidoglycan in the 
cell wall can be sectored by age. If it is taken that after each division daughter cells 
consist of approximately  ½ material from the division that has just occurred and ½ 
from previous generations then the cell wall can be sectored as follows (Turner et al., 
2010a)(Figure 5.2); 
1. 1/2 peptidoglycan from the most recent division 
2. 1/4 from the second most recent division 
3. 1/8 from the third most recent division 
4. 1/8 from a previous division 
However, recently it has been suggested that S. aureus may not produce 50% new 
material but instead 33%. Also further remodelling by autolysins etc. does not affect 
the ratio of 67% old peptidoglycan:33% new peptidoglycan (Monteiro et al., 2015). 
How these theoretical models of sectoring translate in vivo is still uncertain. 
 Aims of the Chapter 
1. To determine the dynamics of peptidoglycan insertion within the septum. 





Figure 5.1. Model of dynamics of nascent peptidoglycan insertion. Green indicates 
localisation of peptidoglycan synthesis. Septum is completed prior to cell splitting and 




Figure 5.2. Schematic of peptidoglycan age by sectoring of cell-wall during multiple 
cell division cycles. Two hemispheres of a single cell rotated through 180°. On the left 
is the recently synthesised hemisphere and the right is the mature hemisphere with 





 Dynamics of synthesis by pulse labelling 
By labelling peptidoglycan insertion with a long pulse of HADA (2 hours) followed by a 
short pulse with a second FDAA there are two consequences. Firstly, labelling by the 
second FDAA should be synthesis only since all available exchange reaction sites 
should have already exchanged with HADA. Secondly peptidoglycan insertion labelled 
by the second FDAA can be put into context of the progression of cell division. 
Labelling over 5 minutes with NADA following the 2 hour HADA pulse was imaged 
using widefield deconvolution and structured illumination microscopy (Figure 5.3). 
NADA labelling has a pattern consistent with previous patterns seen (Figure 4.1; Figure 
5.3 A & B), this has two implications; firstly, that 2 hours incubation with HADA has no 
obvious detrimental effect on cell-division and secondly that previously described 
incorporation patterns (Chapter 4) are due to peptidoglycan synthesis not the 
exchange reaction. In addition, off-septal labelling is still present, albeit at a seemingly 
lower level. This furthers the notion that off-septal labelling is due to synthesis of 
nascent peptidoglycan at the peripheral cell wall as opposed to an artefact of labelling. 
During the deconvolution process a portion of the signal is removed from the sample 
in order to increase signal compared to background, therefore it is not possible to use 
deconvolved images for quantitative analysis of reduction in off-septal with these 
images. For quantification to be possible this would need to be repeated using 
standard widefield microscopy (as used in Chapter 4.2.4). 
There also appears to be two populations of cells (Figure 5.3 A, cells marked a & b); 
one that exhibits a bright ring or plate of fluorescence at the septum (a) and the other 
with reduced fluorescence (b). The presence of bright rings and plates in septating cells 
suggests that once a cell is committed to synthesising a septum a large amount of 
peptidoglycan material is required to be inserted. While many cells that have reduced 
fluorescence are not in the process of septation, a number have the beginnings of 
piecrust synthesis labelled with NADA (Figure 5.3 B, cell marked c). This implies that 
the piecrust may be a temporally consuming stage. The production of the piecrust is 
thought to be an important stage to be completed prior to the synthesis of the septal 
plate. Cells lacking in DivIB become stuck at the piecrust stage (Bottomley et al., 2014), 










Figure 5.3. Localisation of nascent peptidoglycan synthesis using dual labelling. 5 
minutes peptidoglycan synthesis labelled with FDAA following 2 hours labelling with 
HADA (5 mM). Imaged by OMX widefield microscopy with images deconvolved by 
Softworx (A&B) or in structured illumination mode (C&D). (A) 2 fields of labelled S. 
aureus cells labelled for 2 hours with TADA (5 mM) and 5 minutes with NADA (5 mM), 
imaged using OMX widefield. Two patterns of NADA labelling indicated by a & b (Scale 
bar 5 µm, maximum intensity projection). (B) Selected cells from (A) enlarged to 
highlight labelling pattern, cells of interest indicated by arrows (Scale bar 0.5 µm, 
maximum intensity projection). (C) Fields of labelled S. aureus labelled for 2 hours with 
HADA (5 mM) and five minutes with TADA (5 mM) imaged by SIM (Scale bar 1 µm, 
average intensity projection). (D) Selected cells enlarged to highlight labelling pattern. 




the piecrust. Cells throughout the population have a variety of patterns and amounts 
of peptidoglycan insertion during NADA labelling. This may be due to the different 
stages of the cell cycle that cells are in during NADA labelling and may suggest a level 
of heterogeneity in peptidoglycan insertion. 
To further investigate the insertion of peptidoglycan samples were imaged using SIM 
(Figure 5.3 C & D). In this case 2 hour HADA incubation was followed by 5 minute TADA 
incubation since reconstruction is generally improved with TADA over NADA labelling 
(Chapter 3.2.3.1). TADA labelled peptidoglycan insertion is found to continue septal 
synthesis from that incorporated during HADA labelling. This can be seen as the 
presence of ring and plate structures TADA labelled within initial rings that were HADA 
labelled. Off-septal labelling is also present in TADA labelled channel, once again 
indicating that some of the off-septal labelling is due to synthesis. However, it is not 
possible to infer any pattern in off-septal synthesis due to artefacts arising from the 
microscopy technique (Chapter 3.2.3.2). These artefacts can be seen from the Fourier 
transforms in Appendix II (Appendix Figure 13). 
The Fourier transforms suggest that both channels include periodic features from the 
patterned light source. Therefore, the apparent punctate pattern, particularly in the 
TADA channel is likely an artefact from this rather than a pattern of TADA labelling. In 
particular, since these puncta are often present where 2 cells meet (e.g Figure 5.3 D, 
upper panel) where signal density is higher. 
To determine short term peptidoglycan synthesis 2 minutes labelling with TADA was 
used following 2 hours HADA labelling (Figure 5.4). The pattern of incorporation was 
the same as with 5 minutes labelling. However, the SIM artefact was much more 
apparent in the images. In addition, the Fourier transform shows significant periodic 
features (Appendix II, Figure 14). Therefore, any subtle changes in labelling features 
would be masked. 
 Septal dynamics by virtual time-lapse 
Using previous methods, the dynamics of peptidoglycan synthesis have been difficult 
to determine. Most of what we know has been inferred from pulse-chase labelling 
with Vancomycin (Pinho and Errington, 2003; Turner et al., 2010a). FDAAs provide a 




Figure 5.4. Localisation of 2 minutes nascent peptidoglycan synthesis using dual 
labelling. Following 2 hours labelling of peptidoglycan synthesis with HADA (5 mM) 2 
minutes of synthesis was labelled with TADA (5 mM). Resulting cells were imaged using 
SIM. (Scale bar 1 µm, average intensity projection). 
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experiments. The location of synthesis during each time period can be marked by the 
use of spectrally different FDAAs providing a time resolved image of peptidoglycan 
synthesis (Kuru et al., 2012). 
Dynamics of septal peptidoglycan synthesis over 15 minutes were visualised using the 
virtual time-lapse technique. Mid exponential cultures were consecutively labelled 
with HADA, NADA and TADA for 5 minutes and imaged using both conventional 
deconvolution microscopy and SIM (Figure 5.5 & Figure 5.6). To eliminate any probe-
mediated effects the experiment was carried out with the FDAAs in different orders, 
the observed pattern remained consistent. Within cells that were producing a septum 
during the course of the virtual time-lapse, there appears to be a “rainbow-effect” of 
FDAA labelling with the first label (coloured blue) on the outer rim of the labelled 
septum and the final label (coloured red) at the leading edge (Figure 5.5 A). This would 
seem to suggest overlap of synthesis and a zone of synthesis, consistent with my 
previous work (Chapter 4.2.2).  
Within the population the amount of dye overlap can vary from none to almost 
complete where it is almost impossible to distinguish differences between the three 
dyes at available resolutions. Often this occurs since the orientation of cells masks 
synthesis patterns however, when this is not the case the overlap occurs in an 
apparent ring, consistent with piecrust synthesis (Figure 5.5 A, highlighted cells). This 
suggests that individual cells may synthesize the septum at different rates. Within the 
SIM images, each label appears more distinct than within the deconvolved images yet, 
areas of overlap are still visible between consecutive labels (Figure 5.5 B, highlighted 
cells(a)). When images from all three channels are merged it often appears as if each 
label produces a discrete ring of peptidoglycan synthesis (Figure 5.5 B, highlighted cells 
(b)), however when individual channels are analysed it is seen that while most labelling 
occurs at the leading edge to produce the new septum, there is a lesser amount of 
synthesis labelled within the previously synthesised portion of the septum (Figure 5.6 
B, highlighted cell). In all cases the septum is synthesised processively from the outer 
edge to centre of the septum, suggesting that synthesis occurs as a single process of 
synthesis and thickening to correct thickness as opposed to an initial synthesis of the 
septum and subsequent thickening. On the few occasions where a later dye is seen 







Figure 5.5. Septal dynamics by virtual time-lapse. Dynamics labelled via consecutive 
incubation with 3 different FDAAs in the following order; HADA, NADA & TADA (all at 5 
mM). Samples were imaged by OMX widefield microscopy with images deconvolved by 
Softworx (A) or in structured illumination mode (B). Septa are produced via sequential 
peptidoglycan synthesis from the outer edge to the centre & off-septal synthesis 









Figure 5.6. Features of dynamics in septal formation.  Cells labelled consecutively with 
three FDAAs in 5 minute periods as in Figure 5.5 enlarged to highlight labelling pattern. 
(A) OMX widefield images that have been deconvolved using Softworx. Order of FDAAs 
used indicates below each image, false colour is consistent with order of label rather 
than label used. (B) SIM images, Samples labelled in order HADA, NADA, TADA. (Scale 
bar 0.5 µm, average intensity projection).  
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(highlighted cell). In this case the septum has been completed during labelling with the 
second FDAA as can be seen by the dot of green labelling of the cell with the septum 
parallel to the imaging plane. In this case cells are believed to have just split or begun 
the process of splitting and labelling with the third FDAA due to off-septal synthesis. In 
a number of cases off-septal synthesis appears to be almost non-existent. However, 
this could be a limitation of the microscopy technique used for both the deconvolution 
and SIM cannot adjust for large variations in signal intensity, therefore low intensity 
light can be lost, such as the signal from off-septal synthesis. Where off-septal labelling 
is visible, all 3 labels are generally present, regardless of the stage of the cell, 
suggesting that off-septal synthesis occurs throughout the cell cycle. Due to the 
limitations of the microscopy techniques used and since the FDAAs are not normalised, 
quantification of labelling is not possible. However, it is tempting to speculate that the 
amount of off-septal synthesis is at a consistent level throughout the cell cycle. 
 Inheritance of peptidoglycan over several generations 
Peptidoglycan synthesis at the septum with division in 3 orthogonal planes in S. aureus 
gives a theoretical model of the cell wall of S. aureus being sectored due to age (Turner 
et al., 2010a). In spite of the presence of synthesis away from the septum the amount 
of new synthesis at the septum suggests that the cell wall will be sectored in the 
manner previously proposed (Figure 5.2). In order to visualise the sectoring cultures 
were grown in 3 consecutive FDAAs for a generation time, in the case of S. aureus, 30 
minutes (Figure 5.7). Cells that are dividing can be seen to show a sectoring 
phenomenon, where the peripheral cell wall is sectored with the first and second 
labels, the second showing where the cell has just divided, and the third label marking 
the septum being synthesised at the point the sample was fixed (Figure 5.8). Since S. 
aureus cannot be made synchronous each cell is in a slightly different phase of the cell 
cycle when labelling starts, therefore cells with optimal sectoring labelling have been 
selected to examine the phenomenon (Figure 5.8 B). To highlight peptidoglycan 
sectoring a pair of sister cell displaying optimal sectoring have had labelling pattern 
mapped to a schematic of cell division (Figure 5.8 C). A single S. aureus cell divided 
during the first labelling process to produce daughter cells with the new hemisphere 




Figure 5.7. Fields of cells labelled consecutively with ADA-647 (blue), NADA (green) 











Figure 5.8. Inheritance of peptidoglycan over 3 generations. S. aureus cells labelled 
sequentially by FDAAs for a single generation time each (30 minute) and imaged using 
DeltaVision deconvolution microscopy and images deconvolved by SoftWoRx. (A) 
Selections of cells showing characteristic sectoring of peptidoglycan cell wall (Scale bar 
1 µm, average intensity projection).  (B) Cells enlarged to highlight labelling of sectors 
(Scale bar 0.5 µm, average intensity projection). (C) Representative cell of optimal 
peptidoglycan sectoring by age (Scale bar 0.5 µm, average intensity projection) and 
schematic of events within cell division to produce labelling seen. Schematic 
represents the external cell wall of S. aureus while images are an average projection of 
slices from around the focal plane. Final schematic is the representative cells rotated 
90° to best match the merge image shown. 
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the orthogonal plane to produce two cells with one hemisphere labelled with the 2nd 
FDAA and during this process bisecting the old hemisphere such that the sister cells 
inherited a quarter cell wall labelled with the first FDAA. These sister cells synthesized 
a new septum on the third orthogonal plane during the third labelling period. 
However, they did not split prior to the end of the experiment. The final image in the 
schematic is rotated 90° to best match image and to make visualisation of the final 
division septum easier. 3D projections of cells that show sectoring (Figure 5.9) indicate 
the presence of FDAAs on the surface of the cell. The first FDAA used (labelled blue) 
can be seen to cover approximately one quarter of the total cell wall. This can also be 
visualised in Movies 1 & 2 (Enclosed CD; Appendix III). 
 Dynamics reveals heterogeneity in peptidoglycan synthesis 
Within a population of S. aureus each individual cell is at a slightly different stage of 
the cell division cycle. 3 labels are used during growth and the incorporation pattern 
and sectoring can be determined. However, a number of cells within the analysed 
populations have unexpected labelling suggesting that heterogeneity exists within 
peptidoglycan synthesis dynamics (Figure 5.10 & Figure 5.11). 
FDAA labelling of consecutive 5 minute windows suggests that the rate of 
peptidoglycan synthesis differs during the cell cycle as specific structures are made; 
piecrust and septal plate (Figure 5.5 & Figure 5.6). However, there are cells within the 
population that do not label with an FDAA during a labelling period (Figure 5.10 A). 
This pause in peptidoglycan synthesis may occur mid septation or just after completion 
of septation but due to the orientation of cells it is not possible to discern if septation 
is still in progress. Whilst there may still be some low level peptidoglycan synthesis 
occurring this is not at a detectable level. Given the proximity of cells with similar 
phenotypes to each other within an image it may suggest that these cells are related to 
one another. Therefore, it might be that there is an inherited signal that causes this 
pause in peptidoglycan synthesis. 
Another means by which peptidoglycan synthesis heterogeneity has been identified is 
by differential labelling patterns in sister cells (Figure 5.10 B). Cells in both panels have 




Figure 5.9. 3D Maximum intensity projections of cells labelled for consecutive 30 










Figure 5.10. Heterogeneity in peptidoglycan synthesis during the cell cycle. Cells 
labelled sequentially with three FDAAs for 5 minutes each (5 mM). In all cases the first 
FDAA is coloured blue, second FDAA coloured green and third FDAA labelled red. (A) 
Cells not labelled with final FDAA, due to a pause in incorporation, suggesting 
heterogeneity in peptidoglycan synthesis during the cell cycle (Scale bar 1 µm, average 
intensity projection). (B)  Apparent sister cells exhibit different patterns of FDAA 











Figure 5.11. Heterogeneous peptidoglycan synthesis within sister cells. Sister cells 
labelled with 3 FDAAs sequentially for 30 minutes exhibit different labelling patterns. 
In all cases the first FDAA is coloured blue, second FDAA coloured green and third 
FDAA labelled red (500 µM). (A) Sister cells indicated by yellow box, one cell has a red 
septum while the other has not synthesised a septum during generation labelled by 
the third FDAA (Scale bar 1 µm, average intensity projections). (B) Sister cells split at 
different times during labelling experiment. In each pair one sister cell has completed 
the next synthesis cycle and split while the other sister cell has not (Scale bar 0.5 µm, 
average intensity projection). 
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cells the initiation of peptidoglycan synthesis of the septum in the orthogonal plane 
occurs at different times. In the cell marked (a) this is a delay of only approximately 5 
minutes since initiation of septation in the second daughter cell is labelled by the third 
FDAA. However, in cell marked (b) septation is not initiated during the course of the 
experiment. What is important to note is that in both cases the sister cells have off-
septal peptidoglycan synthesis throughout the labelling experiment i.e. labelled with 
all three FDAAs. This suggests that there is not global arrest of incorporation but a 
specific delay in septation in a single daughter cell. Since these cells are in mid-
exponential phase with no limitations on growth this delay is likely due to an intrinsic 
heterogeneity in the cell division progression. This effect is not limited to transient 
heterogeneity as in cells labelled for a full generation time (30 minutes) with each 
FDAA also displayed the same effect (Figure 5.11). In this case sister cells were not only 
identified with delayed septation in a single sister cell (Figure 5.11 A) but also where 
splitting of cells appears delayed in one sister cell (Figure 5.11 B), either due to a 
simple delay in separation or due to a delay in completion of the septum. This results 
in offspring from a single cell becoming asynchronous. 
When analysing fields of cells labelled sequentially for 30 minutes with 3 FDAAs it is 
clear that a large number of different labelling patterns are present across the 
population (Figure 5.12). While many of these patterns are attributable to cells at 
different stages of cell division at the beginning of the labelling process a subset of 
cells is seen to completely lack labelling with one or more FDAAs. The labelling pattern 
of cells was analysed and features of peptidoglycan synthesis across a population were 
revealed (Table 5.1). Of cells analysed 86% were labelled with all 3 FDAAs in a pattern 
compatible with dynamics of peptidoglycan synthesis discussed earlier (Chapter 5.2.3). 
0.5 % of counted cells were found to have no labelling whatsoever, these were 
presumed to be dead, un-lysed cells, a live/dead counterstain would prove this 
however a reliable one compatible with the FDAAs used was not available. A further 
13.5% of cells were missing apparent labelling for at least one of the labels used 
(Figure 5.13 A). In the case when the missing labels were that of the last label, this 
could be attributed to the death or entrance into a stationary phase state, however 







Figure 5.12 Dynamics of peptidoglycan synthesis reveals heterogeneity across a S. 
aureus population. In a population of cells labelled sequentially with 3 FDAAs for 30 
minutes each a number of different labelling patterns are seen across the population, 
in particular a subset of cells lacks labelling with one or more FDAA. (A) Field of cells 
highlighting different labelling patterns across the population. (Scale bar 1 µm). (B) 
Fields of cells for each of the FDAA labelling orders used, order of FDAA labelling did 
not affect frequency of labelling patterns. (Scale bar, 5 µm).  
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Labelling Pattern Percentage of total cells (n=11,604) 
ON  ONON 86.0% 
OFFOFFOFF 0.5% 








ON (Dual Colour) 
 ONONOFF 
 OFFONON 





















Figure 5.13 Population heterogeneity in peptidoglycan incorporation. Cells labelled 
sequentially with 3 FDAAs for a generation time each display population 
heterogeneity. (A) Cells labelled by a single FDAA (Scale bar 1 µm). (B) & (C) Cells 
labelled with 2 consecutive FDAAs but not the third (Scale bar 500 nm). (D) Cells 
labelled with the 1st and 3rd FDAAs but not the 2nd (Scale bar 1 µm).  
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suggesting that growth (& therefore synthesis of peptidoglycan) restarted from a 
temporary state of arrest. A feature of this missing labelling is that it isn’t only septal 
labelling that is missing but also off-septal labelling, suggesting a global arrest of 
peptidoglycan synthesis. Of particular interest are the 1.7% of counted cells which 
during the course of the experiment were actively incorporating for the first and third 
labels but not during the 30 minutes of growth with the second label (Table 5.1, final 
row).  These are particularly useful as the pattern of peptidoglycan synthesis before 
and after pause in synthesis can be visualised (Figure 5.13 D). Peptidoglycan synthesis 
within these so-called “oscillators” shows no apparent gap in the labelling process 
despite a lack of labelling with the second FDAA. This suggests that growth is arrested 
within these individual cells as opposed to the phenomenon being due to the FDAAs or 
microscopy technique. The experiment was carried out with all permutations of FDAA 
labelling (Figure 5.12 B; Appendix V), further suggesting that this is not due to the 
labelling technique but a characteristic of S. aureus growth. Thus with an apparently 
exponentially growing population there are cells that have stopped growing but with 
the potential to restart. 
 
5.3 Discussion 
 Septation dynamics 
In S. aureus septation progression has been followed by transmission electron 
microscopy (TEM) and atomic force microscopy (AFM) (Matias and Beveridge, 2007; 
Touhami et al., 2004). Onset of septation occurs when visible growth of wall material 
was seen protruding into the cytoplasm at the mid-cell by TEM (Touhami et al., 2004). 
The septum then continues inward growth until it meets in the middle. The movement 
of the septation process has been described like the closing of a camera aperture 
(Touhami et al., 2004). Sequential labelling experiments carried out within this chapter 
have revealed that this is indeed the case with later peptidoglycan synthesis occurring 
within the ring of older synthesised peptidoglycan. Following completion of the septa, 
and splitting of cells, daughter cells remain mostly joined with surface features of cell 
splitting apparent (Touhami et al., 2004). 
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Previous single colour STORM imaging of the septation process suggested that 
synthesis does not occur solely at the leading edge of the septum but as a zone across 
the septum (Chapter 4). SIM images of consecutive 5 minutes labelling with FDAAs 
show clear concentric rings of FDAA incorporation. While the majority of incorporation 
occurs at the leading edge forming these concentric rings there is also insertion of 
peptidoglycan into the existing septal material. In SIM images there appears to be 
greater contrast between the leading edge and the existing septum incorporation. 
However, this may be influenced by artefacts from SIM. The consistency between 
labelling experiments and imaging techniques suggests that the previously described 
model of a zone of synthesis is compatible with the dynamics of septal formation. 
 Inheritance of peptidoglycan in sectors 
S. aureus is an approximately “spherical” organism that divides on three orthogonal 
planes (Tzagoloff and Novick, 1977). This influenced the production of models of the 
bacterial cell wall in sectors for both glycan strand orientation and peptidoglycan age 
(Dmitriev et al., 2004; Turner et al., 2010a). The sectoring hypothesis was tested using 
sequential labelling with three FDAAs and was shown to occur in the majority of cells 
within a population. The sectoring model is therefore maintained despite publications 
released during the later stages of this project that suggest S. aureus is ellipsoid during 
the division cycle (Monteiro et al., 2015; Zhou et al., 2015). This new observation also 
affects the percentage of total cell surface area in each sector not the sectoring 
phenomenon itself, as new peptidoglycan has been shown to account for less than half 
of the total cell surface following division. In order to further quantify the 
peptidoglycan sectors super-resolution images of sectored cells rendered in 3D are 
required. This would require further 3D SIM images of sector labelled S. aureus cells, 
however care must be taken on the influence of the artefact associated with SIM on 
these quantifications. 
There are a number questions to answer when it comes to the inheritance of cell wall. 
What percentage of the cell wall of a newly split cell comes from septal peptidoglycan 
and does this change as the cell cycle continues? This has recently been determined to 
be less than 50% and is maintained until the next division cycle begins (Monteiro et al., 
2015; Zhou et al., 2015). However, the dynamics of this over multiple division cycles 
was not followed, it remains possible that expansion of the new septum may continue 
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for multiple generations. Another question to answer is whether the proportions of 
each cell wall sector need to be recalculated? This question has added complication 
due to the presence of off-septal synthesis which may or may not contribute to overall 
cell growth (Chapter 4; Monteiro et al., 2015). However, to assess this question it 
would first be important to repeat sequential 30 minute labelling with FDAAs with SIM. 
 Heterogeneity in peptidoglycan synthesis 
Peptidoglycan synthesis heterogeneity appears to occur at a number of different levels 
within S. aureus; heterogeneity in progression of synthesis, heterogeneity between 
individual cells to produce an asynchronous clonal population and population 
heterogeneity. During the progression of the cell division cycle peptidoglycan synthesis 
heterogeneity seems to occur in two ways. Firstly, individual cells take different 
lengths of time to pass various morphological checkpoints within the cell division 
process. For example, DivIB acts as a molecular checkpoint to ensure synthesis of the 
ring/band of peptidoglycan is completed prior to completion of the septum (Bottomley 
et al., 2014). It is required for the synthesis of the septal plate after piecrust formation. 
Secondly, the actual speed of peptidoglycan synthesis at the different stages of the 
division cycle and between individual cells does not appear consistent. Individual cells 
therefore progress through the division process at different rates, most likely dictated 
by a number of different factors, presumably including availability of peptidoglycan 
precursors. 
The rate of cell division does not appear to be determined by an inherited factor, due 
to the different progression of cell division observed in sister cells. This produces 
asynchrony within a clonal population. The presence of cells at different stages in the 
cell cycle allows continuous expansion of the population and may have advantages in 
speed of reaction of the population to fluctuations in the environment. It is unclear 
what may cause heterogeneous sister cells. Stochastic gene expression and 
partitioning of molecules at division may provide an explanation but are unlikely to be 
the full story (Elowitz et al., 2002; Huh and Paulsson, 2011). However, while in some 
cases apparent sister cells had a different incorporation pattern, in other cases cells in 
close proximity to one another showed the same FDAA incorporation. Cells that are in 
close proximity may be related to one another. This may suggest that inheritance may 
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play a role in FDAA incorporation patterns, in particular when cells undergo growth 
arrest.  
Population heterogeneity gives phenotypic diversity in the absence of any apparent 
genetic or environmental variation (Ackermann, 2015). Even when differences 
(genetic/environmental) are minimised single cells are still seen to differ from one 
another e.g. in gene expression and phenotypic traits. The reason for this is that many 
cellular processes are based on a small number of molecules against a noisy 
background such that fluctuations within individual cells are inevitable (McAdams and 
Arkin, 1999). These fluctuations are tolerated since careful control comes at a high 
energetic cost and the ability of a subset of cells to survive a sudden change in 
environmental conditions is a selective advantage (Balaban et al., 2013). There are two 
means by which population heterogeneity generally occurs within bacteria; bet-
hedging and division of labour (Ackermann et al., 2008; Philippi and Seger, 1989). 
Division of labour occurs when two (or more) phenotypes are encoded by the same 
genotype & each phenotype relies on the other for some benefit (Ackermann et al., 
2008). There are several examples of this within bacteria that occur in both the ability 
to utilise nutrients and in pathogenesis. For example, B. subtilis produces the enzyme 
subtilisin E to digest extracellular proteins during nutrient deprivation. Only a subset of 
cell produce subtilisin E, presumably at high energetic cost, while all cells within the 
population benefit from the additional nutrients (Veening et al., 2008).  
Other examples of heterogeneity do not rely on interaction between individual cells to 
commit to different phenotypes but occur seemingly randomly across a population 
and therefore allow populations to benefit in fluctuating environments (Ackermann, 
2015). There are multiple examples of bet-hedging heterogeneity in bacteria. These 
include competence in B. subtilis and host evasion in Salmonella typhimurium. Non-
expression of flagellin in Salmonella allows evasion of the host immune system 
however prevents ability of Salmonella to migrate to areas of higher nutrients (Stewart 
et al., 2011). The mechanism controlling the two states of flagellin expression (on or 
off) impacts on the ability of an individual to cause infection. 
Perhaps the best known example of population heterogeneity lies in persistence, the 
ability of a subset of genetically identical cells to survive extended exposure to 
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antibiotics without the acquisition of resistance genes. Here, those cells in the S. 
aureus population that cease peptidoglycan synthesis might be persister cells, as they 
are not growing (See Chapter 5.3.4). 
The presence of heterogeneity at multiple levels within a bacterial population 
emphasises the need for single-cell microbiology techniques. Many current analyses on 
bacteria rely on techniques based on averages e.g. optical density. In this case both a 
pause in cell division and individual cell death is masked (Figure 5.14).  
 Bacterial persistence 
When antibiotics are used against a bacterial infection the majority of the population 
are killed. However, a small proportion (between 0.001-0.1%) survive by entering a 
“persister-state” (Van den Bergh et al., 2016; Verstraeten et al., 2016).  Persisters are 
phenotypic variants of a genetically clonal population that have entered a dormant 
state (Levin-Reisman and Balaban, 2016). The dormant state is characterised by 
decrease in important cellular processes such as DNA replication, protein synthesis and 
cell wall synthesis, processes that are also important targets for antibiotics (Balaban et 
al., 2013). Persister cells are thought to be the major cause of recurrence in chronic 
bacterial infections (Verstraeten et al., 2016). Unlike the production of resistant 
mutants, cells that are regrown from persistent bacteria remain sensitive to antibiotics 
(Balaban et al., 2004). The growth state (slow-growth vs. non-growth) and mechanisms 
behind production of persisters remain largely unknown (Helaine et al., 2014). 
There are two types of bacterial persistence. Type I results from stress signals and can 
be eliminated by keeping cells in exponential phase while Type II occurs when cells 
stochastically enter a non-growing state presumably in the absence of an external 
signal (Levin-Reisman and Balaban, 2016). Type II persisters are continuously 
generated within populations (Balaban et al., 2004). Persistence has been linked to 
pre-existing heterogeneity in bacterial populations where phenotypic switching 
produces cells within a population which are “normal” or exhibit reduced growth rates 




Figure 5.14 Whole population versus single cell analysis. Using average based 
detection techniques, heterogeneity within a bacterial population is missed. This 
schematic highlights the different conclusions of the proliferation of 2 cells to form a 
population of 8 cells measured by whole population and single cell analysis. Whole 






of antibiotics and this heterogeneity is thought to be important in adaptation of a 
bacterial population to fluctuating environments, such as those encountered during 
infection (Balaban et al., 2004). Oscillator cells found in my study show that the switch 
between arrested growth & fast growth also occurs within a S. aureus population. This 
phenomenon allows an increased chance of survival in a rapidly changing 
environments. The signals that cause a single cell to enter the “persister-state” are still 
largely unknown, possible candidates include fluctuations in levels of a small number 
of proteins (possibly due to unequal partitioning of proteins on cell division), 
differential exposure to nutrient deprivation and bacterial signalling (Helaine and 
Holden, 2013; Lewis, 2010). 
Signals that may trigger cells to enter the persister state can broadly be split into cell-
intrinsic and cell-extrinsic signals (Balaban et al., 2013). Cell intrinsic signals may be 
due to noisy gene expression, an example of this is the involvement of a toxin-antitoxin 
module in persistence (Verstraeten et al., 2016). In E. coli a mutagenesis screen using 
ethyl methanesulphonate (EMS) led to the discovery of mutations within the hipA gene 
that caused high levels of persistence (Verstraeten et al., 2016).  The hipBA locus 
encodes a toxin-antitoxin (TA) module. TA modules encode a fragile antitoxin that 
controls the activity of a stable toxin, usually targeted to an essential cellular process 
(Verstraeten et al., 2016). The levels of both the toxin HipA and antitoxin HipB during 
normal cell growth are in balance such that the toxin is unable to cause an effect, 
however under stress HipB is degraded by the Lon protease such that HipA is free to 
act within the cell (Rowe et al., 2016). Current understanding is that the balance 
between HipA and HipB is perturbed in a subset of cells allowing the toxin level to 
increase above a threshold causing transient growth arrest as the toxin exerts its effect 
until HipB levels increase (Balaban et al., 2013). This effect may be due to leaky gene 
expression of the hipAB locus or may be due to a more global mechanism of persister 
formation based on guanosine tetraphosphate (ppGpp) concentrations. Slow-growing 
cells often have high concentrations of the bacterial signalling molecule ppGpp, a 
signal involved in environmental stress response. High p(p)Gpp can activate TA loci 
through a regulatory cascade (Balaban et al., 2013; Verstraeten et al., 2016). However, 
since the high ppGpp levels have only been detected once persister cells have been 
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isolated, it is unclear whether ppGpp has a role in formation or maintenance of the 
persister state once an environmental stress has occurred. 
Many extrinsic signals, particularly environmental stresses, induce the formation of 
peristers, these include nutrient stresses e.g. starvation and carbon source transition, 
host signals as well as the presence of antibiotics (Helaine and Kugelberg, 2014).  There 
exists multiple mechanisms of perister formation that may interact with one another 
(Lewis, 2010). This poses difficulty in the eradication of persisters during infection. 
Persisters within infection pose a particular threat not only due to the possibility of 
recurrence but also since persisters have a high propensity to develop resistance, 
especially since stressed bacterial cells have a higher than normal mutation rate 
(Balaban et al., 2013). Recurrence of chronic infection is proposed to be due to a 
combination of biofilm formation and persister cells. Biofilms are aggregated bacteria 
within an extracellular matrix that often stick to both biological and non-biological 
surfaces (Periasamy et al., 2012). In general biofilms are not thought to be less 
permeable to antibiotics however, they pose a barrier to immune cells (Lewis, 2010). A 
model of relapsing infection is as follows; The immune system clears both regular and 
persister cells from the bloodstream while antibiotics kill the majority of other 
bacterial cells within the host (e.g. in biofilms). Any persister cells located within the 
biofilom are not cleared. Once antibiotic levels drop these remaining persisters 
repopulate the biofilm and infection relapses (Lewis, 2010). Within the clinical setting 
an important question is whether remaining cells are due to ineffectiveness of 
antibiotics to kill persister cells or whether antibiotics are unable to reach certain cells 
within the infection (Conlon et al., 2013). Eradication of persisters therefore must rely 
on the development of drugs that target all cells within a population regardless of 
growth state or a molecule that can be used in conjunction with standard antibiotics to 
eliminate persisters through perturbation of the persister state. Since the mechanisms 
of persister formation are varied possible targets will likely be involved in persister 
maintenance (Lewis, 2010). Such targets may include processes such as lipid bilayer 
maintenance which must be continued for a cell to remain viable, indeed reduction in 
PlsB function, a protein involved in the synthesis of phospholipids, leads to reduction 
in persister formation (Lewis, 2010). Recent work from the Lewis group discovered a 
compound that can be used to clear persisters within infections (Conlon et al., 2013). 
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An acyldepsipeptide (ADEP4) activates the ClpP protease resulting in death of cells. 
The ClpP protein is involved in the degradation of misfolded protein however the 
ADEP4-ClpP complex has an open catalytic chamber allowing non-specific degradation 
in a non ATP-dependent manner of multiple proteins forcing cell death (Conlon et al., 
2013).  ClpP null mutants were shown to arise however co-treatment with Rifampicin 
resulted in complete eradication of S. aureus even from biofilms (Conlon et al., 2013). 
A further outcome of this is the observation that persisters are not invulnerable 
suggesting that recurrent infections are due to pathogen tolerance of antibiotics as 
opposed to inability of antibiotics to reach all pathogens within an infection (Conlon et 
al., 2013). 
Within my work S. aureus were seen to enter into a transient dormant state where no 
cell wall synthesis occurred. It could be said that these cells are entering a persistent 
state. Since the experiment was carried out in the complete absence of antibiotics and 
with cells at mid-exponential phase the oscillator cells are examples of S. aureus 
stochastically entering a persistent state, from which they can return to an active 
growing state with no apparent ill-effects. However, there remains a number of 
questions to ask about these cells. Labelling with FDAAs only indicates the state of the 
cell wall synthesis process, it is unclear whether cells that are in a “dormant-state” also 
have reduced other cellular processes or whether cell wall synthesis is the only process 
involved. These two options would suggest two entirely different explanations for the 
occurrence of oscillators. If this process was only due to peptidoglycan synthesis it 
would most likely be due to a checkpoint in cell division, where peptidoglycan 
synthesis is paused until cell division is able to proceed. However, this seems unlikely 
for two reasons. Firstly, oscillators are seen to pause at entirely different stages in cell 
division, if this was due to a cell division checkpoint there should be finite points within 
the cell cycle that cell division is paused. Secondly, it stands to reason that pausing the 
cell cycle would only result in the pause of septal peptidoglycan synthesis, such as is 
the case in the production of heterogeneous population mentioned previously 
(Chapter 5.2.4). Since oscillators completely pause peptidoglycan synthesis for both 
septal and off-septal synthesis it suggests that lack of synthesis is due to entrance of 
individual cells into a dormant state comparable with that of persisters. 
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Another possibility for cells that lack labelling is incomplete transition from stationary 
to exponential phase in individual cells. Overnight cultures of cells used for inoculua 
within these experiments are in a starvation state therefore there will be a high 
proportion of persister cells. Increasing single-cell lag time distribution is a mechanism 
bacterial populations undergo in order to acquire tolerance to antibiotics without the 
need for acquisition of resistance (Fridman et al., 2014). While this may explain those 
cells that either lack labelling or are missing the early labels, once a cell has committed 
to entering exponential phase pauses are likely to be due to transition to persister 
state due to mechanisms associated with that transition rather than a reversion to 
stationary phase. Additionally, cultures were grown for 90 minutes in fresh media prior 
to initiation of labelling. Existing in a dormant state comes at a cost of time available to 
proliferate. Therefore in conditions with a lack of environmental stress remaining in a 
dormant state reduces the number of potential offspring for no apparent advantage 
(Fridman et al., 2014). 
Determination of the presence of pre-existing persisters, or “pre-sisters”, within a mid-
exponential phase culture of S. aureus, which should not be under any environmental 
stress, opens up a new area of investigation. What causes S. aureus to enter into a 
transient dormant state with no environmental stress? Are oscillators actually 
persisters? Despite the original observation of persistence occurring within 
Staphylococci there remains very little within the literature surrounding persistence in 
S. aureus (Verstraeten et al., 2016). First would be to confirm the presence of 
persisters in exponential phase culture by another means, for example using the 
fluorescence dilution method as described by Helaine (Helaine et al., 2010). This 
involves the expression of a plasmid with two fluorescent proteins, one under a 
constitutive promoter and one under an inducible promoter. Following removal of the 
inducer from culture each division dilutes the intensity of the fluorophore under the 
inducible promoter, thereby persisters can be identified by retention of this 
fluorophore (Helaine et al., 2014). Where this method has its advantages over the use 
of FDAAs is in the ability to combine with live-cell microscopy. Should the presence of 
persisters be confirmed it would then be possible to begin to assess their contribution 
to the bacterial population, particularly in survival during antibiotic treatment, as well 






Chapter 6  
General Discussion 
 
6.1 Growth & division in S. aureus 
The cell cycle of S. aureus has the following overall features. First the division plane is 
selected and synthesis of the septum is initiated. Next the septum is completed 
creating two daughter cells still joined together within the mother cell wall. Then the 
daughter cells split apart before the next round of division takes place at an orthogonal 
plane (Figure 6.1). This is however a generalised view of the process and there are 
many questions and models concerning how this process is carried out at the 
molecular level: 
 How are the division planes selected? 
 What is the mechanism of peptidoglycan synthesis? 
 How is the septum divided between the daughter cells? 
 What causes daughter cell separation? 
 Are these processes interlinked? 
 How does the cell grow in between septation events? 
 Selection of division plane 
Since S. aureus divides on 3 orthogonal plans it is not thought that the spatial 
information driving this can be encoded within the DNA therefore there must be some 
other epigenetic feature that drives the selection of division plane (Turner et al., 
2010a).  This is because the factor that specifies division plane must be carried over 
multiple division cycles before their effect is required, yet change on every division. In 
rod shaped organisms localisation of the z-ring and therefore the division septum is 
modified by the Min system which prevents erroneous production of z-rings at cell 
poles (Wu and Errington, 2011). In addition nucleoid occlusion prevents the formation 
of the z-ring prior to chromosome segregation (Wu and Errington, 2011). However, 
apparently spherical bacteria such as S. aureus lack the Min system, therefore, the 








spherical organisms (Wu and Errington, 2011). In S. aureus the Noc protein co-localises 
with the nucleoid and prevents bisection of the chromosome during cell division (Veiga 
et al., 2011). Following chromosome segregation, a space at the S. aureus midcell 
exists where Noc is absent thereby releasing inhibition of z-ring formation. 
Additionally, in S. aureus Noc deletion results in the formation of multiple rings and 
arcs of FtsZ, therefore it was suggested that nucleoid occlusion may coordinate 
localisation of the division plane (Veiga et al., 2011). However, this is not sufficient to 
allow S. aureus to divide on 3 orthogonal planes as a further signal is required either to 
direct the axis of chromosome segregation or define the division plane (Veiga et al., 
2011; Wheeler, 2012). It has been suggested that inherited architectural features of 
peptidoglycan may play a role in this process (Turner et al., 2010a). 
AFM analysis of purified sacculi demonstrated a thick band of peptidoglycan material, 
the “piecrust”, that encircled the septum and was presumably synthesised as the first 
step in septum formation (Figure 6.2 A). On division this structure is divided between 
the 2 daughter cells such that each has a full “rib” of material denoting the division 
plane that has just been used (Figure 6.2 B). Following the second round of division this 
rib is divided in half such that each daughter cell inherits a semicircle rib surrounding 
the old portion of the cell. At the same time daughter cells inherit a second piecrust 
derived full rib. In the third division the semicircle, or half rib, is divided in half to 
produce a quarter rib, the full rib is divided in half to produce a half rib and a new full 
rib is inherited from piecrust material. At the next division (the 4th division) S. aureus 
will divide on the same plane as the first division. This is the plane in which the quarter 
rib material is present. Therefore, it is possible that there is recognition of the quarter 
rib (or rejection of the half and full ribs) to determine the plane of division. There are a 
number of different models for the recognition of the ribs, such that division plane can 
be specified, these include induced membrane curvature which can be recognised by a 
protein recruiter, proximity of peptidoglycan to the membrane thereby being favoured 
by the divisiome, recognition of distinct chemistry that may exist within the rib or the 
pre-existing localisation of proteins or protein anchors to the ribs that may recruit the 






Figure 6.2. Schematic of the piecrust and its subsequent inheritance. (A) 
Representative diagram of placement of piecrust. Diagram of a dividing cell cut in half 
perpendicular to previous division. Following division of the septal plate each daughter 
will inherit a proportion of the piecrust. (B) Schematic of inheritance of piecrust for 3 
divisions. Red indicates the piecrust from the first division, Green indicates piecrust 
from the second division and blue indicates piecrust from the third division. This shows 
how piecrust can be inherited such that each offspring inherits a quarter rib from the 
first division, a half rib from the second division and a full rib from the last division with 
high fidelity.  
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 Peptidoglycan synthesis 
Peptidoglycan synthesis has been thought to occur at the leading edge of the septum 
(Amako and Umeda, 1984; Touhami et al., 2004), however, super-resolution imaging of 
FDAA labelled S. aureus has indicated that synthesis occurs in a zone across the surface 
of the septum (Chapter 4). This is corroborated by EM data (Matias and Beveridge, 
2007), which showed that incomplete septa were flared in thickness towards the 
mother cell wall. Once septation has been initiated the piecrust is synthesised, this 
thick cell wall structure is a time consuming stage (Chapter 5). Following this the 
septum is synthesised in concentric zones of synthesis, where the majority of synthesis 
appears to occur at the leading edge however there is still significant synthesis across 
the rest of septum. Presumably thickening the cell wall such that it is of the correct 
width at cell splitting to withstand the turgor pressure of the cytoplasm (Matias and 
Beveridge, 2007). Only once this has occurred will cell splitting take place, however, 
the mechanisms that may dictate this control are unknown although several models 
have been proposed 
Previous models of S. aureus growth have relied upon the presumption that the 
majority of effective peptidoglycan synthesis in S. aureus occurs at the septum and 
following cell splitting changes in cell shape and volume are due to remodelling of 
septal peptidoglycan. However two recent observations are in opposition to this 
model; Firstly cell volume has been shown to continually increase over several 
generations (Zhou et al., 2015) and secondly the observation of off-septal synthesis 
during FDAA labelling experiments (Chapter 4.2.4)(Monteiro et al., 2015). Concurrently 
with these observations it was also revealed by two separate groups that S. aureus has 
an “elongation phase”, that is S. aureus does not remain as a sphere throughout the 
cell cycle (Monteiro et al., 2015; Zhou et al., 2015). Cells start the cell cycle in a 
spherical shape and become slightly elongated perpendicular to the division plane 
before initiation of septum formation, during septal synthesis cells do not significantly 
elongate however following completion of septal synthesis and prior to cell splitting 
further elongation perpendicular to the division plane occurs (Monteiro et al., 2015). 
 It is possible to speculate that elongation could be mediated by off-septal 
peptidoglycan synthesis. Off-septal synthesis could be associated with repair of the 
mature cell wall or may be productive synthesis in terms of allowing cell volume 
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expansion. Using the FtsZ inhibitor PC190723 I have shown that off-septal synthesis 
can lead to productive growth i.e. peripheral synthesis in PC190723 treated cells leads 
to increased cell diameter. However, whether off-septal synthesis does in fact 
contribute to growth during normal division process is not straight forward. 
Additionally, the presence of productive off-septal synthesis must fit with current 
architectural data. It was suggested that part of the non-essential peptidoglycan 
biosynthetic machinery may produce the off-septal labelling, in particular PBP4 has 
been implicated (Gautam et al., 2015). Using pbp4 mutants I was unable to determine 
a significant reduction in off-septal labelling using either the single amino acid FDAA or 
dipeptide probes. This is contrary to evidence from Monteiro et al. (2015) who showed 
an almost complete loss of peripheral labelling in a COLΔpbpD strain which lacks PBP4. 
My results show that strains lacking PBP4 have a marked reduction in total labelling 
with single amino acid probes such as NADA used within the published study. 
Therefore, it is possible that the reduced signal gave the appearance of removal of off-
septal labelling. This is particularly relevant for SIM imaging since it generally requires 
a high signal:noise ratio compared with diffraction limited microscopy. Whether or not 
a pbp4 mutant strain lacks off-septal labelling, it has been shown to maintain 
elongation suggesting that at least PBP4 is not solely responsible for this process. Off-
septal peptidoglycan synthesis may involve several redundant biosynthetic 
components, combining the mutations in both the monofunctional transglycosylase 
encoding genes and the non-essential PBPs may have an influence on the off-septal 
synthesis and elongation of S. aureus. 
 Splitting of daughter cells 
Separation of daughter cells has long been seen as a “popping” event with very fast 
intermediate stages (Tzagoloff and Novick, 1977), more recently this process has been 
shown to occur on a millisecond timescale (Zhou et al., 2015). This speed suggests that 
separation  of the daughter cells cannot rely entirely on enzymatic action but also on 
mechanical splitting (Zhou et al., 2015). It has been suggested that splitting occurs by 
mechanical crack propagation from a random point of cell wall failure resulting in the 
split daughter cells but with a remaining connection or hinge point opposite the initial 
point of failure (Zhou et al., 2015). Previous models have suggested that cell volume 
doubles at the point of cell splitting (Seligman and Pincus, 1987), however this seems 
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unlikely with a millisecond timescale popping event, and indeed volume increase has 
been shown to increase throughout the cell cycle (Zhou et al., 2015). Immediately 
following splitting the aspect ratio of cells has been shown to decrease as the cells 
round up before it one again increases as cells elongate through the next division cycle 
(Zhou et al., 2015). Neither the role of peptidoglycan synthesis or hydrolysis has yet 
been determined in the shape change of S. aureus. 
 Requirement of peptidoglycan hydrolysis in cell growth 
Growth of the peptidoglycan sacculus cannot be thought of in terms of synthesis 
alone. Bacteria are known to produce a number of peptidoglycan hydrolases with 
redundant functions (Heidrich et al., 2001; Smith et al., 2000). Most bacteria have 
multiple peptidoglycan hydrolases capable of cleaving most bonds within 
peptidoglycan (Vollmer et al., 2008b). Due to this multiplicity of peptidoglycan 
hydrolases there is the potential for a degree of redundancy within the hydrolysis 
system, suggesting an essential role of peptidoglycan hydrolysis in growth of bacteria 
may involve several enzymes (Heidrich et al., 2002). 
During the S. aureus cell cycle the newly synthesised septum was found to be stiffer 
than the surrounding cell wall (Bailey et al., 2014). This implied enzymatic remodelling 
of the septum is responsible for shape change rather than solely expansion through 
stretching of the material. This is because a mechanical expansion only process would 
require the new septum to be soft and stiffen on expansion via stretching (Bailey et al., 
2014). It was found that the major enzymes responsible for this remodelling and 
therefore septum expansion were the peptidoglycan glucosaminidases of which there 
are 4 known in S. aureus (Wheeler et al., 2015). Glucosaminidase activity is required 
for processing glycans into the characteristic short chains with a concomitant 
reduction in cell surface stiffness (Wheeler et al., 2015). Deletion & depletion of 
glucosamindase activity in S. aureus led to the increase in prevalence of hemispherical 
cells, that is cells that have not been able to remodel the septum (Wheeler et al., 2015) 
However peptidoglycan synthesis & selection of division plane can still continue. This 
led to a model where dense, stiff regions of peptidoglycan are formed within the 
septum and as this is hydrolysed it becomes less dense with reduced stiffness allowing 
the expansion of the new septum (Wheeler et al., 2015). In another study similar 
hemispherical cells were seen on the deletion of single peptidoglycan hydrolase Sle1 or 
294 
 
LytM (Monteiro et al., 2015). Sle1 is a N-acetylmuramyl-L-alanine amidase while LytM 
has glyclyglycine endopeptidase activity (Kajimura et al., 2005; Ramadurai et al., 1999). 
This may suggest that these enzymatic activities are also required for expansion of the 
septum. It is therefore possible that a combination of different hydrolase activities is 
required. However whilst glucosaminidase activity is essential for growth both sle1 and 
lytM mutants are viable and the majority of the cell population exhibit a wildtype 
morphology (Monteiro et al., 2015). This raises the question as to how these single 
mutations only dramatically effect a small proportion of the cell population. 
 Inheritance of cell wall material 
Since the determination of an elongation phase and the continual increase in cell 
volume throughout the cell cycle the previous suggestion that following division the 
cell wall consists of 50% old and 50% new peptidoglycan was brought into question 
(Figure 6.3 A) (Seligman and Pincus, 1987; Turner et al., 2010a). In their recent 
publications both Zhou et al. and Monteiro et al. measured the proportion of old vs. 
new peptidoglycan in recently split S. aureus cells and found new cell wall area to 
comprise of 25 – 33% of the total cell wall and that this percentage persists throughout 
the cell cycle (Monteiro et al., 2015; Zhou et al., 2015). However, this would position 
the scars of cell division (ribs) not at the mid cell but off-centre (Figure 6.3 B). Over the 
generations, if division occurs on orthogonal planes, this would result in the cell wall 
being scarred with multiple ribs. This is not seen in AFM images (Turner et al., 2010a). 
If the septal material remains as less than 50%  addition of new material is required or 
else cells would reduce in size on each division, a process incompatible with life (Zhou 
et al., 2015). It has been suggested that this growth occurs from synthesis and/or 
hydrolysis throughout the entire cell wall therefore maintaining the ~33% septal 
peptidoglycan and ~67% old cell wall. This would also propose off-septal synthesis as 
productive synthesis required for the increase in cell size.  
There is another possibility for cell growth such that the newly synthesised septum 
may initially form only ~33% of the daughter cell wall however during the next cell 
cycle this may increase to 50% presumably through hydrolase activity with or without 
off-septal synthesis (Wheeler et al., 2015). This increase could in theory take longer to 




Figure 6.3 Models of cell wall inheritance. (A) 50% new cell wall considering a 
spherical shape throughout cell division. This results in sectoring of peptidoglycan into 
1/2, 1/4, 1/8 etc and place scars & ribs. at the midcell (Turner et al., 2010a). (B) 25% 
new cell wall with elongation perpendicular to division septum resulting in sectors that 




 therefore end up at the midcell as has been seen in AFM and are still a viable 
mechanism for specification of division plane.  
 Model of septum formation in S. aureus 
How S. aureus produces the septum remains an unanswered question. Although it can 
now be proposed that the septum is produced by a gradient of synthesis it still remains 
unclear whether the septum is produced as one or two entities. This may not be 
resolved until we can utilise higher resolution imaging, possibly with the addition of 
live-cell application of such a technology, since many of the subtleties of septum 
formation is thought to occur at length scales below what can currently be resolved. 
While dynamics of peptidoglycan synthesis has been achieved using virtual time-lapse 
labelling (Chapter 5) the use of live cell imaging would allow the dynamics of even 
shorter time periods to be determined and remove any potential labelling artefact 
from the repeated exchange of growth media to permit multi coloured labelling. 
There also remains questions about the cause and control of daughter cell separation 
in the light of the mechanical crack propagation evidence. If we are to believe that cell 
splitting is solely due to a stress fault within the peripheral cell wall at the septum site, 
what is to stop this occurring prior to the completion of septation when the daughter 
cells are in a state where they can withstand turgor pressure. However, control of 
autolysin activity, thought to be linked to cell splitting (such as that of Atl) has to occur 
at locations distant from the finishing septum. 
Models of septum formation and subsequent cell splitting are possible for both 1 and 2 
septal plates. Firstly, the septum can be thought to be synthesised as one and then 
hydrolysed into two halves once complete. This is likely not the case since EM has 
shown incomplete septa consisting of 2 septal plates (Matias and Beveridge, 2007). A 
modification of this is the model proposed by Matias & Beveridge suggesting septa is 
synthesised as one then almost immediately hydrolysed into 2. This would require the 
interaction of hydrolases with the synthesis machinery and tight control such that the 
septum is divided in half so that each daughter cell receives sufficient material and also 
to prevent thinning of the septa through hydrolase activity. Subsequent splitting of 
daughter cells can then occur with control by any of the possible mechanisms 
suggested below. If the septum is produced as 2 separate entities they can exist either 
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with nothing between them or associated by a specific feature, this specific feature 
could act as a checkpoint to prevent initiation of splitting prior to the completion of 
the septation process. 
Splitting of the daughter cells occurs on a millisecond timescale however it must be 
controlled. Therefore, splitting is probably mediated by both mechanical stress and 
hydrolase activity. The initial stage of cell division is the production of the piecrust 
material, following completion of septation this thick band must be split to allow 
separation of the daughter cells, such that each daughter cell receives a rib of piecrust 
material. Due to the localisation of hydrolases such as Atl at the division septum, and 
specifically binding to the piecrust, this splitting is likely due to hydrolase activity (Kent, 
2013). Hydrolase activity may result in the thinning of the peripheral ring (piecrust) in a 
controlled manner to the point where this ring cannot withstand the mechanical force 
causing daughter cell separation (Zhou et al., 2015). At this point the septal plates will 
separate. To ensure this occurs at the appropriate time either hydrolases involved in 
the process are localised to the peripheral ring at the required time or, such as in the 
case of Atl, activated following completion of the septum via an unknown signalling 
pathway. 
I propose a model whereby completion of the septum results in an increase in 
mechanical stress altering the 3D conformation of the hydrolase substrate allowing for 
the digestion of the peripheral ring of peptidoglycan (Figure 6.4). The piecrust is 
synthesised at the division plane and the septal plate is then synthesised. Within this 
model the septum can be synthesised as either one or two but exists as 2 separate 
entities soon after synthesis whether through synthesis or hydrolysis. These septa 
presumably have no structure between them. On completion of the septa the 2 
daughter cells now exert a force upon one another, this mechanical stress can travel 
up the gap between the septa and result in a change to the orientation or stress upon 
the piecrust material where hydrolases are localised (Kent, 2013; Yamada et al., 1996). 
These hydrolases can then be activated by the stressed state of the peptidoglycan, a 
mechanism that has previously been postulated for autolysin activation (Foster and 
Johnstone, 1987; Koch, 1985). At some point the peripheral ring fails at a specific point 
resulting in the “popping” or separation of the daughter cells as described by Zhou et 
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al. (2015). It is unclear whether this occurs at a random point in the peripheral ring or 







Figure 6.4 Model of S. aureus cell division. Division begins by synthesis of the piecrust 
then subsequent synthesis of the septal plate. This is presumed to occur as 2 plates but 
may equally be synthesised as one and hydrolysed into two immediately. Following 
completion of septum, the daughter cells can exert force on each other. This stress is 
transmitted to the piecrust peptidoglycan (green arrow, B) activating hydrolysis of this 
material. Hydrolysis of the piecrust and mechanical force between the daughter cells 
eventually leads to cell splitting. (A) Model of division. (B) Magnified view of area 




rib from a previous division occurs may be stronger or weaker. This may be due to 
different chemistry i.e. the piecrust is devoid of teichoic acids (Kent, 2013) therefore, 
the rib section of the outer cell wall on the division plane will lack teichoic acids while 
the rest of outer cell wall in that plane will contain teichoic acids. 
6.2 Heterogeneity of S. aureus populations 
The discovery of heterogeneous synthesis of the cell wall within a S. aureus population 
has important ramifications for growth and division. Each cell, whilst carrying out the 
same overall cell cycle acts as an individual with potentially a different growth rate 
from its siblings. Also cells have the potential to pause the cell cycle presumably 
occurring due to some signal within an individual cell. This means that analysis of the 
growth cycle requires the use of single cell biology in addition to culture wide 
observations. The signals and checkpoints that control cell cycle progression need to 
be evaluated as such insights into S. aureus growth could be relevant in a clinical 
setting. This is particularly the case for cells that temporarily ceased growth as these 
have the hallmarks of Type II persisters, that is cells that stochastically enter a 
transient stationary phase (Levin-Reisman and Balaban, 2016). However, it still remains 
to be determined whether such cells do indeed persist in an antibiotic environment. If 
this is the case, then my labelling system provides a mechanism to identify potential 
persisters before addition of the antibiotic stress. 
6.3 Future Directions 
 Shape change in S. aureus 
The first important question to answer will be the influence of shape changes during 
the cell cycle. This will involve thorough investigation of the published models along 
with existing data including whole cell AFM of cell growth and both scanning and 
transmission EM. Additionally, it is important to determine whether there are any 
differences in the models of growth dependent upon whether cell wall or membrane 
shape is followed. The role of peptidoglycan synthesis and hydrolysis in this shape 
change must then be determined. Peptidoglycan is either hydrolysed until it reaches a 
maximally hydrolysed state and becomes permanently inert to maintain cell wall 
integrity or the alternative is that hydrolysis of all cell wall material happens all the 
time. This latter hypothesis would not only suggest that the septum may be expanding 
while it is still being synthesised but would also suggest that synthesis of new material 
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in old sectors is required to allow the concomitant hydrolysis while maintaining cell 
wall integrity. It may be possible to determine the role of this hydrolysis by 
determining cell growth and shape change due to the arrest of all synthesis e.g. 
through ᴅ-cycloserine treatment. Following determination of the features and 
mechanisms of shape change throughout the cell cycle it will then be possible to 
investigate the roles of individual division proteins in this process. 
 Future insights into peptidoglycan using microscopy 
Previous studies of the localisation of peptidoglycan synthesis in bacteria have been 
limited by the microscopy resolution available. FDAAs and super-resolution microscopy 
techniques, particularly STORM, allows us to begin to dissect the division process at 
the molecular level. At present this gives us close to the maximum resolution 
achievable with biological samples and florescence microscopy. To further determine 
the mechanism, it would be useful to be able to combine molecular approaches with 
live cell imaging, however the tools with which to carry this out are not currently 
available. Recent work by Stefan Hell & colleagues have developed fluorescent probes 
that have enabled 1 and 2 colour STED images of 40-60 nm resolution. Live cell imaging 
of the division process may allow the dynamics of peptidoglycan synthesis to be 
resolved on time scales not possible with the methods used in my work. 
 Another important aspect is to begin to link peptidoglycan chemistry with 
architecture, for example do certain architectural features, such as the piecrust differ 
in chemical make up? This may begin to be possible with a dual STORM and AFM 
approach (Chacko et al., 2013). However, this technique is still being developed. 
Additionally, a range of probes would need to be developed to label not only the ᴅ-
amino acid side chain at the 4th or 5th position, but also to label glycan strands, 
crossbridges and other features such as modifications etc. 
 Role of S. aureus division proteins 
Growth and division of bacteria involves much more than just the insertion of 
peptidoglycan into the sacculus. A large number of components are required both 
directly in the mechanism and in it regulation. How these proteins interact, are 
controlled, localise within bacteria and effect bacterial growth remains an important 
but unanswered question. While a number of these interactions have already been 
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determined in S. aureus (Figure 6.5) we do not have a complete picture and also do not 
understand what the interactions mean in the context of the whole cell. It is not 
currently understood how hydrolases may interact within the divisome machinery 
although such interactions seem likely. It has recently been suggested that SagB, the 
important glucosaminidase, does not interact with PBP2, MGT or SgtA in S. aureus 
(Chan et al., 2016). However, such interactions may be indirect or may occur with 
other hydrolases. Also hydrolysis of peptidoglycan does not need to occur 
concomitantly with synthesis to permit growth. All 2-hybrid results need to be verified 
independently using as system such as FRET (García-Lara et al., 2015) or 
immunoprecipitation. In addition, these interactions can be further analysed 
biochemically for example through crystal structures. Along with the determination of 
interactions it will be important to elucidate the localisation of these interactions 
within the bacterial cell as well as their outcome e.g. protein activation or repression. 
It is important to note that interactions do not give information as to the stoichiometry 
or dynamics of the proteins. 
To permit determination of the organisation of proteins within the cell it is possible to 
utilise the super-resolution techniques used within my work in conjunction with 
fluorescently tagged proteins. This has been achieved for division proteins using both 
SIM (Monteiro et al., 2015; Strauss et al., 2012) and PALM/STORM (Fu et al., 2010; 
Holden et al., 2014). However, there are a number of obstacles to overcome in order 
to routinely use such techniques. Primarily obstacles have been in finding suitable 
fluorescent proteins that not only express in S. aureus but that work within the 
PALM/STORM system. In addition to the use of fluorescent proteins, SNAP & CLIP tags 
can be used to label proteins with synthetic dyes (Gautier et al., 2008; Keppler et al., 
2003). Synthetic probes have had more success in super-resolution microscopy 
however, are often not cell permeable and cannot access cytoplasmic proteins or 
domains. Due to the increase in resolution gained from super-resolution techniques it 
is also ideal to create single-copy fluorescent fusions. Since many of the proteins of 
interest are essential this has proven challenging. 
How protein interactions and localisations work at a cellular level is also important. By 
analysing the effect of deletion or depletion of proteins within the divisome on both 




Figure 6.5 Interaction map of proteins involved in the division process. (Bottomley, 





dissect the molecular interplay. For example, the role of SagB in both cell wall stiffness 
and glycan chain length was determined using such a regime (Wheeler et al., 2015). In 
particular, the role of the peptidoglycan biosynthetic enzymes and their requirement 
for cell growth will be important. Additionally, the localisation and dynamics of division 
proteins both in relation to one another and to the cell wall dynamics at the molecular 
level is crucial. 
Using an in vitro system it will be possible to determine the roles of the peptidoglycan 
biosynthetic enzymes in isolation from other cell processes. This will allow the role of 
individual constituent parts in the building up of the peptidoglycan sacculus to be 
identified. Recombinant proteins can be reconstituted into liposomes and fed 
substrates. Resulting peptidoglycan material may be investigated both biochemically 
and architecturally. This can reveal the actual substrates for each protein. For example, 
is PBP4 capable of crosslinking lipid II molecules or does it only act on glycan chains of 
a certain length? Information can also be gathered on the molecular interplay and 
control of the process at the molecular level including the stoichiometry of the 
divisome. 
 Effect of antibiotic treatment and resistance 
Finally, S. aureus is a clinically important bacteria and therefore determination of how 
the growth & division system is altered by antibiotics and how resistance mechanisms 
may affect the growth cycle is of interest. How does treatment with different cell wall-
targeting antibiotics effect the peptidoglycan biochemistry including glycan chain 
length and crosslinking? The same questions can also be asked of the effect of 
resistance mechanisms both in the presence and absence of the antibiotic. For 
example, MRSA strains have MecA but both PBP1 & PBP2 are required for high level 
resistance. The effect of MecA on peptidoglycan synthesis from a biochemical, 
architectural and localisation standpoint will determine how it is able to render S. 
aureus so resistant to clinically important antibiotics. It is by an increased 
understanding of peptidoglycan metabolism that new approaches for control of such a 
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Appendix I  - Pattern of FDAA labelling over time  
 
Appendix Figure 1. Incorporation of HADA over time. (A) 5 min. (B) 10 min, (C) 15 min, 




Appendix Figure 2. Incorporation of NADA over time. (A) 5min, (B) 10 min, (C) 15 min, 




Appendix Figure 3. Incorporation of TADA over time. (A) 5min, (B) 10 min, (C) 15 min, 




Appendix Figure 4. Incorporation of dipeptide over time. (A) 5min, (B) 10 min, (C) 15 
min, (D) 20 min, (E) 25 min, (F) 30 min dipeptide labelling. (Scale bar 5 µm).  
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Appendix II  - Fourier transform of SIM images 
 
 
Appendix Figure 5. Fourier Transform of SH1000 labelled with NADA from Figure 3.24 
B. Fourier transforms of slices from the top, middle and bottom of the z stack showing 





Appendix Figure 6. Fourier Transform of SH1000 labelled with TADA from Figure 3.24 
C. Fourier transforms of slices from the top, middle and bottom of the z stack showing 




Appendix Figure 7. Fourier Transform of SH1000 labelled with Alexa Fluor 647 from 
Figure 3.24 D. Fourier transforms of slices from the top, middle and bottom of the z 
stack showing not only periodic features but also lacking in the petal shape suggesting 





Appendix Figure 8. Fourier Transform of SH1000 from Figure 4.1. Fourier transforms 
of slices from the top, middle and bottom of the z stack showing periodic structures. 
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Due to extent of structures in the top and bottom of the full stack a reduced stack was 





Appendix Figure 9. Fourier Transform of SH1000 from Figure 4.18. Fourier transforms 




Appendix Figure 10. Fourier Transform of 4421 (pbp3) from Figure 4.18. Fourier 





Appendix Figure 11. Fourier Transform of 4425 (pbp4) from Figure 4.18. Fourier 






Appendix Figure 12. Fourier Transform of 4424 (pbp3pbp4) from Figure 4.18. Fourier 





Appendix Figure 13. Fourier Transform of dual labelled S. aureus. Labelling for 2 
hours with HADA and 5 minutes with TADA. Example Fourier transform for a field 
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shown in Figure 5.3. Fourier transforms of slices from the top, middle and bottom of 







Appendix Figure 14. Fourier Transform of dual labelled S. aureus from Figure 5.4. 
Labelling for 2 hours with HADA and 2 minutes with TADA. Fourier transforms of slices 





Appendix Figure 15. Fourier transform of triple labelled S. aureus. Cells labelled 
consecutively with HADA, NADA & TADA for 5 minutes. Fourier transforms of slices 
from the top, middle and bottom of the z stack showing periodic structures. Fourier 
transforms shown are representative of images used in Figure 5.5 & Figure 5.6.  
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Appendix III - Stills from movies 1 & 2 
 








Appendix IV - Frequency tables for FtsZ & HADA 
localisations 
 
Appendix Table 1. Frequencies of FtsZ localisation during PC190723 treatment. 
 
Appendix Table 2. Frequencies of HADA localisation (peptidoglycan synthesis) for 
FtsZ-eYFP strains during PC190723 treatment. 
 
Appendix Table 3. Frequencies of HADA localisation (peptidoglycan synthesis) for 
SH1000 during PC190723 treatment. 
Time MidCell Discrete Foci & Arcs Single Foci Whole Cell No Signal Peripheral
No PC190723 100 0 0 0 0 0
5 minutes PC190723 100 0 0 0 0 0
10 minutes PC190723 52.1008403 42.85714286 5.042016807 0 0 0
15 minutes PC190723 6.52173913 85.86956522 1.086956522 2.717391304 2.173913043 1.630434783
20 minutes PC190723 2.43902439 90.24390244 1.829268293 4.268292683 0 0
25 minutes PC190723 1.25786164 92.45283019 1.886792453 4.402515723 0 0
30 minutes PC190723 0 89.05109489 0 5.839416058 0.729927007 0
35 minutes PC190723 0 94.24460432 0 5.755395683 0 0
65 minutes PC190723 0 91.94630872 0 6.711409396 0.67114094 0
95 minutes PC190723 0 40.4109589 0 59.5890411 0 0
125 minutes PC190723 0 15.05376344 0 83.87096774 1.075268817 0
Time Septal Ring Septal Plate Dividing Cells Peripheral Labelling Only No Labelling Cytoplasmic Labelling
No PC190723 38.3116883 59.09090909 1.298701299 0.649350649 0.649350649 0
0-5 minutes PC190723 38.9937107 58.49056604 1.257861635 1.257861635 0 0
5-10 minutes PC190723 38.9937107 58.49056604 1.257861635 1.257861635 0 0
10-15 minutes PC190723 1.08695652 7.065217391 0 87.5 0 4.347826087
15-20 minutes PC190723 0 2.43902439 0.609756098 95.73170732 0 0
20-25 minutes PC190723 0 0.628930818 0 97.48427673 0 0.628930818
25-30 minutes PC190723 0 0 0 100 0 0
30-35 minutes PC190723 0 0 0 95.68345324 0 4.316546763
60-65 minutes PC190723 0 0 0 95.30201342 2.684563758 2.013422819
90-95 minutes PC190723 0 0 0 45.20547945 49.31506849 2.054794521
120-125 minutes PC190723 0 0 0 17.20430108 32.25806452 50.53763441
Time Septal Ring Septal Plate Dividing Cells Peripheral Labelling Only No Labelling Cytoplasmic Labelling
No PC190723 52.3255814 34.88372093 1.162790698 0 0 0
0-5 minutes PC190723 62.5528367 35.51401869 0.46728972 0 0 0
5-10 minutes PC190723 60.0896861 32.73542601 0.896860987 5.829596413 0 0
10-15 minutes PC190723 0 19.13043478 0.434782609 76.08695652 0 2.173913043
15-20 minutes PC190723 0 12.04188482 0.523560209 86.38743455 0 1.047120419
20-25 minutes PC190723 0 0 0 100 0 0
25-30 minutes PC190723 0 0 0 97.88359788 0 2.116402116
30-35 minutes PC190723 0 0 0 100 0 0
60-65 minutes PC190723 0 0 0 85.53459119 1.257861635 13.20754717
90-95 minutes PC190723 0 0.537634409 0 58.06451613 2.150537634 45.16129032
120-125 minutes PC190723 0 0 0 23.91304348 32.60869565 43.47826087
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% of cells 
(n=689) 
Repeat 2 
% of cells 
(n=1159) 
Repeat 3 
% of cells 
(n= 1581) 












































0.72 0.17 0.06 0.23 0.32 0.35 
All 3 
Labels 
77.21 91.03 90.01 87.78 84.42 7.70 










% of cells 
(n=671) 
Repeat 3 
% of cells 
(n=1141) 












































0 0.30 0.46 0.29 0.25 0.23 
All 3 
Labels 
91.88 92.99 86.83 89.73 90.57 3.28 




























































18.60 2.06 2.12 6.21 7.59 9.53 
All 3 
Labels 
66.28 90.97 87.48 83.31 81.58 13.36 











% of cells 
(n= 487) 
Repeat 3 
% of cells 
(n=1421) 












































9.76 9.45 1.69 5.58 6.97 4.57 
All 3 
Labels 
75.98 82.34 91.14 84.26 83.15 7.61 









































































0.23 0.29 6.21 5.58 2.93 3.08 3.26 
All 3 
Labels 
87.78 89.73 83.31 84.26 86.04 86.27 3.00 






Appendix Figure 18. Pie chart of combined quantification of triple labelled cells. 
 
